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Abstract 
Shoulder Complex Motion and Coordination Impairments, and the Associated Clinical 
Factors in Women with a History of Breast Cancer Treatment 
Bryan A. Spinelli 
 
 
 
 
 Common medical management for breast cancer (BC) most often includes 
lumpectomy and radiation (LR) or mastectomy and reconstruction (MR).  Due to these 
procedures involving the shoulder, it is not surprising that some women experience 
shoulder complex motion and coordination problems. However, the long-term effect that 
BC treatments have on shoulder complex motion and coordination during functional 
tasks is not well understood.  The rationale for impaired shoulder complex motion and 
coordination among women with BC is that these women frequently experience 
impairments that are believed to contribute to these problems including soft tissue pain, 
decreased shoulder complex muscle strength, decreased tissue flexibility, altered resting 
scapular alignment (RSA), and lymphedema. However, limited research exists to support 
this notion. Therefore, the aims of this dissertation were 1) determine the effect that 
breast cancer treatments (LR and MR) have on shoulder complex motion and 
coordination, 2) identify clinical factors associated with impaired shoulder complex 
coordination in women with a history of breast cancer treatment.  
 Scapular and humeral kinematic data and clinical measures of pain, RSA, tissue 
flexibility, strength and lymphedema were collected on 30 women with BC (mean age ± 
SD = 53.8 ± 10.9 yrs.) and 30 women without BC (mean age ± SD = 52.7 ± 10.8 yrs.). 
Separate one-way multivariate analysis of variance (MANOVA) were conducted to 
determine whether differences in shoulder complex motion existed between groups (p < 
  
 
xii 
.05). Angle-angle and relative motion graphs were created for 3 scapular and 2 clavicular 
rotations. Mean curves with 95% minimal detectable change bands (MDCB) were 
calculated using data from women without BC. Each woman with BC’s curve was 
individually compared to the mean curve and MDCB. Women with BC were classified as 
having normal (curve fell within MDCB) or impaired shoulder complex coordination 
(curve fell outside MDCB).  Discriminant analyses were used to identify clinical 
variables that could classify women as having normal or impaired shoulder complex 
coordination (p < .05).  
 There were no significant differences in shoulder complex motion between 
women with and without BC or between those with different medical management (LR, 
MR). Over 93% of women with BC demonstrated impaired shoulder complex 
coordination for at least 1 scapular or clavicular rotation. Discriminant analysis revealed 
that clinical measures of pain, RSA, tissue flexibility, strength, and lymphedema were 
associated with impaired shoulder complex coordination.  Cross-validated classification 
showed that 43.4% to 73.3% of women were grouped correctly.  
 Failure to find group differences in motion may be due to the fact that women in 
our study were relatively high functioning and recovered from their medical 
management.  Additionally, the majority of women in our study were previously 
educated on a home exercise program (73.3%) and attended physical therapy (56.7%). A 
lack of significant differences in shoulder complex motion between women with and 
without a BC suggests that the women in our study had sufficient range of motion to 
accomplish the functional tasks. Although we did not find differences in motion between 
women with and without BC across functional tasks, the majority women with BC 
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demonstrated impaired shoulder complex coordination. Clinical measures of tissue 
flexibility (ROM and pectoralis minor length) were associated with impaired shoulder 
complex coordination across multiple scapular and clavicular rotations. 
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CHAPTER 1: DISSERATION PROPOSAL 
 
1A:  SPECIFIC AIMS 
 
Among the 2.6 million women who survive breast cancer in the United States an 
estimated 35% (750,000 women) experience shoulder pain and upper extremity 
functional loss. Restricted shoulder motion has been associated with these problems as 
well as a reduction in health related quality of life (HRQoL).  Although this problem is 
well documented, women continue to experience restricted motion months to years after 
treatment. This problem is potentially because the current understanding of restricted 
shoulder motion is frequently limited to humerothoracic motion with little regard for a 
comprehensive understanding of the effect of breast cancer treatments on the amount and 
coordination of shoulder complex (humerus, scapula, and clavicle) motion. Furthermore, 
the effect that surgical procedures and radiation therapies have on musculoskeletal 
structures of the shoulder complex and whether these effects are associated with impaired 
motion and coordination is poorly understood. These gaps limit the ability of 
rehabilitation specialists to provide optimal care following surgical interventions and 
radiation therapies for women undergoing breast cancer treatment. 
The long-term goal of this research is to reduce shoulder complex impairments, 
associated activity limitations, and participation restrictions amongst breast cancer 
survivors. The objective of the proposed research is to determine the effect that breast 
cancer treatment options have on shoulder complex motion, coordination, and select 
musculoskeletal structures. The central hypothesis is that following breast cancer 
treatment women will demonstrate clinical factors (pain, musculoskeletal impairments, 
and lymphedema) that will be associated with impaired shoulder complex coordination. 
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The rationale for this research is that a better understanding of shoulder complex motion 
and coordination impairments, and the clinical factors associated with these problems 
will lead to improved evidence based examination, intervention, and prevention 
procedures. This in turn may lead to a reduction in the prevalence of shoulder complex 
pain and dysfunction and improved HRQoL amongst breast cancer survivors.     
 
I plan to achieve the objective of this proposal by pursuing the following specific aims: 
 
1. Determine the effect that breast cancer treatments (lumpectomy and radiation, 
and mastectomy with breast reconstruction) have on shoulder complex motion 
and coordination. 
Working hypothesis 1a: Women with a history of surgery and radiation will 
demonstrate greater impairments in shoulder complex motion during functional 
reaching tasks when compared to women with surgery only. 
 
Working hypothesis 1b:  Women with a history of surgery only will demonstrate 
impairments in shoulder complex motion during functional reaching tasks compared 
to women without a history of breast cancer treatment. 
 
Working hypothesis1c: A greater percentage of women with a history of surgery and 
radiation will demonstrate impaired shoulder complex coordination during functional 
reaching tasks compared to women with a history of surgery only. 
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2. Identify clinical factors associated with impaired shoulder complex coordination 
in women with a history of breast cancer treatment. 
Working hypothesis 2:  Pain, decreased shoulder complex muscle strength, decreased 
pectoralis muscle flexibility, altered resting scapular alignment, and upper extremity 
lymphedema will be associated with impaired shoulder complex coordination. 
 
The expected outcome of Specific Aim 1 will be a more thorough understanding of 
the effect that breast cancer treatments have on shoulder complex motion and 
coordination in breast cancer survivors. The expected outcome of Specific Aim 2 will be 
the identification of clinical factors associated with impaired shoulder complex 
coordination. Collectively these findings will provide health care providers with 
advanced understanding of shoulder complex motion and coordination impairments 
following curative treatment regimes. Additionally, knowledge of associated clinical 
factors will lead to development or refinement of clinical examination and intervention 
procedures that ultimately may lead to improvements in function and participation in 
work and leisure activities for this population. 
 
1B: SIGNIFICANCE SUBSECTION 
 Approximately 200, 000 women are diagnosed with breast cancer each year in the 
United States.1 The 5-year survival rate is approximately 90%1, and currently over 2.6 
million breast cancer survivors reside in the United States1. Increased life expectancy 
emphasizes the need to shift focus onto HRQoL after treatment.  
Clinical stage I and II breast cancers account for approximately 60-65% of all 
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breast cancers.2  The National Comprehensive Cancer Network guidelines for the medical 
management of clinical stage I or II breast cancer is lumpectomy with axillary lymph 
node surgery and radiation therapy to the breast, or mastectomy with axillary lymph node 
surgery with or without reconstruction.  These breast cancer treatments involve one or 
more regions of the shoulder, which places women at risk for developing shoulder 
complex impairments. Impaired shoulder motion is an important problem for many breast 
cancer survivors as it has been shown to be associated with activity limitations, 
participation restrictions, and reduced HRQoL.3-8 Impaired shoulder motion has been 
reported to affect up to 67% of breast cancer survivors with reported motion losses 
ranging from 3°- 17° for flexion, 7°- 33° for abduction, 1°- 11° for external rotation, and 
1°- 4° for internal rotation.5,9-12 Although this problem is well documented4-6,8,11-13, the 
majority of investigators have focused on the amount of humeral motion relative to the 
trunk (humerothoracic motion). However, shoulder motion involves motions of the 
scapular, clavicular, and humeral segments. During arm movements, coordinated motion 
of scapular, clavicular, and humeral segments (shoulder complex coordination) are 
important for maintaining alignment of the humeral head and glenoid, and size of the 
subacromial space.14-16 Impaired motion and coordination may lead to excessive stresses 
being placed upon tissues thereby increasing the risk for development of musculoskeletal 
shoulder pathologies (e.g., rotator cuff disease).17 The premise behind breast cancer 
survivors having impaired shoulder complex motion and coordination is based on the 
notion that survivors experience impairments such as pain, decreased shoulder complex 
muscle strength, decreased tissue flexibility, altered resting scapular alignment, and 
lymphedema secondary to the effect breast treatments (surgery and radiation) have on the 
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anatomical structures related to the shoulder complex.12,18-20 The contribution of the 
proposed research is expected to determine whether women after breast cancer treatment 
demonstrate shoulder complex motion and coordination impairments, and identify the 
prominent clinical factors associated with these problems in breast cancer survivors. This 
advancement in knowledge will highlight impairments to be screened for and addressed 
by rehabilitation professionals in order to restore typical shoulder function. Both are 
important steps towards reducing the risk for developing musculoskeletal shoulder 
pathologies, reducing disability, and maximizing HRQoL.  
 
1C:  INNOVATION SUBSECTION 
Many breast cancer survivors experience activity limitations that are dependent 
upon shoulder motion including combing hair, dressing, and reaching overhead.4 In 
previous studies where the segmental contributions of shoulder motion in women with a 
history of breast cancer treatment has been investigated, motion was assessed while 
women performed constrained arm movements. Functional activities that require 
shoulder motion typically are not performed under constrained conditions, and recent 
research has shown that scapular motion differs between constrained and unconstrained 
tasks.21 My proposed research plan is to investigate segmental contributions of shoulder 
motion during functional activities that have been commonly reported to be limited in 
women with a history of breast cancer treatment.   
Additionally, previous investigators analyzed the amount of scapular motion at 
select humeral angles.  This approach does not completely capture shoulder complex 
coordination that is essential for positioning the hand in space to perform various daily 
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and recreational activities. My proposed research is innovative because the analyses used 
in this study will focus on evaluation of continuous patterns of shoulder complex 
coordination. These analyses provide essential information beyond the amount of 
scapular motion, and describe the relationship between multiple segments during arm 
movements. This approach will improve our understanding of shoulder complex 
coordination in women after breast cancer treatment.   
 
1D:  BACKGROUND 
Shoulder motion is essential for positioning the hand in space in order to perform 
many activities of daily living that involve the upper extremity. Impaired shoulder motion 
has been reported to affect up to 67% of breast cancer survivors with reported motion 
losses ranging from 3°- 17° for flexion, 7°- 33° for abduction, 1°- 11° for external 
rotation, and 1°- 4° for internal rotation.5,9-12 Although impaired shoulder motion 
following breast cancer treatment is well documented4-6,8,11-13, breast cancer survivors 
continue to experience motion impairments years after treatment.4,22  This long-term 
complication may be because women failing to discuss their shoulder problems with 
health care providers,8 lack of referrals for women who may benefit from rehabilitation 
services,23 or ineffective screening and rehabilitation interventions because of a poor 
understanding of the mechanisms associated with impaired shoulder motion.   
Additionally, the majority of investigators have focused on traditional measures of 
shoulder motion. These motions represent the range of motion that the humerus moves 
with respect to the trunk (humerothoracic motion). Daily activities require motion of 
multiple bony segments of the shoulder complex including the humerus, scapula and 
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clavicle. The combined motion of glenohumeral, scapulothoracic, acromioclavicular, and 
sternoclavicular joints is necessary for typical shoulder complex motion and function. 
Impaired glenohumeral and scapulothoracic motion have been theorized to be causative 
factors for developing musculoskeletal related shoulder pathologies including 
symptomatic rotator cuff disease. 15 
Symptomatic rotator cuff disease has been suggested to be a significant cause of 
shoulder pain in women following breast cancer treatment and has been reported to be the 
second most common upper limb health condition in woman behind lymphedema.20,24,25 
The12-month post-treatment prevalence of rotator cuff disease has been reported as 
7.1%.20 
The etiology of rotator cuff disease is multi-factorial with proposed mechanistic 
theories suggesting intrinsic and extrinsic factors.  Intrinsic factors refer to degeneration 
within the tendon owing to aging, avascularity, macro-trauma, repetitive micro-trauma, 
and tension overload.26-28 Extrinsic factors refer to mechanical compression of 
subacromial tissues caused by structure(s) outside of the rotator cuff tendon(s)28,29, and 
include impaired shoulder complex motion16. 
During arm motions, the contributions of glenohumeral and scapulothoracic 
motion are believed to influence alignment between the humeral head and glenoid fossa, 
as well as the size of the subacromial space.14-16 Impaired glenohumeral and 
scapulothoracic motion may lead to excessive stresses being placed upon tissues thereby 
increasing the risk for development of symptomatic rotator cuff disease.17 A better 
understanding of these motions may provide evidence to explain why symptomatic 
rotator cuff is a significant problem affecting breast cancer survivors, and highlight 
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impairments to be screened for and addressed by rehabilitation professionals to reduce 
risk for developing symptomatic rotator cuff disease.   
Limited information exists relative to understanding the effects of breast cancer 
treatments on segmental motions of the shoulder complex. Three investigative groups 
have conducted research on scapulothoracic motion in women with a history of breast 
cancer.30-32 Shamley et al.32 compared scapulothoracic motion between the involved and 
uninvolved sides of 152 breast cancer survivors.  Subjects were treated with a variety of 
medical interventions including surgery (breast conserving or mastectomy), radiation (no 
radiation, radiation to chest wall, or radiation to chest wall and axilla), and chemotherapy 
(yes or no). Surgeries were performed, on average, 3.1 years prior to participation in the 
study. Bilateral, three-dimensional scapulothoracic motion was collected during overhead 
scapular plane arm elevation. Impaired scapulothoracic motion was reported on the 
affected side, and the authors noted that the direction of alterations differed based on 
which side was affected.   
Crosbie et al.31 compared scapulothoracic motion between the affected and 
unaffected sides in women with and without a history of breast cancer. Fifty-three women 
who had a unilateral mastectomy at least one year prior to participation in the study were 
age matched with 22 women without a history of breast cancer. Women in both groups 
had no history of upper limb or spine problems, and women in the breast cancer group 
did not have lymphedema. Bilateral three-dimensional scapulothoracic motion was 
collected during seated trials of overhead arm motion in the sagittal, scapular, and frontal 
planes. Although subjects were required to have at least 150° of shoulder flexion motion 
and were instructed to raise their arm overhead as far as they could, the authors only 
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reported scapulothoracic motion up to 90° of humeral elevation. As a group, women with 
breast cancer demonstrated significantly greater scapular upward rotation during scapular 
and frontal plane arm elevation compared to women without breast cancer. Other 
scapulothoracic motion impairments were found; however, the type of motion alteration 
differed based on whether the dominant side or non-dominant side was affected.   
Finally, Borstad and Szucs30 investigated the effect of breast cancer surgery on 
scapulothoracic motion.  Eleven subjects (10 women, 1 male) who were scheduled for 
unilateral breast cancer surgery participated in the study.  All subjects had no shoulder 
pain prior to surgery, or history of previous shoulder surgery.  Scapulothoracic motion 
was collected pre-surgery and 2 months post-surgery during standing trials of scapular 
plane arm elevation.  Post-surgery, subjects demonstrated increased scapular internal 
rotation and increased anterior tilt during arm elevation. 
 While these studies provide preliminary evidence that indicates impaired 
scapulothoracic motion exists in breast cancer survivors, further studies are needed to 
overcome the limitations of these studies and expand our understanding of this problem.  
The primary limitations of these previously mentioned studies include:  measurement of 
scapulothoracic motion during constrained tasks and analysis of scapulothoracic motion 
at select humeral angles.  
Scapulothoracic motions were measured while women raised and lowered their 
arm through a specified plane of motion. Functional activities that require shoulder 
motion are not typically constrained to a specified plane of motion. Recent evidence has 
shown that scapulothoracic motion differs between constrained and unconstrained tasks.21 
Furthermore, in these studies the amount of scapulothoracic motion was analyzed at 
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select humeral angles, which does not completely capture the coordinated motion 
between the scapula or clavicle and humerus (shoulder complex coordination) throughout 
the movement cycle. Daily and recreational activities that involve overhead arm 
movements require continuous shoulder complex coordination. Whether breast cancer 
survivors demonstrate impaired shoulder complex motion or coordination during 
functional tasks has not been investigated.  Determining this is important because many 
breast survivors experience activity limitations that are dependent upon shoulder complex 
motion and coordination.4 
The rationale for impaired shoulder complex motion and coordination among 
breast cancer survivors is that these women frequently experience impairments that are 
believed to contribute to these problems including soft tissue pain, decreased shoulder 
complex muscle strength, decreased tissue flexibility, altered resting scapular alignment, 
and lymphedema.  This is not surprising owing to the affect breast cancer treatments 
(surgery and radiation) have on the anatomical structures of one or more shoulder 
complex regions (pectoral or axillary).  
 The prevalence of shoulder and/or arm pain ranges from 9-68%, and the 
prevalence of breast/scar pain ranges from 15-72% at 6-56 months after surgery.12  
Women experience soft tissue pain after surgery secondary to tissue injury, which may 
result from surgical incisions or muscle injury.33 Pectoralis muscle injury may occur after 
reflection during axillary node dissection or after the pectoralis major is used to create a 
submuscular pouch for tissue expander placement during non-autologous breast 
reconstruction.33   Pain may cause muscle inhibition or lead to compensatory movement 
strategies in order to reduce symptoms during motion. 
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Twenty-two muscles at the shoulder complex contribute to the production of 
motion and coordination. Women may present with muscle performance impairments 
that contribute to impaired shoulder complex motion and coordination such as altered 
muscle activity34, muscle atrophy34,35, and decreased muscle strength10,11,18,36-38 During 
axillary node dissection, structures of the nervous system such as the long thoracic nerve, 
thoracodorsal nerve, and medial and lateral pectoral nerves are located in the surgical 
field.39  Impairment to these nerves may result in atrophy of the innervated muscles and 
lead to muscle performance impairments.35  
The rationale for altered resting scapular alignment contributing to impaired 
shoulder complex motion and coordination is based on the belief that altered resting 
scapular alignment results in structural changes to the musculoskeletal tissues associated 
with the shoulder complex.40 These changes are presumed to affect the active and passive 
forces acting at the shoulder complex resulting in altered shoulder complex motion and 
coordination during arm movements 17,41. Women may demonstrate altered resting 
alignment secondary to protective posturing in order to modulate pain and protect 
surgical sites.42  To the best of our knowledge, only one investigative group has 
compared resting alignment between women with and without a history of breast cancer 
19. In this study, Moire topography was used to perform a photogrammetric assessment of 
resting scapular alignment.  The findings from this study revealed that breast cancer 
survivors demonstrated altered resting alignment of their affected and unaffected 
shoulders when compared to age matched women without breast cancer 19. Visual 
assessment of resting scapular alignment is component of routine shoulder examinations 
performed by rehabilitation professionals who manage musculoskeletal impairments in 
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breast cancer survivors.  However, whether breast cancer survivors demonstrate 
differences in visual resting scapular alignment compared to woman without a history of 
breast cancer is unknown.  
Breast cancer survivors may experience decreased pectoralis major and minor 
muscle flexibility owing to limiting arm motion secondary to pain or fear of 
complications. Pectoralis major and minor muscle flexibility may be further complicated 
by the previously mentioned protective posturing.42  Additionally, radiation therapy has 
been shown to alter collagen synthesis43-45, and cause soft tissue fibrosis affecting the 
flexibility of tissues within the radiation field44-46. Yang et al.20 assessed pectoralis 
flexibility in women at 3 time points following surgery for breast cancer. Decreased 
pectoralis flexibility was defined as the presence of limited passive forward flexion and 
horizontal abduction by more than 10 degrees, with no limited passive external rotation.20   
Prevalence rates for decreased pectoralis flexibility were reported as 8.9%, 12.3%, and 
8.7% at 3, 6, and 12 months respectively.20  However, it was not clear whether the 
definition of decreased pectoralis flexibility using limited passive range of motion was in 
reference to the unaffected side or a normative value.  Whether breast cancer survivors 
demonstrate decreased pectoralis minor flexibility has not been systematically 
determined. The pectoralis minor elongates during arm elevation.47 Although a short 
resting pectoralis minor muscle length has been shown to impair scapulothoracic motion 
48, the relationship between pectoralis minor flexibility and impaired shoulder complex 
motion and coordination has not been investigated in women with a history of breast 
cancer treatment.   
Upper extremity lymphedema has been reported to affect up to 70% of women 
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with a history of breast cancer treatment 49-51.  The risk of women developing 
lymphedema is increased after mastectomy compared to lumpectomy, axillary lymph 
node dissection compared with no axillary dissection, axillary lymph node dissection 
compared to sentinel node biopsy, and radiation therapy.52 Secondary to an abnormal 
accumulation of fluid, upper extremity limb volume and weight on the involved side may 
be increased 42.  An increased limb weight would theoretically place greater demand on 
the shoulder complex muscles, which may in turn impact shoulder complex motion and 
coordination.  
Although women with a history of breast cancer treatment have been shown to 
experience a number of these factors, their association with impaired shoulder complex 
motion and coordination has yet to be supported. Rehabilitation professionals do not 
directly address shoulder complex motion and coordination impairments, but attempt to 
address the mechanisms that are believed to be contributing factors.  A better 
understanding of shoulder complex motion and coordination impairments and the 
underling mechanisms associated with motion and coordination impairments will lead to 
evidence based examination, intervention, and prevention techniques designed to 
maximize functional ability and reduce the risk for developing musculoskeletal related 
shoulder pathologies in women who have been treated for breast cancer. 
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1E:  PRELIMINARY WORK 
Study 1: The Reliability of Measuring Shoulder Complex Motion Patterns and 
Range of Motion and Establishment of Minimal Detectable Change Bands for 
Classifying Movement Patterns 
Nineteen individuals (13 females; 24.5 +/- 3.9 years; 9 dominant side tested) 
without a current episode of shoulder pain participated in a pilot study to investigate the 
reliability of our shoulder complex kinematic measurement procedures and establish 
minimal detectable change bands (MDCB) for classifying movement patterns. The 
LibertyTM (Polhemus, Colchester, Vermont) was used to collect 3D kinematic data from 
the humerus, scapula, and trunk during sagittal and frontal plane arm elevation as well an 
overhead reaching task during 2 testing sessions a week apart.   
 
Study 1a: Repeatability of Scapular and Humeral Segmental Motion Patterns  
Trial to trial and between day repeatability of scapular and humeral motion 
patterns during frontal and sagittal plane arm elevation were determined by calculating 
the coefficient of multiple correlation (CMC).53 Trial to trial and between day CMC 
values for scapular and humeral motion patterns ranged from .82 to .99, and .54 to .98, 
respectively.54 Overall these values indicate moderate to excellent reliability and indicate 
that the measurement of continuous scapular and humeral motion patterns are consistent 
between trials and days.  
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Study 1b: Reliability and Measurement Error of Scapular, Clavicular, and Humeral 
Range of Motion  
 Intra-class correlation coefficients (ICC (3, 3)), standard error of the measurement 
(SEM), and minimal detectable change 95% (MDC95%) values for scapular, clavicular, 
and humeral range of motion were determined from an overhead-reaching task. ICCs (3,3), 
SEMs, MDC95% values for scapular, clavicular, and humeral range of motion can be 
found in Table 1. 0verall these values represent moderate to excellent reliability and 
indicate that these measures are consistent between days.  These results are consistent 
with other investigators who reported the error associated with kinematic 
measurement.55,56   
 
Table 1:  Intraclass correlation coefficient (ICC(3, 3)), standard error of 
measurement (SEM) and minimal detectable change (MDC95%) values for scapular, 
clavicular and humeral range of motion during un-weighted overhead reaching 
Rotation (range of motion) ICC(3, 3) SEM MDC95% 
Scapular Internal Rotation .88 1.6-2.4° 4.3-6.6° 
Scapular Upward Rotation .90 1.5-1.7° 4.2-4.6° 
Scapular Anterior Tilt .91 1.4-1.6° 3.9-4.4° 
Clavicular Elevation .71 1.8-2.1° 5.0-5.7° 
Clavicular Protraction .88 1.8-2.3° 5.1-6.3° 
Glenohumeral Elevation .77 2.1-2.6° 5.7-7.2° 
Glenohumeral Adduction .87 2.6-3.1° 7.4-8.6° 
Glenohumeral Internal Rotation .79 2.7-3.3° 9.1-11.4° 
Humerothoracic Elevation .91 2.7-4.1° 5.6-7.6° 
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Study 1c: Development of Minimal Detectable Change Bands to Assess Shoulder 
Complex Coordination 
Three independent examiners with over five years of clinical experience rated 
scapular motion as typical (normal) or aberrant (subtle or obvious) by viewing 
individuals from behind during five repetitions of bilateral sagittal plane arm elevation as 
described by McClure et al. 2009. Final rating of each individual’s motion was based on 
the majority rating amongst the three examiners. For example if examiner 1 rated 
individual as normal, examiner 2 rated individual as aberrant and examiner 3 rated 
individual as normal, the final rating for the individual would be normal. The LibertyTM 
was then used to collect 3D kinematic data as individuals repeated the elevation task. 
Kinematic data were resampled to 101 data points for each trial using a LabView 
program.  Averaged angle-angle graphs with 95% minimal detectable change bands 
(MDCB95%) were created from data of individuals who were visually rated as having 
typical motion (n = 9).  Averaged angle-angle graphs were created using kinematic data 
from trials 2-4 with humerothoracic elevation on the X-axis and each scapular and 
clavicular rotation on the Y-axis. Intraclass correlation coefficients (ICC (3,3)) were 
calculated for all scapular and clavicular rotations at each of the 101 data points based on 
data collected between days. SEMs were calculated as follows:  SEM = standard 
deviation (1-ICC (3,3)). MDCBs were calculated as follows: MDCB95 = mean +/- 1.96 x 
standard error of the measure (SEM) x √2.  Scapular and clavicular motions from 
individuals (n = 10) who were rated as having visual aberrant motion were compared to 
these angle-angle graphs. All graphs were divided into four phases of the total movement: 
0%-24%, 25%-50%, 51%-75%, and 76%-100%. Individuals were considered to have 
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impaired shoulder complex coordination if a rotation lied outside the MDCB95 for at least 
2 of the 4 phases, or at least 2 rotations fell outside the MDCB95 for at least 1 phase.  
An example of an individual with visually rated as having aberrant scapular 
motion and the differences in shoulder complex coordination compared to individuals 
visually rated as having typical scapular motion is illustrated in Figure 1. The results of 
this work support the use of MDCB95 for detecting impaired shoulder complex 
coordination using kinematic data.57 
 
 
 
Figure 1: Angle-angle graphs. Mean of subjects visually rated as having ideal 
scapular motion (solid black) & +/- minimal detectable change bands (MDCB95) 
(dashed black). Single subject with visually rated as having aberrant scapular 
motion (circle black). 
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Study 2: Shoulder Complex Coordination and Musculoskeletal Impairments in Women 
after Breast Cancer Treatment 
 Five women (mean age +/- SD = 59.6 +/- 7.3 years) with a history of breast 
cancer treatment and 1 woman (56 years of age) without a history of breast cancer 
treatment participated in this pilot study. Descriptive data can be found in Table 2.    
 The primary author who has 11 years of clinical experience performed a series of 
clinical measures typically collected as part of a standard physical therapy examination of 
the shoulder complex. These measures consisted of: self-report of pain during arm 
motion and musculoskeletal assessments of the shoulder complex.  A numeric pain rating 
scale (0 = no pain, 10 = worst imaginable pain) was used to assess pain during arm 
motion.  A universal goniometer was used to measure passive shoulder forward elevation 
and external rotation at 90 degrees abduction range of motion. The PALpation Meter 
(PALM) (Performance Attainment Associates, St. Paul, Minnesota) was used to measure 
resting and elongated pectoralis minor length in order to assess pectoralis minor 
flexibility.  Shoulder forward elevation, external rotation, and internal rotation strength 
was measured using a hand held dynamometer (Lafayette Instrument Company, 
Lafayette, Indiana).  A visual assessment of resting scapular alignment was performed. 
Clinical data can be found in table 3.    
 The LibertyTM (Polhemus, Colchester, Vermont) was used to collect 3D kinematic 
data from the humerus, scapula, and trunk during 5 trials of an overhead reaching task. 
Averaged angle-angle graphs were created using kinematic data from trials 2-4 with 
humerothoracic elevation on the X-axis and each scapular and clavicular rotation on the 
Y-axis. Averaged angle-angle graphs were created from data of the woman without a 
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history of breast cancer with 95% minimal detectable change bands (MDCB95%) 
calculated from study 1c.  Each averaged angle-angle graph of woman with a history of 
breast cancer was individually compared to the angle-angle graphs with MDCB95%of the 
woman without a history of breast cancer. An example of a woman (60 years of age) with 
a history of breast cancer treatment and the differences in coordination of the shoulder 
complex compared to a woman (56 years of age) without a history of breast cancer 
matched by age (+/- 5 years of age) and hand dominance (preferred hand for performing 
tasks) is illustrated in Figure 2.   
 The results of this pilot study demonstrate the feasibility of collecting the 
measures related to the aims of this proposal.  There were no adverse events that occurred 
as a result of testing.   
 
Table 2: Subject descriptive data 
 Age 
(yrs.) 
Side Affected/ 
Tested 
Breast 
Surgery 
Lymph node 
surgery 
Radiation 
BrCa_1 48 D BCS ALND Yes 
BrCa_2 60 D BCS SLNB Yes 
BrCa_3 68 D BCS ALND Yes 
BrCa_4 60 ND BCS SLNB Yes 
BrCa_5 62 ND BCS SLNB Yes 
Control_1 56 ND    
D: dominant side; ND: non-dominant side; BCS: breast conserving surgery; ALND: axillary 
lymph node dissection; SLNB: sentinel lymph node biopsy 
 
  
20 
 
 
Table 3:  Clinical data from the involved sides of women with a history of breast 
cancer (n = 5) and non-dominant side of woman without a history of breast cancer 
(n = 1) 
 Pain 
during 
arm 
motion 
PROM 
Forward 
Elevation 
(°) 
PROM  
ER at 
90° 
ABD 
(°) 
Pectoralis 
minor 
flexibility^ 
Forward 
Elevation 
Force 
(kg) 
IR 
Force 
(kg) 
ER 
Force 
(kg) 
Resting 
Scapular 
Alignment* 
BrCa_1 0/10 154 95 10.3 10.0 7.1 6.4 Typical 
BrCa_2 5/10 138 80 17.8 4.5 4.1 1.8 Obvious 
BrCa_3 6/10 135 68 7.5 3.4 2.7 3.1 Obvious 
BrCa_4 1.5/10 158 75 0.6 9.0 8.6 6.2 Subtle 
BrCa_5 9/10 160 70 9.5 6.2 8.4 8.5 Typical 
Control_1 0/10 170 90 16.2 11.7 10.5 6.6 Typical 
PROM: passive range of motion; ER: external rotation; ABD: abduction; IR: internal 
rotation; 
^ : pectoralis minor flexibility =  ((pectoralis minor elongated length/clavicle length) – 
(pectoralis minor resting length/clavical length))* 100; 
* : rating scale (typical, subtle, obvious) 
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Figure 2: Averaged angle-angle graphs of subject Control_ 1 (woman without a 
history of breast cancer) (solid black), +/- minimal detectable change bands 
(MDCB95%) from previous pilot study (dashed black), and averaged angle-angle 
graphs of subject BrCa_4 (woman with history of breast cancer) (circles black). 
Note the pattern of Brca_4 falls outside the MDCB95% indicating we can be 95% 
confident that the difference in her pattern is beyond our measurement error  
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1F:  RESEARCH DESIGN AND METHODS 
 
a. Research Design  
One study using a cross sectional design will test the two specific aims. 
 
b. Subjects/Participants 
A sample of convenience will be obtained from the greater Philadelphia area 
through the use of flyers, advertisement in local media, and personal contact. Seventy-
five female participants (50 with a history of breast cancer treatment and 25 controls) will 
be recruited.  An equal number of breast cancer survivors treated with lumpectomy and 
radiation (n = 25), and mastectomy with immediate breast reconstruction (n = 25) will be 
recruited.  Inclusion and exclusion criteria can be found in Table 4.   
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Table 4: Study participant inclusion and exclusion criteria. 
 Lumpectomy and 
radiation group 
Mastectomy with 
reconstruction group 
Controls 
Inclusion 
criteria 
Age 30-70 years Age 30-70 years Age 30-70 years 
Unilateral breast 
cancer  
Unilateral breast 
cancer  
 
History of 
lumpectomy  
History of mastectomy 
with immediate breast 
reconstruction  
History of sentinel 
lymph node biopsy or 
axillary lymph node 
dissection  
History of sentinel 
lymph node biopsy or 
axillary lymph node 
dissection  
One to 3 years after 
surgery  
One to 3 years after 
surgery  
 
History of breast 
radiation 
Exclusion 
criteria 
Inability to reach 
overhead 
Inability to reach 
overhead 
Inability to reach 
overhead 
Allergy to adhesive 
materials 
Allergy to adhesive 
materials 
Allergy to adhesive 
materials 
History of 
neuromuscular 
condition (ie CVA, 
cervical myopathy) 
History of 
neuromuscular 
condition (ie CVA, 
cervical myopathy) 
History of 
neuromuscular 
condition (ie CVA, 
cervical myopathy) 
History of shoulder 
musculoskeletal 
condition requiring 
medical intervention 
prior to breast cancer 
diagnosis 
History of shoulder 
musculoskeletal 
condition requiring 
medical intervention 
prior to breast cancer 
diagnosis 
History of shoulder 
musculoskeletal 
condition requiring 
medical intervention 
History of partial 
breast radiation or 
brachytherapy 
History of latissimus 
dorsi flap 
reconstruction 
History of breast 
cancer  
 Surgery within 
previous 3 months (ie 
breast revision, nipple 
reconstruction) 
 
History of radiation 
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We will strive for equal numbers of women across 4 age brackets (30-39 yrs., 40-49 yrs., 
50-59 yrs., 60-70 yrs.) between groups.  This will be achieved by initially delaying 
recruiting control participants.  
 
Sample Size / Power Analysis 
Aim 1a and 1b: 
An a-priori power analysis using GPower 3.1 revealed a total sample size of 67 
subjects would be needed to achieve power equal to 0.80 and alpha equal to 0.05 for 3 
groups with 8 measurements (scapular, clavicular, and humeral range of motion) 
anticipating a 5° difference between groups with a standard deviation of 15° and a 
correlation of 0.40 among variables.  A 5° difference between groups was based on the 
amount needed to exceed our standard error of measurement for range of motion during 
overhead reaching. 
 
Aim 1c and 2: 
Because the proportion of breast cancer survivors with impaired shoulder 
complex coordination and the associated clinical factors are unknown, a-prior power 
analysis was not conducted.  These aims are exploratory and results of these aims could 
be used to power any future studies. 
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Recruitment 
Approximately 10 breast cancer survivors are evaluated for physical therapy 
services per month at Good Shepherd PENN Partners (GSPP).  A meeting will be 
scheduled to present research proposal to therapists at Good Shepherd PENN Partners.  
Therapists at Good Shepherd PENN Partners will inform potential subjects of this study.  
Interested individuals will be issued the contact information for researchers at Drexel 
University, and instructed to contact the researchers at Drexel University. An 
appointment will be scheduled to obtain informed consent and participate in data 
collection. 
A breast cancer surgeon affiliated with Hahnemann Hospital and Drexel 
Medicine, who is a dissertation committee member, currently sees approximately 80 new 
breast cancer cases per year.  This surgeon will be shadowed each week.  Potential 
subjects will be informed of the study.  Interested individuals will be issued the contact 
information for researchers at Drexel University, and instructed to contact the researchers 
at Drexel University. An appointment will be scheduled to obtain informed consent and 
participate in data collection. 
 
c. Clinical Measures and Instrumentation 
Clinical Shoulder Measures 
 A series of clinical measures typically collected as part of a standard physical 
therapy examination of the shoulder complex will be performed. These measures include: 
self-report questionnaires, musculoskeletal assessments, and lymphedema assessment. 
Musculoskeletal assessments and lymphedema assessment will be performed by the 
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primary author who has 11 years of clinical experience. 
 
Self-report questionnaires   
 Subjects will complete a self-report questions relating to pain intensity, shoulder 
pain and disability, fear of physical activity and/or exercise, and health related quality of 
life (Appendix D). 
 
Pain Intensity: Pain at rest and during arm motion will be determined using the 11-point 
Numeric Pain Rating Scale (0 = “no pain”, 10 = “most imaginable pain”).58 
 
Shoulder Pain and Disability: The PENN Shoulder Score is a self-report measure based 
on a 100-point scale that consists of three-subscales: pain, satisfaction, and function.59 
The pain subscale is based on 30 points, where subjects rate their level of pain at rest, 
with normal activities, and with strenuous activities using an 11-point numeric rating 
scale.59 The satisfaction subscale is assessed using an 11-point numeric rating scale, 
where 0 = “non satisfied” and 10 = “very satisfied.”59 The function subscale is based on 
the sum of 20 items, using a 4-point Likert Scale (0 = “can’t do at all”, 1 = “much 
difficulty”, 2 = “with some difficulty”, and 3 = “no difficulty”).59 Lower scores indicate 
greater pain and disability. 59     
 
Fear of Physical Activity: The Fear of Physical Activity/Exercise Scale-Breast Cancer 
(FPAX-B) is a self-report measure based on a 92-point scale that covers 7 constructs: side 
effects/symptoms, overall health, pain/injury, lymphedema, body image, recurrence, lack 
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of knowledge/misinformation.60  It is based on the sum of 23 items, using a 5-point Likert 
Scale (0 = “Not at all”, 1 = “A little bit”, 2 = “Somewhat”, 3 = “Quite a bit”, and 4 = 
“Very much”). 60   Higher scores indicate more fear of physical activity or exercise. 60   
 
Health Related Quality of Life: The Functional Assessment of Cancer Therapy-Breast 
Cancer + 4 (FACT-B+4) is a self-report measure based on a 144-point scale that includes 
the Functional Assessment of Cancer Therapy-General (FACT-G), breast-cancer 
subscale, and arm-subscale.61,62 The FACT-G is a multi-dimensional scale that includes 
the following domains:  physical well-being, social well-being, emotional well-being, and 
functional well-being.61,62  The breast-cancer subscale (9 questions) and arm subscale (5 
questions) relate specifically to women with history of breast cancer treatment.61,62  
Lower scores indicate reduced quality of life.61,62   
 
Musculoskeletal Assessments 
 The primary author who is a physical therapist with 11 years of expertise in 
examination of the shoulder and treatment of breast cancer survivors will perform the 
following tests and measures. 
 
Shoulder Strength: Bilateral isometric shoulder force production will be measured using 
a hand-held dynamometer. The following measures will be obtained:  external rotation 
force at 0 degrees abduction with neutral internal/external rotation, internal rotation force 
at 0 degrees abduction with neutral internal/external rotation, and forward elevation in the 
plane of the scapular at 45 degrees of elevation. For these tests the subject will be seated 
  
28 
in an upright position and the dynamometer will be placed proximal to the wrist at the 
level of the ulnar styloid process for external rotation and internal rotation, and distal 
humerus for forward elevation. For each measurement, a “make test” will be used which 
consists of the examiner holding the dynamometer in the desired testing position and then 
the subject is asked to exert maximal force against the dynamometer for 5 seconds.63,64 
Each measurement will be performed three times. The average of the three trials will be 
used for subsequent analysis.             
 
Shoulder Range of Motion (ROM): Bilateral active and passive shoulder ROM (forward 
elevation, abduction, external rotation at 0 degrees abduction, external rotation at 90 
degrees abduction) will be assessed with a goniometer using standardized patient 
positioning.65 Bilateral active and passive shoulder internal rotation ROM will be 
measured by the vertebral level reached by the thumb as the hand is placed behind the 
back and up the spine as far as possible.63 Each measurement will be performed once. 
 
Pectoralis Minor Resting and Elongated Length: A PALpation Meter (PALM) caliber 
will be used to measure bilateral pectoralis minor resting and elongated length. Pectoralis 
minor resting and elongated length will be defined as the distance from the coracoid 
process to the inferior aspect of the 4th rib just lateral to (1 finger width) the sternal-costal 
junction. For resting length, subjects will stand in their normal relaxed posture while the 
measurement is taken. For elongated length, subjects will fully elevate and retract their 
scapula and hold this position while the measurement is taken. Each measurement will be 
performed twice. The average of the two trials will be used for subsequent analysis. 
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Resting Scapular Alignment: For visual assessments subjects will be asked to wear a 
halter-top. Subjects will stand in their natural, relaxed posture while the examiner 
assesses the resting alignment of each scapula on the thorax from posterior, lateral, 
anterior views. From this procedure the examiner evaluates whether or not: 1) the scapula 
lies flat against the upper back, 2) the vertebral border of the scapula is parallel to the 
thoracic spinous processes 3) the clavicle is either horizontal or elevated by 6-10 degrees 
at the acromial end, and 4) the acromion is forward respect to the center of the thorax 
(Table 5). 
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Table 5: Operational definitions for resting scapular alignment 
 
Normal Mal-alignment 
Scapula lies flat against upper back. Scapula is winging, with either the 
medial border and/or inferior angle 
displaced off the thorax. 
Vertebral borders are parallel to spinous 
processes. 
Medial-lateral difference exists 
between root of the scapular spine 
and inferior angle of the scapula with 
respect to the thoracic spine midline 
(upward or downward rotation). 
From a frontal view, the clavicle is either 
horizontal or elevated by 6-10 degrees at the 
acromial end. 
From a frontal view, the clavicle is 
either depressed or elevated by more 
than 10 degrees at the acromial end. 
From a lateral view, the midpoint of the 
acromion is centered with respect to the 
midline of the thorax. 
From a lateral view, the midpoint of 
the acromion is anterior or posterior 
to the midline of thorax. 
Subtle = mild or questionable mal-alignment   
Obvious = marked or clearly apparent mal-alignment 
 
 
Final Rating:  
 
Normal: All normal ratings or 1 subtle rating  
 
Subtle abnormality: 2 or more subtle ratings 
 
Obvious abnormality: At least 1 obvious rating 
 
 
 
Visual Assessment of Scapular Motion: Subjects will perform a modified version of the 
scapular dyskinesis test.66 The scapular dyskinesis test consists of 5 repetitions of 
bilateral, active shoulder flexion and shoulder abduction. Subjects will be asked to raise 
(3-second count) and lower (3-second count) their arms while keeping their elbows 
straight and thumbs pointed up. Each motion will be demonstrated, and subjects will be 
asked to perform a few practice trials. The Visual Scapular Dyskinesis Test will be 
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conducted during kinematic data collection. Operational definitions and rating scale for 
the scapular dyskinesis test were taken from McClure et al66 (Table 6). 
 
 
Table 6: Operational definitions scapular dyskinesis test 66 
 
 
Normal shoulder 
complex rhythm 
 
The scapula is stable with minimal motion during the initial 30° to 
60° of humerothoracic elevation, then smoothly and continuously 
rotates upward during elevation and smoothly and continuously 
rotates downward during humeral lowering. No evidence of winging 
is present. 
 
Scapular dyskinesis 
 
Either or both of the following motion abnormalities may be present. 
  
Dysrhythmia: The scapula demonstrates premature or excessive 
elevation or protraction, non-smooth or stuttering motion during arm 
elevation or lowering, or rapid downward rotation during arm 
lowering.  
  
Winging: The medial border and/or inferior angle of the scapula are 
posteriorly displaced away from the posterior thorax.  
Rating Scale  
 
Each test movement (flexion and abduction) rated as:  
a) Normal motion: no evidence of abnormality  
 
b) Subtle abnormality: mild or questionable evidence of abnormality, not 
consistently present  
 
c) Obvious abnormality: striking, clearly apparent abnormality, evident on at least 
3/5 trials (dysrhythmias or winging of 1 in (2.54 cm) or greater displacement of 
scapula from thorax)  
 
Final rating is based on combined flexion and abduction test movements.  
 
Normal: Both test motions are rated as normal or 1 motion is rated as normal and 
the other as having subtle abnormality.  
 
Subtle abnormality: Both flexion and abduction are rated as having subtle 
abnormalities.  
 
Obvious abnormality: Either flexion or abduction is rated as having obvious 
abnormality.  
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Shoulder Special Tests: The following special tests for rotator cuff disease will be 
performed on each of the subjects’ shoulders: Neer impingement sign, Hawkins-Kennedy 
test, empty can test, resistive external rotation test, painful arc sign, and external rotation 
lag signs.  Special tests will be recorded as “positive” or “negative” as described in Table 
7.  
      
Table 7: Operational Definitions for Special Tests67-69  
 
Neer impingement 
sign:  
 
Examiner stabilizes the scapula with a downward force while 
passively flexing the humerus overhead maximally with 
overpressure. A positive test is reproduction of pain at the superior or 
superolateral aspect of the shoulder. 
Hawkins-Kennedy:  
 
With the arm and elbow flexed to 90 degrees, examiner passively 
internally rotates humerus maximally with overpressure. A positive 
test is reproduction of pain at the superior or superolateral aspect of 
the shoulder. 
Empty can test:  
 
With the arm elevated 90 degrees in the plane of the scapular and 
internally rotated (thumb pointing towards ground), the examiner 
applies a downward directed force at the wrist while the subject 
attempts to resist. A positive test is weakness or reproduction of pain 
at the superior or superolateral aspect of the shoulder. 
External rotation 
resistance test:  
 
With the arm at the subject’s side and elbow flexed 90 degrees, 
examiner applies an internal rotation force at the wrist while the 
subject attempts to resist. A positive test is weakness or reproduction 
of pain at the superior or superolateral aspect of the shoulder.    
External rotation lag 
signs:  
 
Examiner supports the arm elevated 20 degrees in the plane of the 
scapula with the elbow flexed 90 degrees. Examiner maximally 
externally rotates arm. The subject is asked to maintain the arm in 
maximal external rotation. A positive test is an inability to maintain 
external rotation or a lag of more than 5 degrees into internal 
rotation. The test is repeated with the arm supported in 90 degrees of 
elevation in the scapular plane. 
Painful arc sign:  
 
The subject is asked to actively abduct his/her arm and report any 
pain during the motion. A positive test is superior or superolateral 
shoulder pain reported by the subject between 60 and 120 degrees of 
abduction. 
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Lymphedema Assessment  
 
Lymphedema Assessment of Breast Arm and Torso (LABAT): Each subject will undergo 
an assessment for lymphedema based on the Common Toxicity Criteria version 3.070 
(Table 8).   This involves assessing tissue texture, obscuration of anatomical architecture, 
deviation from normal anatomical contour, obliteration of skin folds, presence of pitting 
or non-pitting edema, Stemmer’s sign, limb volume, and alterations of activities of daily 
living because of symptoms. 
 
Table 8:  Common Toxicity Criteria version 3.070 
Stage Definition70 
Stage 1 5%-10% inter-limb discrepancy in volume or circumference at point 
of greatest visible difference; swelling or obscuration of anatomic 
architecture on close inspection pitting edema 
Stage 2 10-30% inter-limb discrepancy in volume or circumference at point of 
greatest visible difference; readily apparent obscuration of anatomic 
architecture; obliteration of skin folds; readily apparent deviation 
from normal anatomic contour  
Stage 3 30% inter-limb discrepancy in volume; lymphorrhea; gross deviation 
from normal anatomic contour; interfering with ADL 
Stage 4 Progression to malignancy (i.e., lymphangiosarcoma); amputation 
indicated; disabling 
 
 
Upper extremity limb volume: A tape measure will be used to obtain circumferential 
measurements at the MCP joints, palm, wrist (ulnar styloid), and 4 cm intervals from the 
wrist to shoulder. Total limb volume will be obtained by adding the volumes of the 
truncated cones between these points.71 For woman with a history of breast cancer 
treatment, the percent difference between limbs will be calculated by the following 
formula: (limb volume affected-limb volume unaffected)/limb volume unaffected. For 
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women without a history of breast cancer treatment, the percent difference will be 
calculated by (limb volume dominant side-limb volume non-dominant side)/limb volume 
non-dominant. Each circumferential measurement will be performed once.  Each 
woman’s lymphedema status will be graded based on the criteria found in Table 9. 
 
Table 9: Operational Definitions for Lymphedema Grade 
 
 A review of the literature was conducted to determine the reliability and/or 
measurement error of the clinical measures.  The results of this review can be found in 
Table 10. 
 
 
 
 
 
Grade Definition 
0 <5% inter-limb discrepancy in volume; no obscuration of anatomical 
architecture; normal anatomical contour; no pitting or non-pitting edema; 
normal tissue texture; negative Stemmer’s Sign; no obliteration of skin 
folds  
1 <10% inter-limb discrepancy in volume; and obscuration of anatomical 
architecture on close inspection; normal anatomical contour; pitting or 
non-pitting edema with spongy or firm tissue texture 
2 11-20% inter-limb discrepancy in volume; or readily apparent obscuration 
of anatomical architecture; normal anatomical contour; pitting or non-
pitting edema with spongy or firm tissue texture  
3 21-30% inter-limb discrepancy in volume; or readily apparent obscuration 
of anatomical architecture; readily apparent deviation from normal 
anatomical contour; pitting or non-pitting edema with spongy or firm 
tissue texture 
4 >31% inter-limb discrepancy in volume; or or readily apparent obscuration 
of anatomical contour; gross deviation of normal anatomical architecture; 
pitting or non-pitting edema with spongy or firm tissue texture 
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Table 10:  Summary of literature investigating the reliability and measurement 
error associated with clinical shoulder measures. 
Authors Subjects Clinical 
Measure 
ICC SEM MDC (90%) 
Mintken 
et al. 
200958 
101 adults with 
shoulder pain 
who received 
physical 
therapy (mean 
age +/- SD of 
stable patients = 
44.4 +/- 17.4 
years; mean age 
+/- SD of 
improved 
patients = 39.1 
+/- 18.8 years) 
Numeric 
Pain Rating 
Scale 
Test-retest = .74 1.07 points 2.5 points 
Leggin et 
al. 199664 
17 adults (7 
men with mean 
age = 31 +/- 5 
years; 10 
women with 
mean age 30 +/- 
6 years) with no 
known shoulder 
dysfunction 
Shoulder 
Strength 
Intra-rater 
IR=.94- .97 
ER=.89- .95 
Ele=.84-.96 
 
Inter-rater 
IR=.90 
ER=.94 
Ele=.79  
Not reported Not reported 
Leggin et 
al. 200372 
40 adults (22 
men with mean 
age = 42.4 +/- 
11.7 years; 18 
women with 
mean age = 
54.8 +/- 17.1 
years) receiving 
post-operative 
or non-
operative 
rehabilitation 
for a variety of 
shoulder 
conditions 
Shoulder 
Strength 
Interrater 
IR=.91 
ER=.89 
Ele=.93 
IR=2.2kg 
ER=1.4kg 
Ele=1.9kg 
IR=3.1kg 
ER=3.3kg 
Ele=2.7kg 
 
 
ICC = intraclass correlation coefficient; SEM = standard error of measurement; MDC = minimal 
detectable change; ROM = range of motion; ABD = abduction; FE = forward elevation; ER = 
external rotation; IR = internal rotation;  Ele = elevation; V = volume; h = height; C = 
circumference 
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Table 10 (continued):  Summary of literature investigating the reliability and 
measurement error associated with clinical shoulder measures. 
Authors Subjects Clinical 
Measure 
ICC SEM MDC (90%) 
Leggin et 
al. 200372 
 
40 adults (22 
men with mean 
age +/- SD = 
42.4 +/- 11.7 
years; 18 
women with 
mean age +/- 
SD = 54.8 +/- 
17.1 years) 
receiving post-
operative or 
non-operative 
rehabilitation 
for a variety of 
shoulder 
conditions 
Shoulder 
ROM 
Interrater 
FE=.89 
ER at 0°=.89 
ER at 90°=.88 
IR=.86 
FE=12.3° 
ER at 0°=10.3° 
ER at 90°=17.9° 
IR=2 levels 
FE=17.4° 
ER at 0°=14.6° 
ER at 90°=25.3° 
IR=3 levels 
 
 
Leggin et 
al. 200372 
 
40 adults (22 
men with mean 
age +/- SD = 
42.4 +/- 11.7 
years; 18 
women with 
mean age +/- 
SD = 54.8 +/- 
17.1 years) 
receiving post-
operative or 
non-operative 
rehabilitation 
for a variety of 
shoulder 
conditions 
Shoulder 
ROM 
Interrater 
FE=.89 
ER at 0°=.89 
ER at 90°=.88 
IR=.86 
FE=12.3° 
ER at 0°=10.3° 
ER at 90°=17.9° 
IR=2 levels 
FE=17.4° 
ER at 0°=14.6° 
ER at 90°=25.3° 
IR=3 levels 
 
 
Harrington 
et al. 2011 
Pilot data on 
breast cancer 
survivors 
(number of 
subjects was 
not reported) 
Shoulder 
AROM/ 
PROM 
 
Intrarater 
AROM =  
.84-1.0 
 
PROM =  
.97-1.0 
Not reported Not reported 
ICC = intraclass correlation coefficient; SEM = standard error of measurement; MDC = minimal 
detectable change; ROM = range of motion; ABD = abduction; FE = forward elevation; ER = 
external rotation; IR = internal rotation; V = volume; h = height; C = circumference 
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Table 10 (continued):  Summary of literature investigating the reliability and 
measurement error associated with clinical shoulder measures. 
Authors Subjects Clinical Measure ICC SEM MDC (90%) 
Ebaugh 
and 
Oravitz, 
200873 
8 healthy 
subjects (4 
men; mean age 
= 24.1 years) 
Pectoralis Minor 
Length 
(resting and 
elongated) 
 
Intra-rater = 
.98-.99 
 
Inter-rater =  
.86-.95 
Not 
reported 
Intra-rater 
.5 – .8   cm 
 
Inter-rater 
1.4 – 2.2 cm 
Sander et 
al. 200274 
 
50 women with 
primary or 
secondary 
lymphedema 
(mean age +/- 
SD = 56  +/- 
13.3 years) 
Limb volume 
V = Σ (hCi
2/4π) 
 
h = 3, 6, or 9cm 
Intra-rater = .99 
Inter-rater = .99    
h= 3cm: 
120mL 
h= 6cm:  
124 mL 
h= 9cm: 
130mL 
Not reported 
Deltombe 
et al. 
200775 
30 women with 
unilateral 
breast cancer 
related 
lymphedema 
(mean age +/- 
SD = 63 +/- 9 
years) 
Limb volume 
V = Σ (hCi
2/4π) 
 
h = 5cm 
Intra-rater = .99 
Inter-rater = .99    
Not 
reported 
Not reported 
Czerniec 
et al. 
201076 
33 women with 
breast cancer 
related 
lymphedema 
(mean age +/- 
SD = 58.6 +/-
10 years); 
 
18 women 
without history 
of either 
lymphedema or 
breast cancer 
(mean age +/- 
SD = 52.2 +/-7 
years) 
Limb volume 
V=Σ h (Ci
2+Ci2Ci-
1
2 +Ci-12 ) /12π 
 
h = 10 cm 
 
Lymphedema group 
Inter-rater = .98 
 
Control group 
Inter-rater = .98 
 
93mL Not reported 
ICC = intraclass correlation coefficient; SEM = standard error of measurement; MDC = minimal 
detectable change; ROM = range of motion; ABD = abduction; FE = forward elevation; ER = 
external rotation; IR = internal rotation; V = volume; h = height; C = circumference
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 Review of the literature revealed no data supporting the intra or inter-rater 
reliability of visual assessment of resting scapular alignment.  Our lab developed the 
procedures and operational definitions for the resting scapular alignment measure based 
on a review of the literature.  A pilot study was conducted to determine the intra-rater and 
inter-rater reliability of visual assessment of resting scapular alignment and visual 
assessment of scapular motion.  The results of this study revealed that when individuals 
were rated as normal or abnormal visual assessment of resting scapular alignment had 
moderate to substantial agreement within and between raters and visual assessment of 
scapular motion had fair to almost perfect agreement within and between raters.77,78  
Kappa values (95% CI) for intra-rater reliability of resting scapular alignment across 3 
raters ranged from .41 to .64 (.02-1.0).  Kappa value (95% CI) for inter-rater reliability 
(average kappa values between raters) was .67 (.30-0.98).  Kappa values (95% CI) for 
intra-rater reliability of scapular motion across 3 raters ranged from .36 to .93 (.12-1.0).  
Kappa value (95% CI) for inter-rater reliability (average kappa values between raters) 
was .41 (.11-0.86). 
 
Instrumentation 
 Instrumented measures of scapular, clavicular, and humeral motion will be 
collected using an electromagnetic position tracking system (LibertyTM, Polhemus, 
Colchester, Vermont).  
 Continuous kinematic data will be collected on the shoulder complex at a 
sampling frequency of 120Hz per sensor. The validity of electromagnetic tracking 
systems for measuring scapulothoracic motion has been established.55,79 In the proposed 
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study 5 sensors will be placed on the subjects in the following locations: 1) sternum just 
inferior to the sternal notch, 2) left scapula via means of a custom made scapular jig79, 3) 
right scapula via means of a custom made scapular jig79, 4) left humerus by means of a 
humeral cuff80, and 5) right humerus by means of a humeral cuff.80 Adhesive tape, wig 
glue (spirit gum adhesive), and Velcro strips will be used to secure the sternal receiver 
and scapular jigs to the skin and elastic straps will secure the humeral cuff on the distal 
arm.81 While standing in a natural relaxed posture, bony landmarks on the thorax, 
scapula, and humerus will be digitized to create local body reference frames.82   
 
d. Procedures 
Interested women will be contacted, and provided a brief description of the study.  
A telephone screening will be performed in order to determine her eligibility (Appendix 
B). Potential subjects will be scheduled for an appointment at the research laboratory 
where they will again be provided with a brief description of the study. Those subjects 
who are willing to participate will read and sign the informed consent form.  
Descriptive data will be collected including age, hand dominance, side affected, 
time since surgery, type of surgery (mastectomy/lumpectomy, SLNB/ALND), 
chemotherapy (yes/no), chemotherapy drugs, radiation (yes/no), radiation field (breast, 
chest wall, regional lymph nodes), history of physical therapy, home exercise program, 
and current exercise routine (Appendix C).   Subjects will complete questionnaires 
addressing self-report of pain and disability, fear of physical activity/exercise, and health 
related quality of life.   
 A clinical examination will be conducted including active and passive shoulder 
  
40 
ROM, shoulder strength, pectoralis minor length, and resting scapular alignment 
(Appendix D).  A lymphedema assessment according to the Common Toxicity Criteria 
will be performed (Appendix E).  A tape measure will be used to collect the following 
anthropometric measurements: sternum length clavicle length, shoulder height, and arm 
length (Appendix F). Shoulder height will be measured from the anterior aspect of the 
acromion process to the ground 21. The length of each subject’s arm will be measured 
from the anterior aspect of the acromion process to the tip of the middle finger while the 
subject is seated, with the elbow extended at the their side.21  Sternum length and clavicle 
length will be used for pectoralis length normalization.  Shoulder height and arm length 
will be used to standardize shelf height for the reaching task. 
 Following this, kinematic sensors will be attached to the subject as previously 
described.  While standing in a natural relaxed posture, bony landmarks on the thorax, 
scapula, and humerus will be digitized to create local body reference frames.82  
Kinematic data will be collected while the subject performs five repetitions of the 
following tasks: 1) un-weighted shoulder flexion, 2) weighted shoulder flexion, 3) un-
weighted shoulder abduction, 4) weighted shoulder abduction, 5) un-weighted scapular 
plane arm elevation, 6) weighted scapular plane arm elevation, 7) un-weighted overhead 
reaching, 8) weighted overhead reaching, and 9) simulated washing/combing hair. For all 
trials subjects will be instructed to stand in their natural upright position and not move 
their feet as they raise and lower their arms. Each trial of arm raising and lowering will be 
performed within 2-4 seconds and subjects will be allowed to practice until they are 
comfortable performing the motion. A two-minute rest period will be provided between 
tasks to reduce the risk of fatigue. The order in which the tasks will be performed will be 
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randomized. 
For the first 6 tasks subjects will move both arms simultaneously. For the 
overhead reaching tasks subjects will move one arm at a time. The overhead reaching 
tasks require subjects to transfer a small object from in front of them to an overhead shelf 
and back. Shelf height will be normalized using anthropometric data from each subject. 
The bottom shelf will be positioned at a horizontal distance of 60% arm length and height 
of 50% of arm length below shoulder height. The top shelf will be positioned at a 
horizontal distance of 60% arm length, and a height of 50% of arm length above shoulder 
height. For weighted tasks, subjects will lift 0.91 kg (2 lbs.), which is similar to lifting a 
large can of soup (1.2 lbs.) and less than a half gallon of milk (4.3 lbs.). For simulated 
washing/combing hair, subjects will reach to the top of their head.  
 
e. Kinematic Data Reduction 
 Digitized boney landmarks, establishment of local coordinate systems, and 
description of scapular, clavicular, and humeral motions will generally follow the 
recommendations of The International Society of Biomechanics.82 Descriptions of 
scapular motion relative to the thorax (scapulothoracic), humeral motion relative to the 
scapula (glenohumeral), and humeral motion relative to the thoracic (humerothoracic) 
can be found in Appendix A. 
For specific aim 1, working hypothesis “a” and “b”, a LabView linear 
interpolation program will be used to determine the amount of scapulothoracic and 
glenohumeral motion during the raising phase of each of the previously mentioned tasks. 
The mean from trials 2 - 4 will be calculated.   
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For specific aim 1, working hypothesis “c”, a LabView program will be used to 
filter [zero lag, 4th order Butterworth filter (8Hz)] and resample (101 points) kinematic 
data across a common range of humerothoracic elevation that will be performed during 
trials 2 – 4 of the overhead reaching tasks.  
In order to provide insight into shoulder complex coordination, angle-angle 
graphs and relative motion graphs will be created.  Angle-angle graphs will be created for 
all scapular and clavicular rotations by plotting scapular or clavicular motion on the X-
axis and humeral motion on the Y-axis (Figure 3). Data obtained from angle-angle graphs 
will be used to calculate each coupling angle, which is defined as the angle between the 
vector formed between two adjacent data points relative to the right horizontal. 83,84 
Relative motion graphs plot percent of movement on the X-axis and coupling angles on 
the Y-axis (Figure 4).  
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Figure 3: Angle-Angle Plots: Scapular and clavicular angular position on 
“Y” axis and humerothoracic elevation angular position on “X” axis 
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Figure 4: Relative motion plots: scapular and clavicular coupling angle on 
“Y” axis and percent of movement on “X” axis 
  
IR – internal rotation; UR –upward rotation; AT – anterior tilt; CE – 
clavicular elevation; CP – clavicular protraction; GH - glenohumeral 
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f. Data Analysis 
 
Specific Aim 1: Determine the effect that breast cancer treatments (surgery and 
radiation) have on shoulder complex motion and coordination. 
Working hypothesis 1a: Women with a history of surgery and radiation will 
demonstrate greater impairments in shoulder complex motion during functional 
reaching tasks when compared to women with surgery only. 
 
Working hypothesis 1b:  Women with a history of surgery only will demonstrate 
impairments in shoulder complex motion during functional reaching tasks compared 
to women without a history of breast cancer treatment. 
 
 The primary variables of interest are scapular, clavicular, and humeral range of 
motion (scapular internal/external rotation, upward/downward rotation, anterior/posterior 
tilt; clavicular protraction/retraction, elevation/depression; glenohumeral 
adduction/abduction, elevation/depression, internal/external rotation, and humerothoracic 
elevation/depression) during overhead reaching and simulated combing hair. Range of 
motion will be defined as maximum angle minus resting angle.  A one-way multivariate 
analysis of variance (MANOVA) will be conducted to determine whether differences in 
scapular, clavicular, and humeral range of motion exist between groups (surgery and 
radiation, surgery only, and no breast cancer). The involved side in women with breast 
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cancer will be matched by hand dominance with the appropriate side in women without 
breast cancer. 
 
Working hypothesis1c: A greater percentage of women with a history of surgery and 
radiation will demonstrate impaired shoulder complex coordination during functional 
reaching tasks compared to women with a history of surgery only. 
 
 The primary variable of interest is the frequency of women treated with surgery 
and radiation, and surgery only who demonstrate impaired patterns of shoulder complex 
coordination. Angle-angle and relative motion graphs, for each subject with a history of 
breast cancer, will be plotted against comparative profiles derived from women in the 
control group. These comparative profiles will consist of averaged graphs with 95% 
MDCB for all scapular and clavicular angle-angle and relative motion graphs. All graphs 
will be divided into 4 phases of the total movement: 0%-24%, 25%-50%, 51%-75%, and 
76%-100%. Individuals will be considered to have impaired shoulder complex 
coordination when a rotation lies outside the MDCB for at least 2 of the 4 phases, or at 
least 2 rotations fall outside the MDCB for at least 1 phase. The percentage of women 
treated with surgery and radiation, and surgery only who present with impaired patterns 
of shoulder complex coordination will be calculated. Fisher Exact Test will be used to 
determine whether there is a difference in the proportion of women who demonstrate 
impaired coordination in women treated with surgery and radiation, and surgery only. For 
this analysis the involved side of the women with breast cancer will be matched by hand 
dominance with the appropriate side of women without breast cancer. 
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Specific Aim 2: Identify clinical factors associated with impaired shoulder complex 
coordination in women with a history of breast cancer treatment. 
Working hypothesis 2:  Pain, decreased shoulder complex muscle strength, decreased 
pectoralis muscle flexibility, altered resting scapular alignment, and upper extremity 
lymphedema will be associated with impaired shoulder complex coordination. 
  
 Individual variables from the musculoskeletal and lymphedema assessments will 
be tested to determine whether there is a significant difference between women with and 
without impaired coordination by using independent t-tests for continuous variable and 
Mann-Whitney U test for ordinal variables.85  
 A receiver operator characteristic (ROC) curve analysis will be performed on any 
continuous and ordinal variable found to be significant.85 The ROC curve will be used to 
determine a cut off score associated with impaired coordination.85 Sensitivity, specificity, 
positive and negative likelihood ratios with 95% confidence intervals will be calculated 
based on the cutoff score.85   
 Only variables significantly different between women with and without impaired 
coordination (p < 0.10) will be included as potential predictors in the regression model.  
A logistic regression will be used to determine the associations of clinical factors with 
impaired shoulder complex coordination.  
 
g. Potential Problems and Alternate Strategies 
Some individuals may not be able to perform the overhead reaching task at the 
predetermined shelf height secondary to motion restrictions. In this situation the shelf 
will be placed at a height that the individual can reach and this new shelf height will be 
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recorded.  
The activities that the women will participate in are consistent with activities of 
daily living and a standard physical therapy examination of the shoulder complex. 
However, if an individual experiences fatigue or shoulder pain while performing any of 
the required activities they will be provided with increased rest times. Although the 
adhesive material used to attach the sensors to the skin is hypoallergenic and designed for 
skin use, it is possible that minor skin irritation could occur. In the rare case where skin 
irritation occurs the subject will be told to contact their physician if it does not clear 
within 24 hours.  
If difficulty in recruiting occurs, the Cancer Support Community: Philadelphia 
and other community-based organizations will be contacted to request an opportunity to 
present the research proposal and post flyers. An offer will be made to provide education 
to women with a history of breast cancer.  Topics may include benefits of exercise or 
lymphedema risk reduction. 
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1I:  RESOURCES NEEDED TO COMPLETE DISSERTATION 
 
Laboratory: The Neuromuscular Performance Lab is a 412 sq. ft. space located in the 
Rehabilitation Sciences Research Laboratories at Drexel University.   
Equipment: Polhemus Liberty System is an electromagnetic device needed to collect 3-
dimensional kinematic data.  PALM (Palpation Meter) is a caliber needed to collect 
pectoralis minor length data.  Lafayette Manual Muscle Test System is a dynamometer 
needed to collect shoulder strength data. 
Computer: PC with Labview 8.6 located in the Drexel University biomechanics 
laboratory is needed for data collection, processing, and reduction. 
Supplies:  Velcro, double-sided tape, skin pen, alcohol pads, and halter-tops are need for 
kinematic set-up.   A tape measure is needed to measure limb circumferences.  A 
goniometer is needed to measure shoulder range of motion. 
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1J: APPENDICES 
 
Appendix A:  
 
Description of Scapular, Clavicular and Humeral Motions 
 
Scapular and Clavicular Motions 
 
The position and orientation of the scapula relative to thorax (scapulothoracic) will be 
described as 3 scapular and 2 clavicular rotations. Scapular rotations will be described 
using an Euler angle sequence (z, y’, x’’), where scapular internal/external rotation 
occurs about the vertically oriented z-axis, upward/downward rotation occurs about the 
anteriorly oriented y-axis, and anterior/posterior tilt occurs about the laterally oriented x-
axis. Motions of the clavicle with respect to the thorax will not measured directly, but 
will be derived from boney landmarks on the sternum and scapula. These motions consist 
of clavicular elevation/depression (representing scapular superior/inferior translation) and 
clavicular protraction/retraction (representing scapular anterior/posterior translation). 
 
Humeral Motions 
Motions of the humerus relative to the scapula (glenohumeral) will be described as 
glenohumeral elevation, adduction/abduction, and internal/external rotation using y, x’, 
z’’ Cardan angles.  An Euler angle sequence of z, y’, z’’ will be used to describe motions 
of the humerus relative to the thoracic (humerothoracic), which will be defined as 
humerothoracic adduction/abduction, elevation/depression, and internal/external rotation.  
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Appendix B 
Eligibility Screening Examination 
 
 Yes No 
Have you ever been treated for breast cancer? 
(If no, skip to questions A-F for eligibility of women without BrCa) 
 
  
Have you had surgery to remove any lymph nodes (ie sentinel lymph node 
biopsy or axillary lymph node dissection)? 
  
Did you have your entire breast removed (mastectomy), undergo a breast 
reconstruction, and NOT receive radiation 
 
Or 
 
Did you have a portion of your breast removed (lumpectomy) and receive 
radiation to your breast? 
  
Was your surgery more than 1 year ago but less than 3 years ago? 
 
  
Are you between the ages of 30 and 70 years? 
 
  
Can you raise your arms overhead? 
 
  
Did you receive chemotherapy or radiation? (if no, skip to question 10)   
Have you finished your chemotherapy or radiation treatments? 
 
  
Did you finish your chemotherapy or radiation treatments more than 6 
months ago? 
  
Do you have a history of shoulder pain prior to your breast cancer diagnosis 
that required medical intervention? 
  
Do you have a history of any conditions affecting your neck or arms? (ie 
stroke, fracture, dislocation, nerve injury) 
  
Do you have an allergy to adhesive materials? 
 
  
 
Subjects with a history of breast cancer who qualify: 
“Yes” to questions 1-6, 8, 9 
“No” to questions 10-12 
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Subjects without a history of breast cancer who qualify 
“Yes” to questions E and F 
“No” to questions A-D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Yes No 
Have you ever been treated for breast cancer?   
Do you have a history of shoulder pain that required medical treatment?   
Do you have a history of any conditions affecting your neck or arms? (ie 
stroke, fracture, dislocation, nerve injury) 
  
Do you have an allergy to adhesive materials?   
Are you between the ages of 30 and 70 years?   
Can you raise your arms overhead? 
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Appendix C 
Descriptive Data Form 
 
 
 
 
 
Age (years) 
 
 
Hand Dominance 
 
Left              Right                    Ambidextrous  
 
History of breast cancer treatment 
 
No                  Yes 
 
If answer to history of breast cancer treatment is “yes” obtain information below 
 
Side Affected 
 
Left                  Right  
 
Type of Surgery 
 
Lumpectomy                   Mastectomy 
 
Date of Surgery 
 
 
Reconstruction 
 
No                    Yes  (Type:______________) 
 
Type of lymph node surgery 
 
SLND               AND 
 
Number of lymph nodes removed 
 
 
Date of lymph node surgery 
 
 
Radiation 
 
No                    Yes  
 
Location of radiation 
 
Partial Breast         Full breast            
Axilla                    SCF 
 
Type of radiation 
 
External Beam       Brachytherapy     
Other: __________ 
 
Dates of radiation 
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Chemotherapy 
 
No                  Yes  (Type: __________________) 
 
 
Dates of chemotherapy 
 
 
Hormone therapy 
 
No                  Yes  (Type: __________________) 
 
Currently on hormone therapy 
 
No                  Yes  (Type: __________________) 
 
Level of pain at rest (0-10/10) 
 
 
Location 
 
 
Level of pain during arm motion 
(0-10/10) 
 
 
Location 
 
 
History of physical therapy 
 
Yes                  No 
 
Number of visits 
 
  
64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HEP prescribed 
 
Yes                  No 
 
HEP description (type and frequency 
prescribed) 
 
 
What percentage of time did you perform 
your HEP? 
 
0%       25%       50%      75%      100% 
 
Still perform HEP 
 
Yes                  No 
 
Frequency of HEP  
 
 
 
Currently Exercise 
 
Yes                  No 
 
 
Type of exercise 
 
 
 
 
 
Frequency of exercise 
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Appendix D 
 
Clinical Examination Forms and Procedures 
 
Shoulder Range of Motion, Shoulder Strength, Pectoralis Minor Length 
Data Collection Form 
 
 
 
 
 
Shoulder Range of Motion (Degrees) 
 AROM PROM 
Right Left Right Left 
 
FE 
 
 
 
 
 
   
 
Abduction 
 
 
 
 
   
 
ER at 0 
 
 
 
 
   
 
ER at 90 
 
 
 
 
   
 
IR (hand up back) 
 
 
 
 
   
Muscle Strength (kg force) 
 Right Left 
Trial 1 Trial 2 Trial 3 Trial 1 Trial 2 Trial 3 
 
Elevation 
 
 
 
 
     
 
ER 
 
 
 
 
     
 
IR 
 
 
 
 
     
Pectoralis Minor Length (cm) 
 Right Left 
Trial 1 Trial 2 Trial 1 Trial 2 
 
Resting 
 
 
    
 
Elongated 
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Clinical Assessment of Resting Scapular Alignment: Rating Form 
 
 
Left Right 
Normal Abnormal Normal Abnormal 
 
Scapula lies flat against upper back 
 
  
S          O 
  
S          O 
 
Vertebral borders parallel to SPs 
 
   
S          O 
  
S          O 
 
Root of scapular spine at T3-T4  
 
  
S          O 
  
S          O 
 
Clavicle is either horizontal or 
elevated by 6-10 degrees at the 
acromial end.  
  
S          O 
  
S          O 
 
Scapula is forward respect to the 
thorax 
 
  
S          O 
  
S          O 
Final Score 
 
    
S = subtle, questionable presence of mal-alignment   
O = obvious, marked presence of mal-alignment 
 
Remarks: 
Scapula lies flat against upper back:  
 
 
Vertebral borders parallel to SPs:  
 
 
Root of scapular spine at T3-T4 level:  
 
 
Clavicle is either horizontal or elevated 
by 6-10 degrees at the acromial end:  
 
 
 
Scapula is forward respect to thorax:  
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Shoulder Special Tests Data Collection Form 
 
 
  
Right 
 
 
Left 
 
Neers 
 
 
Positive       Negative  
 
Positive       Negative  
 
Hawkins 
 
 
Positive       Negative  
 
Positive       Negative  
 
 
Empty Can 
 
 
Pain: 
 Positive    Negative  
 
Weak:  
Positive    Negative  
 
 
Pain:  
Positive    Negative  
 
Weak:  
Positive  Negative  
 
 
Resistive ER 
 
 
Pain:  
Positive      Negative  
 
Weak:  
Positive    Negative  
 
 
Pain:  
Positive   Negative  
 
Weak:  
Positive  Negative  
 
 
ER lag at 20 
degrees 
 
 
Positive       Negative  
 
Positive       Negative  
 
ER lag at 90 
degrees 
 
 
Positive       Negative  
 
Positive       Negative  
 
Painful arc 
 
 
Positive       Negative  
 
Positive       Negative  
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Clinical Assessment of Scapular Dyskinesis: Rating Form 
 
 
Left Right 
Normal Subtle Obvious Normal Subtle Obvious 
Unweighted Flexion  W     D W     D  W     D W     D 
Unweighted 
Abduction 
 W     D W     D  W     D W     D 
Weighted Flexion  W     D W     D  W     D W     D 
Weighted Abduction  W     D W     D  W     D W     D 
 
Final Score 
 
      
W= winging 
D= dyskinesis 
 
Remarks: 
Un-weighted 
flexion: 
 
 
 
Un-weighted 
abduction: 
 
 
 
Weighted flexion:   
 
 
Weighted abduction:   
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Appendix E:  
Lymphedema Assessments 
 
Circumferential Measurements Data Collection Form 
 
 
 
 
Right 
 
 
Left 
MCPs 
 
  
Palm 
 
  
Wrist 
 
  
4 cm 
 
  
8 cm 
 
  
12 cm 
 
  
16 cm 
 
  
20 cm 
 
  
24 cm 
 
  
28 cm  
 
 
32 cm  
 
 
36 cm  
 
 
40 cm  
 
 
44 cm  
 
 
48 cm  
 
 
52 cm 
 
  
Comments: 
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Appendix F 
Anthropometric Data Collection Form 
  
Right 
 
 
Left 
 
Sternum Length 
 
  
 
Clavicle Length 
 
  
 
Shoulder Height 
 
  
 
Arm Length 
 
  
 
50 % Arm Length 
 
  
 
Bottom Shelf Height 
(Shoulder Height minus 
50% Arm Length) 
 
  
 
Top Shelf Height  
(Shoulder Height plus 
50% Arm Length) 
 
  
 
Horizontal Distance  
(60 percent arm length) 
 
  
 
 
Height (cm) 
 
Weight (kg) 
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CHAPTER 2: GLENOHUMERAL AND SCAPULOTHORACIC MOTION 
DURNING FUNCTIONAL REACHING TASKS IN WOMEN WITH HISTORY 
OF BREAST CANCER AND HEALTHY AGE-MATCHED CONTROLS 
 
ABSTRACT 
Background: Common medical management for breast cancer (BrCa) most often includes 
lumpectomy and radiation (LR) or mastectomy and reconstruction (MR).  Due to these 
procedures involving the shoulder, it is not surprising that some women experience 
shoulder motion problems. However, the long-term effect that BrCa treatments (LR and 
MR) have on glenohumeral (GH) and scapulothoracic (ST) motions during functional 
tasks is not well understood.  
 
Purposes: 1) determine differences in GH and ST motion between women with and 
without a BrCa during functional tasks; 2) determine the effect of different breast cancer 
treatments (LR and MR) on GH and ST motion. 
 
Subjects: 30 women with BrCa (mean age ± SD = 52.7 ± 10.8 yrs.; mean time since 
surgery ± SD = 2.4  ± .9 yrs.; LR n = 20) and 30 women without BrCa (mean age ± SD = 
53.8 ± 10.9 yrs.) 
 
Methods: ST and GH kinematic data were collected using an electromagnetic device 
during 3 functional tasks (un-weighted overhead reaching, weighted overhead reaching, 
hair combing). Separate one-way multivariate analysis of variance (MANOVA) were 
conducted to determine whether differences existed between groups (p < .05). 
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Results: There were no significant differences in GH and ST motion between women 
with and without BrCa or between those with different medical management (LR, MR). 
 
Discussion: Failure to find group differences in motion may be due to the fact that 
women in our study were relatively high functioning and recovered from their medical 
management.  Additionally, the majority of women in our study were previously 
educated on a home exercise program (73.3%) and attended physical therapy (56.7%). 
 
Conclusions: A lack of significant differences in ST and GH range of motion between 
women with and without a BrCa suggests that the women in our study had sufficient 
range of motion to accomplish the functional tasks. 
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INTRODUCTION 
 The lifetime probability for a woman developing breast cancer is 1 in 8.1 
Currently over 200, 000 women are diagnosed with breast cancer each year in the United 
States.2 An estimated 3.1 million women with a history of breast cancer reside in the 
United States, and this number is estimated to rise to 3.9 million by 2024.2 Due to 
improvements in the medical management of breast cancer, the overall 5-year relative 
survival rate has improved from 75% in 1975 to 90% between 2003 and 2009.2 Although 
survival has improved, many woman experience shoulder and arm problems as a result of 
breast cancer treatment.3 Shoulder and arm problems have been shown to be associated 
with activity limitations, participation restrictions, and reduced health related quality in 
women with a history of breast cancer.4,5  
 Treatment for breast cancer includes surgery, radiation, chemotherapy, or 
hormonal therapy. Because of surgery and radiation to anatomical structures involving 
the shoulder, it is not surprising that women experience shoulder and arm problems that 
impact the use of their upper extremity for functional activities.6 Up to 67% of women 
have reported impaired shoulder motion after treatment, including women who undergo 
less extensive surgical procedures such as lumpectomy and sentinel lymph node biopsy 
(SLNB).3,7 Although impaired shoulder motion is a well-documented problem3,7, the 
majority of investigations focused on the amount of shoulder motion (i.e. flexion, 
abduction) represented by motion of the humerus with respect to the trunk 
(humerothoracic motion). However, shoulder motions consist of a complex interaction 
between glenohumeral and scapulothoracic joints. Proper glenohumeral and 
scapulothoracic motion is important for ensuring proper alignment between the humeral 
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head and glenoid fossa, as well as the size of the subacromial space and contact area of 
the humerus with the posterior superior glenoid.8-10  
 Impaired glenohumeral and scapulothoracic motion have been found in 
individuals with shoulder pain and various musculoskeletal pathologies including rotator 
cuff disease.8,9,11-13 Rotator cuff disease is a common shoulder pathology in the general 
population 14, and is thought to be a significant source of shoulder pain in women with a 
history of breast cancer.6,15,16 The etiology of rotator cuff disease is multi-factorial with 
mechanistic theories suggesting intrinsic and extrinsic factors. Intrinsic factors refer to 
changes within the tendon due to aging, avascularity, macrotrauma, repetitive micro-
trauma, and tension overload.17-20 Extrinsic factors refer to mechanical compression of 
the tissues caused by elements outside of the rotator cuff tendon(s).17-20 Impaired 
glenohumeral and scapulothoracic motion are reported extrinsic factors.10,21 
 Investigators have recently shown that women with a history of breast cancer 
demonstrate impaired scapulothoracic motion post-operatively when compared to women 
without a history of breast cancer.22-25 However, two of these three investigative groups 
only included women who had undergone breast cancer surgery at least 12 months 
previously.22-25 Therefore, little is known about the long-term effect that breast cancer 
treatments have on scapulothoracic motion. Additionally, the women included in these 
studies received a broad range of breast cancer treatments (i.e. mastectomy with and 
without radiation; wide local excision with or without radiation to axilla).23-25 Radiation 
therapy has been shown to alter collagen synthesis26-28, and cause soft tissue fibrosis 
affecting the flexibility of tissues within the radiation field contributing to impaired 
motion.27-30 Breast reconstruction is a common breast cancer treatment option for women 
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who undergo mastectomy.2 One investigative group excluded women if they underwent 
breast reconstruction.24,25 It is unclear if women who underwent breast reconstruction in 
the studies were included or not. Finally, scapulothoracic motion was measured as 
women raised and lowered their arms while performing a constrained task (i.e. moving in 
a specified plane of motion such as sagittal, scapular, or frontal).  Overhead functional 
activities typically are not constrained to specific planes of motion31,32, and 
scapulothoracic motion has been shown to differ between constrained tasks and 
functional activities in a healthy population.33 Currently little is known about the impact 
of breast cancer treatments on scapulothoracic motion during functional activities. Thus, 
the first purpose of this study was to determine whether differences in glenohumeral and 
scapulothoracic motion existed between women with and without a history of breast 
cancer during functional tasks. The second purpose of this study was to determine the 
effect that different breast cancer treatments (lumpectomy and radiation, and mastectomy 
with breast reconstruction) have on glenohumeral and scapulothoracic motion during 
functional reaching tasks. We hypothesize that: 1) women with a history of breast cancer 
will demonstrate impairments in GH and ST motion during functional reaching tasks 
compared to women without a history of breast cancer treatment, 2) women with a 
history of lumpectomy and radiation will demonstrate greater impairments in motion 
during functional reaching tasks when compared to women treated with mastectomy and 
reconstruction, and 3) women with a history of mastectomy and reconstruction will 
demonstrate impairments in motion during functional reaching tasks compared to women 
without a history of breast cancer treatment. 
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METHODS 
Subjects 
 Women between the age of 30 and 75 years, with and without a history of breast 
cancer, were recruited from the Greater Philadelphia area through personal contact, 
flyers, media advertisement, local oncologist offices, and local physical therapy clinics, 
to participate in the study that was approved by the university institutional review board 
(See Figure 1 for the flow diagram of subject recruitment and enrollment through 
different phases of the study). All subjects provided informed consent prior to 
participating in the study. Two groups of women with a history of breast cancer were 
recruited. Group 1 consisted of women who underwent mastectomy and immediate breast 
reconstruction (implant or autologous tissue). Women in this group were excluded if they 
had surgery within the previous 3 months (i.e. breast revision, nipple reconstruction), 
radiation, or a latissimus dorsi breast reconstruction.  Women who had latissimus dorsi 
reconstructions were excluded because it is a breast reconstruction option that involves a 
shoulder muscle other than the pectoralis major, which raised concerns that women may 
present with different altered patterns of motion. Group 2 consisted of women with a 
history of breast cancer treatment that included lumpectomy and radiation. Women in 
Group 2 were excluded if they had a history of partial breast radiation or brachytherapy, 
or had radiation within the past 3 months. All women with a history of breast cancer must 
have undergone either sentinel lymph node biopsy (SLNB) or axillary lymph node 
dissection (ALND) and be 1-5 years post-surgery. Any woman in Group 1 or 2 was 
excluded if they had a history of shoulder pain prior to breast cancer treatment that 
required medical attention. Woman without a history of breast cancer were excluded if 
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they had a history of shoulder pain that required them to seek medical care. All women 
who were unable to reach overhead, had an allergy to adhesive material, or had a history 
of any medical condition affecting the arms (i.e. fracture, stroke, cervical myopathy) were 
excluded. We attempted to match women with a history of breast cancer to women 
without a history of breast cancer by age (+/- 5 years) and body mass index (BMI) (+/- 
3).  
 A total of 60 women participated in the study (10 mastectomy and reconstruction, 
20 lumpectomy and radiation, and 30 without history of breast cancer). Descriptive 
statistics and clinical characteristics can be found in Table 1. There were no significant 
differences in age, BMI, race or amount of physical activity per week between groups 
(Table 1). Women with a history of breast cancer reported higher shoulder pain, lower 
satisfaction and decreased function compared to women without a history of breast 
cancer (Table 1).  
 
Instrumentation 
 Continuous kinematic data were collected by an electromagnetic tracking system 
(LibertyTM, Polhemus, Colchester, Vermont) at a sampling frequency of 120Hz per 
sensor. The validity of electromagnetic tracking systems for measuring scapulothoracic 
motion has been established.34,35 Double sided tape, Velcro, and thermoplastic cuffs were 
used to secure sensors to the subjects in the following locations: sternum just inferior to 
the sternal notch; left and right scapula via means of a custom made scapular jig34; and, 
left and right humerus by means of a humeral cuff36.  
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Procedures 
 Descriptive data were collected including age (years), height (cm), weight (kg), 
and hand dominance. All women completed questionnaires addressing self-report of 
shoulder pain and disability (Penn Shoulder Score) and average amount of physical 
activity per week (Paffenbarger Physical Activity Questionnaire). The following clinical 
characteristics were collected on women with a history of breast cancer: side affected, 
time since surgery (days), type of surgery (mastectomy or lumpectomy, SLNB or 
ALND), chemotherapy (yes/no), radiation (yes/no), history of physical therapy (yes/no 
and number of visits), and home exercise program instruction (yes/no and adherence). 
Women with a history of breast cancer also completed two additional questionnaires; fear 
of physical activity/exercise (Fear of Physical Activity/Exercise Scale-Breast Cancer) and 
health related quality of life (Functional Assessment of Cancer therapy-Breast Cancer + 
4).   
 Upon completing the questionnaires kinematic sensors were placed on the 
previously described locations, and bony landmarks on the thorax, scapula, and humerus 
were digitized to create local body reference frames.37,38 Kinematic data were collected as 
women stood in their natural relaxed posture and while performing 5 repetitions of 
unilateral un-weighted overhead reaching, weighted overhead reaching (0.91 kg), and 
simulated hair combing. For all trials, subjects were instructed to stand in their natural 
upright position and perform motions, as they would do on a normal basis. Practice trials 
were allowed to be sure subjects understood the tasks they were asked to perform.  
 Overhead reaching tasks required women to move their hand from a shelf in front 
of them to an overhead shelf and back. Shelf height was normalized using shoulder 
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height and arm length anthropometric data from each woman.33 Shoulder height was 
measured in standing as the distance from the anterior aspect of the acromion process to 
the ground. With the subject seated, arm at their side, and elbow extended, arm length 
was measured as the distance from the anterior aspect of the acromion process to the tip 
of the middle finger.33 The bottom shelf was positioned at a height equal to 50% of arm 
length below shoulder height. The top shelf was positioned at a height equal to 50% of 
arm length above shoulder height. The horizontal distance from the shelf to the subject 
was equal to 60% of the subject’s arm length.  
 
Kinematic Data Reduction 
 Digitized boney landmarks, establishment of local coordinate systems, and 
description of scapulothoracic, glenohumeral, and humerothoracic motion generally 
followed the recommendations of The International Society of Biomechanics.38 The 
position and orientation of the scapula relative to thorax (scapulothoracic) were described 
as 3 scapular and 2 clavicular rotations. Scapular rotations were described using an Euler 
angle sequence (z, y’, x’’), where scapular internal/external rotation occurred about the 
vertically oriented z-axis, upward/downward rotation occurred about the anteriorly 
oriented y-axis, and anterior/posterior tilt occurred about the laterally oriented x-axis. 
Motions of the clavicle with respect to the thorax were not measured directly, but were 
derived from boney landmarks on the sternum and scapula.34,39 These motions consisted 
of clavicular elevation/depression (representing scapular superior/inferior translation) and 
clavicular protraction/retraction (representing scapular anterior/posterior translation).34,39 
Motions of the humerus relative to the scapula (glenohumeral) were described as 
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glenohumeral elevation, adduction/abduction, and internal/external rotation using y, x’, 
z’’ Cardan angles. An Euler angle sequence of z, y’, z’’ was used to describe motions of 
the humerus relative to the thoracic (humerothoracic), which were defined as 
humerothoracic adduction/abduction, elevation/depression, and internal/external rotation. 
After data were collected, a linear interpolation program was used to obtain 
scapulothoracic and glenohumeral data at 5° increments of humerothoracic elevation. 
 
Variables 
Range of motion 
 Resting scapulothoracic (ST) and glenohumeral (GH) positions were determined 
from kinematic data while women stood in their naturally relaxed posture. The common 
maximum humerothoracic elevation angle amongst subjects across tasks was 85°. The 
amount of ST and GH motion at rest was subtracted from the amount of ST and GH 
motion at 85° humerothoracic elevation, and the resultant value was defined as ST and 
GH range of motion. The mean ST and GH range of motion from trials 2-4 of each task 
was used for subsequent analysis. 
 
Data Analysis  
 Statistical analyses were performed using SPSS Version 23 (IBM Corporation, 
Armonk, NY). Separate one-way multivariate analysis of variance (MANOVA) were 
conducted to determine if differences in ST and GH range of motion existed between 
women with and without a history of breast cancer during overhead reaching and 
combing hair tasks. Significance levels were set at .05. 
  
83 
 In order to determine the effect that different breast cancer treatments 
(lumpectomy and radiation, and mastectomy with breast reconstruction) have on ST and 
GH motion, separate one-way multivariate analysis of variance (MANOVA) were 
conducted to determine whether differences existed between the two groups of women 
with history of breast cancer and women without history of breast cancer for the overhead 
reaching and combing hair tasks. Significance levels were set at .05. Because of the 
unequal number of women treated with mastectomy/reconstruction (n = 10), 
lumpectomy/radiation (n = 20), and women without a history of breast cancer (n = 30), 
we performed the statistical analyses using data from an equal number of women within 
each group (10 per group). Subjects in the lumpectomy/ radiation and control group were 
selected to ensure that comparison was made within the same age range (30-50 years or 
50+ years) and BMI category (normal, overweight, obese).  The involved side in women 
with a history of breast cancer was matched by hand dominance with the appropriate side 
in women without a history of breast cancer. Descriptive statistics and clinical 
characteristics for these women can be found in Table 2. 
 
RESULTS 
 Mean and standard deviations for ST and GH range of motion variables 
comparing women with and without a history of breast cancer can be found in Table 3. 
Results of the multivariate analysis of variance revealed no significant differences in ST 
or GH range of motion between women with (n = 30) and without (n = 30) a history of 
breast cancer (Table 4).  
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 Mean and standard deviations for ST and GH range of motion variables 
comparing women treated with mastectomy/reconstruction, lumpectomy/radiation, and 
women without a history of breast cancer can be found in Table 5 and 6. Results of the 
multivariate analysis of variance revealed no significant differences in ST or GH range of 
motion between women treated with mastectomy/reconstruction (n = 10), 
lumpectomy/radiation (n = 10), and women without a history of breast cancer (n = 10) 
(Table 7). 
  
DISCUSSION 
 Women with and without history of breast demonstrated similar amounts of 
movement during overhead and hair combing tasks. On average, the scapula upwardly 
rotated and posteriorly tilted while the clavicle elevated and retracted (Table 3). Minimal 
scapular internal/external rotation occurred (Table 3). With respect to GH motion, the 
humerus elevated, abducted, and externally rotated respect to the scapula during the 
functional tasks performed in this study (Table 3). These movement patterns are 
consistent with previously published studies that reported the contributions of GH and ST 
motion during similar functional tasks in healthy individuals.32,33,40     
 Findings from our study did not reveal differences in ST and GH motion between 
women with or without history of breast cancer or women who underwent 
lumpectomy/radiation, women who had mastectomy/reconstruction, and women without 
a history of breast cancer. Although our results are in line with those reported by 
Harrington et al. 201141, our findings are not consistent with the majority of other studies 
that have investigated ST motion in women with history of breast cancer.22-25 These 
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differences may be due, in part, to different study methodologies. We elected to 
investigate ST motion during functional tasks while previous studies22-25 investigated ST 
motion during constrained tasks. Constraining tasks to a specific plane of humeral 
elevation reduces the variability of motion between subjects. In our study, the average 
plane of elevation at our common maximal humerothoracic elevation angle (85°) was 
45.6 ± 12.3°, 42.9 ± 12.5°, and 49.0° ± 12.9° during un-weighted reaching, weighted 
reaching, and hair combing tasks respectively. Differences in ST motion have been 
reported between planes of humeral elevation35, and variability in elevation plane 
suggests similar motions were not being performed between subjects. Additionally, our 
subjects, on average, raised their arms slightly anterior to the scapular plane. Previous 
studies found differences in ST motion during humeral elevation in the coronal and 
scapular plane22-25,41; however no differences in ST motion have been found during 
humeral elevation performed in the sagittal plane23, which is anterior to scapular plane 
motion. 
  Conflicting results between our study and other studies may also be due to 
differences in how ST motion was defined. We elected to investigate ST range of motion, 
which we defined as scapular position at a common maximum humerothoracic elevation 
angle minus resting scapular position. This approach focuses on the movement of a 
subject’ s scapula rather than posture (absolute position).42 Borstad and Szucs 201122 
analyzed ST motion at select humerothoracic angles (30°, 60°, 90°, and 120°) without 
subtracting resting values. Crosbie et al. 201023 defined ST motion by subtracting resting 
position from ST position at various positions of humeral elevation  (0°, 30°, 60°, and 90° 
with respect to the global coordinate), while we analyzed ST motion at 85° of humeral 
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elevation with respect to the thorax. We analyzed ST at motion at a humeral elevation 
angle respect to the trunk because thoracic motion was not constrained in our study and 
the amount of scapular motion that occurs during overhead reaching is dependent on the 
amount of humeral elevation respect to the trunk subjects perform.31,35,39 Finally, 
Shamley et al. 2009 and 201424,25 analyzed data that were calculated by subtracting ST 
position of the unaffected side from the affected side.  This approach may be limited by 
some women with a history of breast cancer demonstrating impaired shoulder range of 
motion on the unaffected side after surgery and radiation.43 
 Three of five previous studies on ST motion in women with a history of breast 
cancer included women who were either 2, 6, or 12 months post-surgery.22,23,41 Women in 
our study were 1-5 years post-surgery (mean time since surgery: 2.4 ± .9 yrs.). Studies 
have shown that the prevalence of impaired shoulder motion decreases with time.3,44 In 
two studies, by the same investigative group that included women who were more than 
12 months post-surgery, women who underwent mastectomy may have also received 
radiotherapy to their axilla.24,25 This cohort was not included in our study because we 
chose to include two current, most common treatment options (lumpectomy and radiation 
or mastectomy and reconstruction) for stage I and II breast cancers, which account for the 
majority of breast cancers.1,45 Collectively, our subjects were further out from surgery 
and received less extensive breast cancer treatment than subjects in the majority of other 
studies.3,22-25,41 This suggests that the probability of women experiencing shoulder motion 
problems was lower in our study.  
 Failure to find group differences in motion may also be because of the fact that 
women in our study were relatively high functioning (Table 1). Review of the responses 
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on the Penn Shoulder Score revealed that items that were similar to the tasks women 
performed in our study showed only 6 out of 30 women with a history of breast cancer 
reported at least “some difficulty” related to combing hair (item 5). Seven out of 30 
women with history of breast cancer reported at least “some difficulty” with reaching a 
shelf above head (item 14), and 8 out of 30 reported at least “some difficulty” with 
placing a soup can (1-2 lb.) on a shelf overhead (item 15). Not a single woman treated 
with mastectomy and reconstruction reported difficulty with combing hair, reaching a 
shelf, or placing a soup can overhead. Additionally, only 46.7% of women with history of 
breast cancer reported experiencing shoulder pain with the average pain level being 26.1 
± 5.8 (30 indicates no pain) as measured by the Penn Shoulder Score-Pain Subscale. 
Women experiencing low shoulder pain and disability in our study may be due to the fact 
that 73.3% reported being educated on a home exercise program, which women reported 
being approximately 65.9% adherent to, and 56.7% reported attending physical therapy 
for an average of 7.5 visits. Home exercise program education and performance may also 
have contributed to the lack of motion differences between these groups. This point needs 
to be systematically examined in prospective studies. 
 Lack of significant differences between women with and without history of breast 
cancer and women treated with mastectomy/reconstruction, lumpectomy/radiation, and 
women without a history of breast cancer may also be secondary to our small sample size 
and low statistical power (power < .49 for two group comparison and power < .39 for 
three group comparison). An a-priori power analysis (GPower 3.1) revealed that a total 
sample size of 67 subjects was needed to achieve power equal to .80, alpha of .05, for 3 
groups with 8 measurements anticipating a 5° difference between groups with a standard 
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deviation of 15° and a correlation of .40 among variables. It should be noted that effect 
sizes associated with group differences in our study were small with the largest being for 
clavicular elevation during hair combing (partial eta squared = 0.10).  Additionally, the 
largest group mean difference for ST and GH motion was 3.8° of posterior tilt during 
weighted overhead reaching and 8.2° of GH adduction during un-weighted overhead 
reaching (Table 5), respectively. Even if enough subjects were recruited to achieve power 
of .80, these differences in ST and GH motion have questionable meaningfulness as they 
fail to exceed minimal detectable change 95% (MDC95%) values previously established in 
our lab (MDC95% for ST posterior and GH adduction 4.4° and 8.6°, respectively). 
 Although we did not find group differences in the total amount of ST or GH 
motion during the overhead activities, we did notice, on several occasions, that the 
manner in which women with a history of breast cancer performed the overhead 
movements looked different from how women without a history of breast cancer 
performed the movements. Women with history of breast cancer appeared to have 
excessive scapular motion and/or lack of smooth scapular and humeral motion, which 
suggests that women with history of breast cancer may have impaired movement 
coordination between the scapula and humerus (scapulohumeral coordination). Other 
statistical approaches such as continuous motion angle-angle and coupling angle-
movement cycle graphs with predication bands may prove to be useful for better 
understanding the effect of breast cancer treatments on scapulohumeral coordination.42   
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CONCLUSION 
Although impaired shoulder motion is well documented in earlier stages of recovery (up 
to 12 months) in women who have been treated for breast cancer3, we did not find 
differences in ST and GH range of motion between women with (over 12 months post 
op) and without a history of breast cancer during the performance of three overhead 
functional reaching tasks. This suggests that the women in our study who were treated for 
breast cancer had sufficient range of motion to accomplish the functional tasks performed 
in our study. Further research is needed to determine whether these women demonstrate 
impaired ST and GH motion during more demanding tasks such as heavy lifting or 
repetitive reaching. Additionally, the impact of breast cancer treatment on 
scapulohumeral coordination is not well understood and warrants further investigation.  
  
90 
FIGURES AND TABLES 
 
 
Figure 1: Flow diagram of subject recruitment and enrollment through different phases of the study
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Table 1: Descriptive statistics for all subjects (n = 60) 
 
  
BrCa 
(n = 30) 
 
Controls 
(n =30) 
 
p values 
Age (years) 
   Mean ± SD 
 
53.8 ± 10.9 
 
52.7 ± 10.8 
 
ns 
BMI (kg/m2) 
   Mean ± SD 
 
28.3 ± 6.1 
 
29.1 ± 6.0 
 
ns 
Race (n) 
   Caucasian 
   African-American 
   Asian 
 
18 
10 
2 
 
16 
14 
0 
 
ns 
Penn Shoulder Score 
   Pain Subscale 
   Satisfaction Subscale 
   Function Subscale 
   Total Score 
 
26.1 ± 5.8 
7.9 ± 2.9 
51.2 ± 11.7 
85.3 ± 19.5 
 
29.7 ± .9 
9.2 ± 1.4 
57.5 ± 4.4 
96.4 ± 5.4 
 
p < .05 
p < .05 
p < .05 
p < .05 
Paffenbarger Physical Activity 
Questionnaire (kcal/wk) 
 
1596 ± 943 
 
1913 ± 1562 
 
ns 
Type of breast cancer treatment (n) 
   Lumpectomy/radiation 
   Mastectomy/reconstruction 
 
20 
10 
 
Type of lymph node surgery (n) 
   SLNB 
   ALND 
 
25 
5 
Side affected (n)                
Dominant side 
   Non-dominant side 
 
17 
13 
Time since surgery (days) 
   Mean ± SD  
 
893 ± 325 
Chemotherapy (n) 
   Yes 
   No 
 
12 
18 
FPAX-B 
   Mean ± SD 
 
9.7 ± 11.1 
FACT-B + 4 
   Mean ± SD 
 
122.6 ± 22.0 
Educated on HEP (n) 
   Yes 
   No 
 
22 
8 
 
Attended physical therapy (n) 
   Yes 
   No 
 
17 
13 
 
BrCa: women with history of breast cancer treatment 
ns: no significant difference between groups 
FPAX-B: Fear of Physical Activity/Exercise Scale-Breast Cancer 
FACT-B+4: Functional Assessment of Cancer therapy-Breast Cancer + 4 
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Table 2: Descriptive statistics for subjects (n= 30) matched by age and body mass index  
 
  
Controls 
(n =10) 
 
LR 
(n =10) 
 
MR 
(n =10) 
 
p values 
Age (years) 
      Mean ± SD 
 
50.5 ± 12.4 
 
52.1 ± 6.2 
 
49.6 ± 13.9 
 
ns 
BMI (kg/m2) 
     Mean ± SD 
 
26.5 ± 5.2 
 
26.9 ± 6.3 
 
26.1 ± 6.7 
 
ns 
Penn Shoulder Score 
Pain Subscale 
Satisfaction Subscale 
Function Subscale 
Total Score 
 
30 ± 0 
9.7 ± .9 
58.8 ± 3.5 
98.5 ± 4.4 
 
25.5 ± 6.3 
7.3 ± 3.6 
49.1 ± 11.5 
81.9 ± 20.4 
 
28.9 ± 1.7 
9.2 ± 1.2 
57.3 ± 2.4 
95.4 ± 4.4 
 
p < .05# 
ns 
p < .05#, * 
p < .05# 
Paffenbarger Physical 
Activity Questionnaire 
(kcal/wk) 
 
1826 ± 
1911 
 
1316 ± 610 
 
2064 ± 433 
 
ns 
Time since surgery (days) 
     Mean ± SD  
  
931 ± 380 
 
806 ± 310 
 
ns 
FPAX-B 
     Mean ± SD 
  
9.7 ± 11.9 
 
7.6 ± 7.5 
 
ns 
FACT-B + 4 
     Mean ± SD 
  
124.7 ± 
24.4 
 
127.1 ± 
24.4 
 
ns 
LR:  lumpectomy/radiation; MR: mastectomy/reconstruction 
ns: no significant difference between groups 
#: significant difference between controls and lumpectomy/radiation group  
*: significant difference between lumpectomy/radiation group and mastectomy/reconstruction group 
FPAX-B: Fear of Physical Activity/Exercise Scale-Breast Cancer 
FACT-B+4: Functional Assessment of Cancer therapy-Breast Cancer + 4 
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Table 3: Scapulothoracic and glenohumeral motion (degrees) during un-weighted reaching, weighted reaching, and hair combing tasks for all subjects grouped 
by controls, women with history of breast cancer, and all subjects combined 
 
 Un-weighted Reaching 
Mean (SD) 
Weighted Reaching 
Mean (SD) 
Hair Combing 
Mean (SD) 
Controls 
(n = 30) 
BrCa 
(n = 30) 
Total 
(n = 60) 
Controls 
(n = 30) 
BrCa 
(n = 29) 
Total 
(n = 60) 
Controls 
(n = 30) 
BrCa 
(n = 30) 
Total 
(n = 60) 
 
 
 
 
 
ST 
IR/ER* 1.5 -0.6 0.4 0.9 -0.8 0.1 0.4 -0.6 -0.1 
 (4.5) (5.6) (5.2) (4.4) (5.7) (5.1) (4.5) (4.9) (4.7) 
UR 18.5 16.4 17.4 20.0 18.4 19.2 17.4 15.8 16.6 
 (5.3) (3.7) (4.6) (5.6) (3.7) (4.8) (5.4) (4.5) (5.0) 
PT 9.0 8.0 8.5 9.5 8.0 8.7 8.0 7.0 7.5 
 (5.8) (5.9) (5.8) (6.2) (5.9) (6.1) (5.1) (4.8) (4.9) 
CE 10.2 8.3 9.3 10.7 9.3 10.0 9.8 8.7 9.3 
 (4.3) (5.1) (4.7) (4.5) (5.2) (4.9) (3.7) (3.9) (3.8) 
CR 10.2 9.9 10.0 11.9 11.2 11.5 9.9 9.2 9.6 
  (5.7) (5.9) (5.7) (6.2) (5.8) (5.9) (4.1) (4.2) (4.1) 
 Ele 57.0 58.5 57.7 55.3 56.5 55.9 59.1 59.9 59.5 
GH  (8.5) (5.3) (7.1) (8.7) (5.2) (7.2) (7.9) (6.5) (7.2) 
Add -11.8 -16.1 -13.9 -8.9 -14.2 -11.5 -17.5 -18.7 -18.1 
 (10.4) (14.2) (12.6) (10.7) (15.2) (13.3) (11.5) (14.7) (13.1) 
ER 43.2 48.5 45.8 42.5 47.6 45.0 39.3 45.0 42.2 
  (15.7) (11.6) (13.9) (15.5) (10.8) (13.5) (15.9) (14.1) (15.2) 
ST: scapulothoracic; GH: glenohumeral; IR: internal rotation; ER: external rotation; UR: upward rotation; PT: posterior tilt; CE: clavicular elevation; CR: 
clavicular retraction; Elv: elevation; Add: adduction; BrCa: women with history of breast cancer 
*: positive value indicates more ST internal rotation 
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Table 4: Results of multivariate analysis of variance to determine differences between controls and women with history 
of breast cancer 
 
 F value df p value 
Un-weighted reaching 1.20 8, 51 .32 
Weighted reaching .914 8, 50 .51 
Combing hair .614 8, 51 .76 
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Table 5: Scapulothoracic and glenohumeral motion (degrees) during un-weighted reaching, weighted reaching, and hair combing tasks for 30 subjects matched 
by age and body mass index 
 
 Un-weighted Reaching 
Mean (SD) 
Weighted Reaching 
Mean (SD) 
Hair Combing 
Mean (SD) 
Controls 
(n = 10) 
LR 
(n = 10) 
MR 
(n = 10) 
Controls 
(n = 10) 
LR 
(n = 10) 
MR 
(n = 10) 
Controls 
(n = 10) 
LR 
(n = 10) 
MR 
(n = 10) 
 
 
 
 
 
ST 
IR/ER* 0.7 -1.6 -0.9 0.5 -1.2 -1.0 -1.0 -0.8 -1.3 
 (3.5) (4.8) (7.1) (3.3) (5.2) (7.3) (3.1) (5.3) (5.8) 
UR 18.6 17.9 16.1 20.1 19.5 18.0 19.4 17.0 16.0 
 (4.0) (4.4) (2.6) (3.8) (4.4) (2.5) (5.0) (5.8) (3.0) 
PT 8.6 7.9 5.2 9.2 8.0 5.4 7.0 6.1 5.3 
 (6.0) (6.4) (5.4) (6.1) (5.8) (5.7) (4.9) (6.0) (2.5) 
CE 9.7 10.1 7.0 9.9 10.7 7.9 9.2 9.9 7.4 
 (5.7) (6.0) (4.7) (5.9) (5.5) (5.1) (3.2) (4.1) (2.9) 
CR 11.2 10.8 9.9 12.3 11.4 11.0 11.2 9.8 8.7 
  (8.2) (4.7) (7.5) (9.2) (4.8) (7.1) (5.1) (3.4) (4.0) 
 Ele 59.5 59.8 57.2 58.0 57.8 55.2 60.8 61.5 57.8 
GH  (10.1) (4.8) (6.2) (9.5) (4.4) (5.8) (11.7) (5.3) (7.3) 
Add -12.0 -18.8 -20.1 -10.0 -17.2 -18.2 -21.1 -20.7 -22.2 
 (9.0) (15.5) (12.2) (10.3) (16.0) (13.0) (10.7) (13.8) (14.5) 
ER 46.4 50.3 51.7 46.0 48.6 50.7 43.8 48.3 46.7 
  (17.8) (7.9) (11.1) (17.6) (6.9) (10.6) (21.6) (9.0) (10.5) 
ST: scapulothoracic; GH: glenohumeral; IR: internal rotation; ER: external rotation; UR: upward rotation; PT: posterior tilt; CE: clavicular elevation; CR: 
clavicular retraction; Elv: elevation; Add: adduction; LR:  lumpectomy/radiation; MR: mastectomy/reconstruction 
*: positive value indicates more ST internal rotation 
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Table 6: Scapulothoracic and glenohumeral motion (degrees) during un-weighted reaching, weighted reaching, and hair combing tasks for all subjects 
grouped by controls, women who underwent lumpectomy/radiation and women who underwent mastectomy/reconstruction 
 Un-weighted Reaching 
Mean (SD) 
Weighted Reaching 
Mean (SD) 
Hair Combing 
Mean (SD) 
Controls 
(n = 30) 
LR 
(n = 20) 
MR 
(n = 10) 
Controls 
(n = 30) 
LR 
(n = 20) 
MR 
(n = 10) 
Controls 
(n = 30) 
LR 
(n = 20) 
MR 
(n = 10) 
 
 
 
 
 
ST 
IR/ER* 1.5 -0.5 -0.9 0.9 -0.7 -1.0 0.4 -0.3 -1.3 
 (4.5) (4.9) (7.1) (4.4) (4.9) (7.3) (4.5) (4.5) (5.8) 
UR 18.5 16.5 16.1 20.0 18.6 18.0 17.4 15.7 16.0 
 (5.3) (4.2) (2.6) (5.6) (4.3) (2.5) (5.4) (5.2) (3.0) 
PT 9.0 9.3 5.2 9.5 9.3 5.4 8.0 7.8 5.3 
 (5.8) (5.7) (5.4) (6.2) (5.6) (5.7) (5.1) (5.4) (2.5) 
CE 10.2 9.0 7.0 10.7 10.0 7.9 9.8 9.4 7.4 
 (4.3) (5.2) (4.7) (4.5) (5.2) (5.1) (3.7) (4.2) (2.9) 
CR 10.2 10.0 9.9 11.9 11.3 11.0 9.9 9.5 8.7 
  (5.7) (5.1) (7.5) (6.2) (5.2) (7.1) (4.1) (4.3) (4.0) 
 Ele 57.0 59.1 57.2 55.3 57.2 55.2 59.1 61.0 57.8 
GH  (8.5) (4.8) (6.2) (8.7) (4.9) (5.8) (7.9) (5.9) (7.3) 
Add -11.8 -14.1 -20.1 -8.9 -12.1 -18.2 -17.5 -16.9 -22.2 
 (10.4) (15.1) (12.2) (10.7) (16.2) (13.0) (11.5) (14.8) (14.5) 
ER 43.2 46.8 51.7 42.5 46.0 50.7 39.3 44.1 46.7 
  (15.7) (11.7) (11.1) (15.5) (10.9) (10.6) (15.9) (15.8) (10.5) 
ST: scapulothoracic; GH: glenohumeral; IR: internal rotation; ER: external rotation; UR: upward rotation; PT: posterior tilt; CE: clavicular elevation; CR: 
clavicular retraction; Elv: elevation; Add: adduction; LR:  lumpectomy/radiation; MR: mastectomy/reconstruction 
*: positive value indicates more ST internal rotation 
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Table 7: Results of multivariate analysis of variance to determine differences between controls, women 
treated with lumpectomy/radiation, and women treated with mastectomy/reconstruction that were matched 
by age and body mass index 
 F value df p value 
Un-weighted reaching .698 16, 42 .78 
Weighted reaching .819 16, 42 .66 
Combing hair 1.15 16, 42 .35 
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CHAPTER 3:  CLINICAL FACTORS ASSOCIATED WITH IMPAIRED 
SHOULER COMPLEX COORDINATION IN WOMEN WITH A HISTORY OF 
BREAST CANCER TREATMENT 
 
ABSTRACT 
Background: Impaired scapulohumeral coordination is believed to be a problem 
experienced by women after treatment of breast cancer (BC). Factors including pain, 
resting scapular alignment (RSA), tissue flexibility, strength, and lymphedema have been 
proposed to contribute to this problem, but limited research exists to support this notion.  
 
Objective: 1) determine the proportion of women with BC who demonstrate impaired 
scapulohumeral coordination during overhead reaching; 2) identify clinical factors 
associated with impaired scapulohumeral coordination. 
 
Design: Observational study 
 
Methods: Scapular and humeral kinematic data and clinical measures of pain, RSA, tissue 
flexibility, strength and lymphedema were collected on 30 women with BC (mean age ± 
SD = 53.8 ± 10.9 yrs.) and 30 women without BC (mean age ± SD = 52.7 ± 10.8 yrs.). 
Angle-angle and relative motion graphs were created for 3 scapular and 2 clavicular 
rotations. Mean curves with 95% minimal detectable change bands (MDCB) were 
calculated using data from women without BC. Each woman with BC’s curve was 
individually compared to the mean curve and MDCB. Women with BC were classified as 
having normal (curve fell within MDCB) or impaired scapulohumeral coordination 
(curve fell outside MDCB). 
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Results: Over 93% of women with BC demonstrated impaired scapulohumeral 
coordination for at least 1 scapular or clavicular rotation. Discriminant analysis revealed 
that clinical measures of pain, RSA, tissue flexibility, strength, and lymphedema were 
associated with impaired scapulohumeral coordination.  Cross-validated classification 
showed that 43.4% to 73.3% of women were grouped correctly. 
 
Conclusion: Clinical measures of tissue flexibility (ROM and pectoralis minor length) 
were associated with impaired scapulohumeral coordination across multiple scapular and 
clavicular rotations. 
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INTRODUCTION 
 Impaired shoulder girdle motion affects up to 67% of breast cancer survivors.  
Motion losses have been reported to range from 3°- 17° for flexion, 7°- 33° for 
abduction, 1°- 11° for external rotation, and 1°- 4° for internal rotation.1-5  Although this 
problem is well documented6,7, breast cancer survivors continue to experience shoulder 
girdle motion impairments years after treatment.7-9 This long-term complication may be 
because women fail to discuss their shoulder problems with health care providers10 or 
providers fail to prospectively screen for impairments contributing to a lack of referrals 
for women who may benefit from rehabilitation services.11 Complications may also result 
from less effective rehabilitation interventions that stem from a poor understanding of 
mechanisms associated with impaired shoulder girdle motion in this population. 
 Shoulder girdle motion involves multiple bony segments (scapula, clavicle, and 
humerus). Investigators who have researched segmental contributions of shoulder girdle 
motion have found that women with a history of breast cancer demonstrate impaired 
scapulothoracic motion post-surgically when compared to their unaffected side, as well as 
when compared to women without a history of breast cancer.12-15 Impaired 
scapulohumeral coordination amongst women with history of breast cancer is likely as 
these women frequently experience shoulder girdle soft tissue pain6,7, decreased shoulder 
girdle muscle strength6,7, decreased tissue flexibility16, altered resting scapular 
alignment17,18, and lymphedema.6,19  These impairments are not surprising as breast 
cancer treatments (surgery and radiation) directly affect anatomical structures of the 
shoulder girdle.20 Although women with a history of breast cancer treatment have been 
shown to experience a number of impairments believed to impact scapulohumeral 
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coordination, the association of these impairments with altered scapulohumeral 
coordination has yet to be supported. 
 The majority of investigators who found that women with a history of breast 
cancer demonstrate impaired scapulothoracic motion have focused on the position and 
orientation of the scapula on the thorax at select angles of humeral elevation  (i.e. 
scapular position/orientation at 30°, 60°, and 90° of humerothoracic elevation).12,13,21  
While this approach suggests that altered movement may be present, the approach does 
not adequately capture the complex relationship between glenohumeral and 
scapulothoracic motion (scapulohumeral coordination) throughout the movement cycle. 
Continuous motion angle-angle graphs, relative motion graphs, and their respective 
predication bands have been recommended for better understanding scapulohumeral 
coordination.22-24 Prediction bands represent movement variability, and can be used to 
determine if a movement pattern from a woman with a history of breast cancer is 
different than a population of women without breast cancer.22 This approach allows 
investigators to assess the proportion of woman with a history of breast cancer who 
demonstrate impaired scapulohumeral coordination.   
 Studies designed to assess scapulohumeral coordination in women with a history 
of breast cancer are needed because many women experience activity limitations such as 
overhead reaching and hair combing.8  These activities require proper scapulohumeral 
coordination in order to position the hand in space without subjecting the 
nueromusculoskeletal tissues of the shoulder girdle to potentially harmful stresses.25-28  
Furthermore, impaired scapulohumeral coordination has been associated with individuals 
demonstrating various shoulder pathologies including symptomatic rotator cuff  
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disease.29-33  
Rotator cuff disease is a common shoulder pathology in the general population34, 
and is thought to be a significant source of shoulder pain in women with a history of 
breast cancer.16,20,35 During upper extremity movements, glenohumeral and 
scapulothoracic motions are believed to influence humeral head and glenoid fossa 
alignment as well as the size of the subacromial space.29,32,36 Impaired scapulohumeral 
coordination may lead to excessive stresses being placed upon tissues thereby increasing 
the risk for development of symptomatic rotator cuff disease.36,37 A better understanding 
of scapulohumeral coordination in women with a history of breast cancer may provide 
evidence to explain why symptomatic rotator cuff disease is a significant problem in this 
population.  Additionally, this information may highlight impairments to be screened for 
and addressed by rehabilitation professionals in order to reduce the risk of developing 
symptomatic rotator cuff disease.   
 Identifying impairments associated with impaired scapulohumeral coordination is 
important because rehabilitation professionals do not directly address altered 
scapulohumeral coordination, rather they attempt to address the mechanisms that are 
believed to be contributing to impaired scapulohumeral coordination. A better 
understanding of impaired scapulohumeral coordination and the underling variables 
associated with it will lead to evidence-based examination, intervention, and prevention 
techniques designed to maximize functional ability and reduce the risk for developing 
musculoskeletal-related shoulder pathologies in women who have been treated for breast 
cancer. Therefore, the purposes of this study were to:  1) determine the proportion of 
women with a history of breast cancer that demonstrate impaired scapulohumeral 
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coordination during an overhead functional reaching task; and 2) identify clinical factors 
associated with impaired scapulohumeral coordination in women with history of breast 
cancer.  
METHODS 
Subjects 
 Women with and without a history of breast cancer between the ages of 30-75 
years were recruited from the Greater Philadelphia area through personal contact, flyers, 
media advertisement, local oncologist offices, and local physical therapy clinics to 
participate in the study that was approved by the university institutional review board. 
(See Figure 1 for the flow diagram of subject enrollment and recruitment through  
different phases of the study).  All subjects provided informed consent prior to 
participating in the study. Women with a history of breast cancer were eligible to 
participate if they: were treated with either mastectomy and immediate breast 
reconstruction, or lumpectomy and radiation; underwent either sentinel lymph node 
biopsy or axillary node dissection; and were 1-5 years post surgery.  Women with history 
of breast cancer were excluded if they had a history of shoulder pain prior to breast 
cancer treatment. Women who underwent mastectomy and immediate breast 
reconstruction were excluded if they had a latissimus dorsi breast reconstruction, surgery 
within the previous 3 months (i.e. breast revision, nipple reconstruction), or radiation.  
Women who underwent lumpectomy and radiation were excluded if they had partial 
breast radiation or brachytherapy, or radiation within the past 3 months. Woman without 
a history of breast cancer were excluded if they had a history of shoulder pain that 
required them to seek medical care.  All women who were unable to reach overhead, 
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allergic to adhesive material, or had a history of any medical condition affecting the arms 
(i.e. fracture, stroke, cervical myopathy) were excluded. We attempted to match women 
with a history of breast cancer to women without a history of breast cancer by age (+/- 5 
years) and body mass index (BMI) (+/- 3).  
 A total of 60 women participated in this study (30 women with and 30 women 
without a history of breast cancer). Descriptive data can be found in Table 1. One woman 
with history of breast was unable to perform weighted reaching due to increased shoulder 
pain; therefore, the number of women with a history of breast cancer for analysis of 
weighted reaching was 29. 
 
Clinical Examination 
 Women with a history of breast cancer underwent a musculoskeletal and 
lymphedema assessment of the upper extremity. This was performed by the primary 
author who has 11 years of clinical experience working with survivors of breast cancer.  
Tests and measures included: self-report of shoulder pain intensity, active and passive 
shoulder range of motion, shoulder strength, pectoralis major and minor muscle length 
assessment, visual assessment of resting scapular alignment, and upper extremity limb 
volume.  Summary of literature investigating the reliability and measurement error 
associated with these clinical shoulder measures along with intraclass correlation 
coefficient (ICC(3, 2)), standard error of measurement (SEM) and minimal detectable 
change (MDC90%) values for pectoralis minor and major length assessment derived from 
repeated measurements performed on10 of the women with history of breast cancer 
treatment can be found in Appendix A. 
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Pain Intensity: Pain at rest and during arm motion was assessed with the 11-point 
Numeric Pain Rating Scale (0 = “no pain”, 10 = “most imaginable pain”).38 The Pain 
Subscale of the PENN Shoulder Score39 was also used to assess shoulder pain. The pain 
subscale is based on 30 points, where subjects rate their level of pain at rest, with normal 
activities, and with strenuous activities using an 11-point numeric rating scale.39 
 
Active and Passive Shoulder Range of Motion (ROM): Active and passive shoulder ROM 
(forward elevation (FE), abduction (ABD), external rotation (ER) at 0° ABD, external 
rotation at 90° ABD) were measured bilaterally with a universal goniometer using 
standardized patient positioning.40 Active and passive shoulder internal rotation (IR) 
ROM were measured as the vertebral level reached by the thumb when the hand was 
placed behind and up the back as far as possible.41 Each measurement was performed 
once.   
 
Shoulder Strength: Bilateral isometric shoulder force production was measured using a 
hand-held dynamometer (Lafayette Instrument Company, Lafayette, Indiana). The 
following measures were obtained:  ER force at 0° ABD with neutral internal/external 
rotation, IR force at 0° ABD with neutral internal/external rotation, and FE in the plane of 
the scapula at 45° of elevation. For these tests, the subject was seated in an upright 
position. The dynamometer was placed proximal to the wrist at the level of the ulnar 
styloid process for ER and IR, and the distal humerus for FE. For each measurement, a 
“make test” was performed.  This test requires the examiner to hold the dynamometer in 
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the desired testing position while the subject is asked to exert maximal force against the 
dynamometer for 5 seconds.41,42 Each measurement was performed three times, and the 
average of the three trials was calculated.  Non-normalized and normalized (force/ body 
weight (kg)) data were used for subsequent analysis.      
 
Pectoralis Major Muscle Length: Our approach for assessing pectoralis major muscle 
length was based on a simulation model.43 This model demonstrated pectoralis major 
muscle strains on the order of 31-33% when the shoulder was abducted to 90° and 
externally rotated, and 22-55% when the shoulder was in full flexion.43 Bilateral shoulder 
flexion, and ER with the arm positioned at 90° ABD were measured using a universal 
goniometer while subjects were positioned supine. Two measurements for each motion 
were taken, and the average of the two measurements was calculated.  Pectoralis major 
muscle length was defined as a composite score calculated by the sum of the flexion and 
ER values.  
  
Pectoralis Minor Muscle Resting and Elongated Length: A PALpation Meter (PALM) 
caliber was used to measure bilateral pectoralis minor muscle resting and elongated 
length. Pectoralis minor muscle resting and elongated length was defined as the distance 
from the coracoid process to the inferior aspect of the 4th rib just lateral to (1 finger 
width) the sternal-costal junction.44 For resting length, subjects stood in their normal 
relaxed posture while the measurement was taken. For elongated length, subjects fully 
elevated and retracted their scapula and held this position while the measurement was 
taken. Each measurement was performed twice. The average of the two trials was 
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normalized by clavicle length (cm), sternal length (cm) and height (cm). 
 
Resting Scapular Alignment: Subjects stood in their natural relaxed posture while resting 
alignment of each scapula on the thorax was visually assessed from posterior, lateral, and 
anterior views to determine whether or not: 1) the scapula lay flat against the upper back, 
2) the vertebral border of the scapula was parallel to the thoracic spinous processes 3) the 
clavicle was either horizontal or elevated by 6°-10° at the acromial end, and 4) the 
acromion was forward respect to the center of the thorax. Each of the four criteria was 
rated as normal or mal-aligned (subtle or obvious).  A final rating for each scapula was 
defined as normal (all normal ratings or 1 subtle rating), subtle (2 or more subtle ratings), 
or obvious (at least 1 obvious rating). 
 
Upper extremity limb volume: A tape measure was used to obtain circumferential 
measurements at the wrist (ulnar styloid process), as well as 4 cm intervals from the wrist 
to the shoulder. Total limb volume was calculated by adding the volumes of the truncated 
cones between these points.45 For woman with a history of breast cancer treatment, the 
percent difference between limbs was calculated by the following formula: (limb volume 
affected-limb volume unaffected)/limb volume unaffected.  
 
Kinematic Data 
Instrumentation 
 An electromagnetic device (LibertyTM, Polhemus, Colchester, Vermont) was used 
to collect continuous kinematic data of the scapula and humerus during the performance 
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of two functional tasks.  Kinematic data were collected at a sampling frequency of 120Hz 
per sensor. Double sided tape, Velcro, and thermoplastic cuffs were used to secure five 
sensors to the subjects in the following locations: sternum just inferior to the sternal 
notch; left and right scapula via means of a custom made scapular jig46; left and right 
humerus by means of a humeral cuff.47 
 
Functional Tasks 
 Kinematic data were collected while women stood in their natural relaxed posture 
as well as during the performance of 5 repetitions of unilateral un-weighted and weighted 
(0.91 kg) overhead reaching. For all trials, subjects were instructed to stand in their 
natural upright position and then perform motions as they would do on a normal basis.  
Practice trials were allowed to be sure subjects understood the motions they were asked 
to perform.  
 Overhead reaching tasks required women to move their hand from a shelf in front 
of them to an overhead shelf and back. Shelf height was normalized using shoulder 
height and arm length anthropometric data from each woman.25 Shoulder height was 
measured in standing as the distance from the anterior aspect of the acromion process to 
the ground. With the subject seated, arm at their side, and elbow extended, arm length 
was measured as the distance from the anterior aspect of the acromion process to the tip 
of the middle finger.25 The bottom shelf was positioned at a height equal to 50% of arm 
length below shoulder height. The top shelf was positioned at a height equal to 50% of 
arm length above shoulder height. The horizontal distance from the shelf to the subject 
was equal to 60% of the subject’s arm length. 
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Kinematic Data Reduction 
 Digitized boney landmarks, establishment of local coordinate systems, and 
description of scapulothoracic, glenohumeral, and humerothoracic motion generally 
followed the recommendations of The International Society of Biomechanics.48 The 
position and orientation of the scapula relative to thorax (scapulothoracic) were described 
as 3 scapular rotations and 2 clavicular rotations. Scapular rotations were described using 
an Euler angle sequence (z, y’, x’’), where scapular internal/external rotation occurred 
about the vertically oriented z-axis, upward/downward rotation occurred about the 
anteriorly oriented y-axis, and anterior/posterior tilt occurred about the laterally oriented 
x-axis. Clavicular motions with respect to the thorax were not measured directly, but 
were derived from boney landmarks on the sternum and scapula.46,49 These motions 
consisted of clavicular elevation/depression (representing scapular superior/inferior 
translation) and clavicular protraction/retraction (representing scapular anterior/posterior 
translation).46,49 Motions of the humerus relative to the scapula (glenohumeral) were 
described as glenohumeral elevation, adduction/abduction, and internal/external rotation 
using y, x’, z’’ Cardan angles. An Euler angle sequence of z, y’, z’’ was used to describe 
motions of the humerus relative to the thoracic (humerothoracic), which were defined as 
humerothoracic adduction/abduction, elevation/depression, and internal/external rotation. 
 After data were collected, a linear interpolation program was used to obtain 
scapulothoracic and glenohumeral data at 5° increments of humerothoracic elevation. 
Data were filtered [zero lag, 4th order Butterworth filter (8Hz)] using a custom LabView 
program and resampled (101 points) across a common range of humerothoracic elevation 
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that was performed during trials 2 – 4 of the overhead reaching tasks. Data were then 
averaged and used to create angle-angle graphs and relative motion graphs that 
represented the pattern of motion during the task. Angle-angle graphs (Figure 2) were 
created for scapular and clavicular rotations by plotting scapular or clavicular motion on 
the Y-axis and humerothoracic elevation on the X-axis. Relative motion graphs (Figure 
3) were created by plotting percent of movement on the X-axis (0-50% of movement 
represents the raising phase and 51-100% represents the lowering phase) and coupling 
angles on the Y-axis. Coupling angles were derived for scapular internal rotation (IR), 
upward rotation (UR), and anterior tilt (AT), as well as clavicular elevation (CE), and 
protraction (CP) relative to glenohumeral elevation (Appendix B). Coupling angles 
quantify the relative amount of motion between two bony segments and provide 
information relative to intersegment coordination. Coupling angles range from -90° to 
90°. The sign of the coupling angle indicates whether segments are moving in the same 
(+) or different (-) direction, while the magnitude provides information about the amount 
of relative motion that occurs between segments. A coupling angle of 45° indicates 1:1 
motion between segments.  A coupling angle greater than 45° indicates more motion of 
the proximal segment (scapula or clavicle) relative to the distal segment (humerus), while 
a coupling angle less than 45° indicates more motion of the distal segment.  
 
Scapulohumeral Coordination 
 In this study scapulohumeral coordination was represented by three scapular 
rotations (UR, IR, and AT) and two clavicular rotations (CP and CE). For each rotation 
typical averaged angle-angle and relative movement pattern profile were created from the 
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group of women without history of breast cancer. Ninety-five percent minimal detectable 
change bands (MDCB95%) were derived around the control group’s mean curves by 
calculating the minimal detectable change value at each data point (Appendix B). Once 
this step was completed, data from each woman with a history of breast cancer were 
individually compared to the mean curve and MDCB95% derived from the group of 
women without breast cancer (Figure 4). A woman with history of breast cancer was 
considered to have impaired scapulohumeral coordination if her curve fell outside the 
MDCB95% for greater than 10% of the movement during the raising or lowering phases of 
arm movement. Women with a history of breast cancer were classified as having normal 
movement patterns (curve fell within MDCB95%), a movement pattern with more scapular 
or clavicular motion (curve fell outside the upper limit of the MDCB95%), or movement 
pattern with less scapular or clavicular motion (curve fell outside the lower limit of the 
MDCB95%) (Figure 4).  
 
Data Analysis 
 The percentage of women with a history of breast cancer that demonstrated each 
scapulohumeral coordination pattern (normal, more, or less motion) was calculated.  In 
order to determine the association between clinical variables and impaired 
scapulohumeral coordination, we first used multiple one-way analyses of variance, or 
Kruskal-Wallis tests to determine whether there was a significant difference in shoulder 
range of motion, shoulder strength, pectoralis major length, pectoralis minor length, 
resting scapular alignment and upper extremity limb volume between women classified 
as having normal, more, or less motion for each scapular (i.e. IR, UR, AT) and clavicular 
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(i.e. CE and CR) rotation.  Next, stepwise discriminant analyses were used to identify 
clinical variables that could classify women as having normal, more, or less scapular or 
clavicular motion patterns (p < .05). Separate discriminant analyses were performed for 
each scapular and clavicular rotation and the two functional tasks. Clinical variables 
identified by results of the one-way analyses of variance, or Kruskal-Wallis tests to be 
significantly different between women with normal, more, or less scapular or clavicular 
motion were included as potential predictors in the discriminant analyses. Since we did 
not wish to exclude a variable that may be a useful predictor, a more liberal significance 
level (p < .10) was used to identify variables entered into the discriminant analysis.50  
   
RESULTS 
 Proportion of Women with Impaired Scapulohumeral Coordination during Un-weighted 
and Weighted Reaching Tasks 
1. ANGLE-ANGLE GRAPH ANALYSES 
 For un-weighted reaching, 10% of women with a history of breast cancer were 
classified as having impaired scapulohumeral coordination (i.e. a movement pattern with 
more or less scapular or clavicular motion) across all scapular and clavicular rotations. 
Only 3.3% of women were classified as having normal scapulohumeral coordination 
across all scapular and clavicular rotations. The percentage of women with history of 
breast cancer that were classified with impaired scapulohumeral coordination for 1, 2, 3, 
or 4 scapular/clavicular rotations during un-weighted reaching was 40%, 20%, 20% and 
6.7%, respectively.  
 For weighted reaching, angle-angle graphs classified 6.7% of women with a 
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history of breast cancer as having impaired scapulohumeral coordination across all 
scapular and clavicular rotations, and 6.7% of women with normal scapulohumeral 
coordination across all rotations.  The percentage of women who were classified as 
having impaired coordination for 1 rotation was 30%, 2 rotations was 20%, 3 rotations 
was 23.3%, and 4 rotations was 10%. The proportion of women with a history of breast 
cancer that were classified with impaired scapulohumeral coordination for each specific 
scapular and clavicle rotation during un-weighted and weighted reaching can be found in 
Table 2.   
 
2. RELATIVE MOTION ANALYSES 
 Relative motion graphs revealed that 93.3% of women with history of breast 
cancer demonstrated impaired scapulohumeral coordination for at least 1 scapular or 
clavicular rotation during un-weighted reaching. The percentage of women who 
demonstrated impaired coordination for 1, 2, 3, 4, or 5 rotations during un-weighted 
reaching was as follows:  6.7%, 20%, 26.7%, 23.3%, and 16.7%. For weighted reaching, 
all women demonstrated impaired scapulohumeral coordination for at least 1 rotation. 
The percentage of women who demonstrated impaired coordination for 1 rotation was 
10%, 2 rotations was 6.7%, 3 rotations was 20%, 4 rotations was 26.7%, and 5 rotations 
was 33.3%. The proportion of women with a history of breast cancer that demonstrated 
impaired coordination for each specific scapular and clavicle rotation during un-weighted 
and weighted reaching can be found in Table 3. 
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Clinical Variables Associated with Impaired Scapulohumeral Coordination 
 For the sake of simplicity, the results reported in this section will only refer to the 
un-weighted reaching task with respect to the following scapular and clavicular rotations: 
UR, CE, and CP.  It was decided to only report un-weighted reaching results due to the 
level of agreement for scapulohumeral coordination classification between the un-
weighted and weighted tasks.  There was substantial to perfect agreement for 
scapulohumeral coordination classification based on angle-angle graphs between un-
weighted and weighted reaching tasks.  Kappa values ranged from .68 to 1.0. For 
scapulohumeral coordination classification based on relative motion graphs, there was 
fair to moderate agreement between un-weighted and weighted reaching tasks evident by 
kappa values ranging from .32 to .53. Un-weighted reaching was chosen over weighted 
reaching due to clinical variable being able to better classify women with history of 
breast cancer as having impaired scapulohumeral coordination during un-weighted 
reaching.  Results for the weighted reaching task can be found in Appendix C. 
 The rationale for selecting scapular UR and clavicular elevation and protraction 
rotations were as follows.  Scapular UR is the predominant scapulothoracic motion that 
occurs during arm elevation. 32 While scapular IR and AT are important scapulothoracic 
motions these rotations are highly variable 32 and predominantly occur at arm elevation 
angles above 90° of arm elevation49. Clavicular elevation and protraction were chosen 
because women with history of breast cancer may experience impaired pectoral muscle 
flexibility due to trauma that may occur from surgery. 16,20,43 Additionally, radiation 
therapy has been shown to alter collagen synthesis51-53, and cause soft tissue fibrosis 
affecting the flexibility of the pectoral muscles within the radiation field.52-55, Impaired 
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pectoral muscle flexibility is likely to directly or indirectly influence clavicular motion 
due to the anatomical orientation of the pectoral muscles. Additionally, clavicular 
elevation and protraction motions were not previously been measured by 3 out of 4 
investigative groups who found that women with history of breast cancer demonstrate 
impaired scapulothoracic motion.12-15, 21 Significant results for IR and AT can be found in 
Appendix D. 
 
1. ANGLE-ANGLE GRAPH ANALYSES 
  Significant group (women classified with normal, more, or less 
scapular/clavicular motion) differences in continuous clinical variables were found for 
UR and CP during un-weighted reaching (Table 4).  
Results of discriminant analysis for UR and CP can be found in Table 5.  For un-
weighted reaching, discriminant analysis revealed a significant association between 
groups and ER muscle strength normalized by body weight for UR (p < .05). Cross-
validated classification showed that 43.3% of women were grouped correctly. For CP, 
discriminant analysis revealed a significant association between groups and resting 
pectoralis minor muscle length, elongated pectoralis minor muscle length, active shoulder 
ER ROM at 0° ABD, and active ER ROM at 90° ABD (p < .05).  Cross-validated 
classification showed that 73.3% of women were grouped correctly.    
  
2. RELATIVE MOTION ANALYSES  
 Results of the ANOVAs for continuous clinical variables that were significantly 
different between women with normal, more, or less relative scapular or clavicular 
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motion during un-weighted reaching can be found in Table 6.  Kruskal-Wallis test 
revealed significant differences in resting alignment variables for UR and CP (Table 7). 
However, these resting scapular alignment variables were not entered into the 
discriminant analyses due to causing fewer than two nonsingular group covariance 
matrices. 
Discriminant analysis results for UR, CE, and CP can be found in Table 8. For 
scapular UR, there was significant association between groups and active ABD and % 
inter-limb volume difference during un-weighted reaching (p < .05). Cross-validated 
classification showed that 73.3% of women were grouped correctly. For CE, discriminant 
analysis revealed a significant association between groups and passive ABD and active 
ER at 0° ABD during un-weighted reaching (p < .05). Cross-validated classification 
showed that 71.4% of women were grouped correctly. Results of the discriminant 
analysis revealed that IR muscle strength was able to classify women as having normal, 
more, or less CP during un-weighted reaching (p < .05). Cross-validated classification 
showed that 67.9% of women were grouped correctly.    
 
DISCUSSION 
   This study’s findings demonstrate the value of using predication bands to 
investigate scapulohumeral coordination in women with a history of breast cancer.  The 
results indicate that the majority of women with a history of breast cancer demonstrate 
impaired scapulohumeral coordination during overhead reaching.  Data from the angle-
angle graphs revealed that over 93% of women with a history of breast cancer 
demonstrated more or less motion for at least one scapular or clavicular rotation. This 
  
 
121 
finding indicates that during overhead reaching tasks women with history of breast cancer 
have differences in the position/orientation of their scapula compared to women without 
history of breast cancer. Furthermore, over 93% of women with a history of breast cancer 
had at least 1 relative motion curves fall outside of the prediction bands derived from 
women without a history of breast cancer. This indicates that women with a history of 
breast cancer demonstrate more, or less, relative scapular motion of the scapula than 
women without a history of breast cancer.   
 
ANGLE-ANGLE GRAPHS  
We were able to identify clinical variables that classified women with history of 
breast cancer as having normal, more, or less scapular or clavicular motion. Impaired CP 
was associated with ER ROM and pectoralis minor length. This suggests that anterior 
shoulder girdle tissue flexibility is associated with impaired scapulohumeral coordination.  
The pectoralis minor originates from the anterior surface of ribs 3 through 5 and 
inserts on the coracoid process. This orientation suggests that a smaller resting pectoralis 
minor muscle length could lead to a more forward shoulder posture, which in turn would 
be consistent with more CP during overhead reaching. Our finding of smaller normalized 
resting pectoralis minor muscle length in women who demonstrated more CP (pectoralis 
minor length = 61.3) when compared to women who demonstrated normal amounts of 
CP (pectoralis minor length = 63.5) supports this concept. It should be noted that this 
difference exceeds our standard error of measurement (1.4) for resting pectoralis minor 
length normalized by clavicle length but is less than the 90% minimal detectable change 
value (3.2) (Appendix A).  A longer pectoralis minor length may allow for greater 
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amounts of clavicular retraction (less CP) during overhead reaching. This is supported by 
the fact that the averaged normalized pectoralis minor muscle length for women who 
demonstrated less CP was 73.6.  
 Our failure to identify clinical variables associated with impaired CE may be due 
to the small percentage of women who demonstrated impairment in this rotation.   During 
un-weighted reaching, we found that 63.3% and 60.0% of women with history of breast 
cancer demonstrated impaired UR and CP, respectively, compared to only 30% who 
demonstrated impaired CE coordination. It may also be due to the fact that we did not 
take measurements of all of the clinical variables that could possibly influence CE. For 
example, we did not measure serratus anterior or trapezius muscle strength. These 
muscles have been shown to play an important role in the production and control of 
scapular and clavicular motion.56 This may also be the reason why ER muscle strength 
was the only variable associated with impaired UR, being able to only correctly classify 
43.3% of subjects. Future studies should consider strength measures of these muscles. 
 
RELATIVE MOTION GRAPHS 
We were able to identify clinical variables associated with normal, more, or less 
relative motion during un-weighted reaching for UR, CE, and CP.  ABD ROM was the 
only clinical variable, across multiple scapular and clavicular rotations, that was able to 
classify women with a history of breast cancer into normal, more, or less motion. Our 
findings revealed that women with less ABD ROM demonstrated more relative UR and 
CE motion.  
Women with more relative CE had an average of 115.7° of passive ABD, while 
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women with normal relative CE had an average of 170.6° and women with less relative 
CE had an average of 155.8° of passive ABD. Women with more relative upward 
rotation had an average of 108.7° of active ABD, while women with normal and less 
relative UR had an average of 158.2° and 151.8°, respectively.  This finding is consistent 
with the finding that individuals with painful shoulders and limited glenohumeral ROM 
demonstrate more scapular UR during arm motion.57-59 Overall these findings suggest 
that women with history of breast cancer demonstrate more scapulothoracic motion as a 
compensatory strategy in the presence of impaired glenohumeral motion.   
 Although the majority of women demonstrated impaired scapulohumeral 
coordination, which scapular or clavicular rotation was impaired (scapular UR, CE, and 
CE) and direction of impairment (i.e. more or less motion) varied between subjects.  This 
is not surprising since women with a history of breast cancer may or may not experience 
a number of different impairments (soft tissue pain6,7, decreased shoulder girdle muscle 
strength6,7, decreased tissue flexibility16, altered resting scapular alignment17,18, and 
lymphedema6,19) that can influence scapulohumeral coordination.20  Further research is 
needed to determine why some women with history of breast cancer experience these 
impairments and others do not even though the breast cancer treatment they received was 
the same.     
 
LIMITATIONS 
  The method we used to derive our predication bands around the control group’s 
mean curves could be viewed as a limitation. We chose to calculate predication bands as 
the 95% coverage probability using a minimal detectable change method. This method is 
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commonly used in clinical practice to determine whether a true difference or a true 
change has occurred. Other methods such ±1 standard deviations, ±1.6449 standard 
deviations, and Bootstrap have been used to capture movement variability, with different 
methods resulting in different coverage probabilities.22,60  
 Another limitation of this study was that we did not assess all clinical factors that 
may influence scapulohumeral coordination. Although we assessed shoulder muscle 
strength, we did not assess other muscle performance measures such as endurance or 
muscle activity levels both of which may influence glenohumeral and scapulothoracic 
motion. While measures of anterior shoulder flexibility were included, posterior capsule 
tightness was not. Posterior capsule tightness has been found to influence scapulohumeral 
coordination.58,61 Finally, our measure of pectoralis major flexibility was based on a 
computer simulation model and the validity of this measure has yet to be supported.  
 
CONCLUSION 
  Although a large percentage of women with a history of breast cancer 
demonstrated impaired scapulohumeral coordination, a consistent impairment pattern was 
not identified. However, we were able to identify clinical variables associated with a 
number of different impaired scapulohumeral coordination patterns. We found that 
clinical measures of shoulder flexibility (pectoralis minor length) were associated with 
impaired CP coordination patterns. Another relevant finding was that shoulder ABD 
ROM was associated with impaired scapulohumeral coordination across multiple 
scapular and clavicular rotations.   
 It is our hope that these findings will lead to a better understanding of the 
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relationships between shoulder flexibility (ROM and pectoralis minor) impairments and 
impaired scapulohumeral coordination. We also hope that this improved understanding 
will lead to the better intervention plans intended to restore optimal scapulohumeral 
coordination in order to maximize functional abilities and reduce risk of shoulder pain 
and dysfunction in women who have been treated for breast cancer.   
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FIGURES AND TABLES 
 
 
Figure 1: Flow diagram of subject recruitment and enrollment through different phases of the study 
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Figure 2: Angle-angle graphs: scapular and clavicular angular position on “Y” axis and humerothoracic 
elevation angular position on “X” axis
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Figure 3: Relative motion graphs: scapular and clavicular coupling angle on “Y” 
axis and percent of movement on “X” axis. GH: glenohumeral elevation; IR: 
internal rotation; UR: upward rotation; AT: anterior tilt; CE: clavicular elevation; 
CP: clavicular protraction 
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Figure 4: Angle-angle graphs. Mean of women without history of breast cancer (dashed black) & +/- 
minimal detectable change bands (MDCB95) (solid black); A. Single subject classified as having normal 
motion (black dots); B. Single subject classified as having more motion (black dots); C. Single subject 
classified as having less motion (black dots)  
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Table 1: Descriptive statistics for all subjects (n = 60) 
 
  
BrCa 
(n = 30) 
 
Controls 
(n =30) 
 
p values 
Age (years) 
   Mean ± SD 
 
53.8 ± 10.9 
 
52.7 ± 10.8 
 
ns 
BMI (kg/m2) 
   Mean ± SD 
 
28.3 ± 6.1 
 
29.1 ± 6.0 
 
ns 
Race (n) 
   Caucasian 
   African-American 
   Asian 
 
18 
10 
2 
 
16 
14 
0 
 
ns 
Penn Shoulder Score 
   Pain Subscale 
   Satisfaction Subscale 
   Function Subscale 
   Total Score 
 
26.1 ± 5.8 
7.9 ± 2.9 
51.2 ± 11.7 
85.3 ± 19.5 
 
29.7 ± .9 
9.2 ± 1.4 
57.5 ± 4.4 
96.4 ± 5.4 
 
p < .05 
p < .05 
p < .05 
p < .05 
Paffenbarger Physical Activity 
Questionnaire (kcal/wk) 
 
1596 ± 943 
 
1913 ± 1562 
 
ns 
Type of breast cancer treatment (n) 
   Lumpectomy/radiation 
   Mastectomy/reconstruction 
 
20 
10 
 
Type of lymph node surgery (n) 
   SLNB 
   ALND 
 
25 
5 
Side affected (n)                
Dominant side 
   Non-dominant side 
 
17 
13 
Time since surgery (days) 
   Mean ± SD  
 
893 ± 325 
Chemotherapy (n) 
   Yes 
   No 
 
12 
18 
FPAX-B 
   Mean ± SD 
 
9.7 ± 11.1 
FACT-B + 4 
   Mean ± SD 
 
122.6 ± 22.0 
Educated on HEP (n) 
   Yes 
   No 
 
22 
8 
 
Attended physical therapy (n) 
   Yes 
   No 
 
17 
13 
 
BrCa: women with history of breast cancer treatment 
ns: no significant difference between groups 
FPAX-B: Fear of Physical Activity/Exercise Scale-Breast Cancer 
FACT-B+4: Functional Assessment of Cancer therapy-Breast Cancer + 4 
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Table 2: Proportion of women with history of breast cancer who demonstrate normal, more, or less motion 
based on angle-angle graphs 
 
  % Normal Motion 
(n) 
% More Motion 
(n) 
% Less Motion 
(n) 
Un-weighted 
Reaching 
Internal rotation 73.3 (22) 10.0 (3) 16.7 (5) 
Upward rotation 36.7 (11) 33.3 (10) 30.0 (9) 
Anterior tilt 63.3 (19) 20.0 (6) 16.7(5) 
Clavicular elevation 70.0 (21) 10.0 (3) 20.0 (6) 
Clavicular protraction 40.0 (12) 23.3 (7) 36.7 (11) 
Weighted 
Reaching 
Internal rotation 65.5 (19) 13.8 (4) 20.7 (6) 
Upward rotation 34.5 (10) 37.9 (11) 27.6 (8) 
Anterior tilt 51.7 (15) 34.5 (10) 13.8 (4) 
Clavicular elevation 69.0 (20) 10.3 (3) 20.7 (6) 
Clavicular protraction 58.6 (17) 20.7 (6) 20.7 (6) 
 
  
 
 
 
 
Table 3: Proportion of women with history of breast cancer who demonstrate normal, more, or less motion based on relative motion graphs 
 
  % Normal Motion   
(n) 
% More Motion   (n) % Less Motion   (n) % More or Less Motion (n) 
Un-weighted 
Reaching 
Internal rotation 50.0 (15) 23.3 (7) 23.3 (7) 3.3 (1) 
Upward rotation 30.0 (9) 10.0 (3) 60.0 (18)  
Anterior tilt 26.7 (8) 40.0 (12) 26.7 (8) 6.7 (2) 
Clavicular elevation 40.0 (12) 10.0 (3) 46.7 (14) 3.3 (1) 
Clavicular protraction 50.0 (15) 33.3 (10) 10.0 (3) 6.7 (2) 
Weighted 
Reaching 
Internal rotation 37.9 (11) 24.1 (7) 31.0 (9) 6.9 (2) 
Upward rotation 13.8 (4) 20.7(6) 55.2 (16) 10.3 (3) 
Anterior tilt 31.0 (9) 41.4 (12) 27.6 (8)  
Clavicular elevation 31.0 (9) 27.6 (8) 41.4 (12)  
Clavicular protraction 17.2 (5) 55.2 (16) 20.7 (6) 6.9 (2) 
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Table 4: Significant results of ANOVAs for angle-angle graph analysis during un-weighted reaching 
 
Task Rotation Clinical Variables Women with  
Less Motion 
Mean (SD) 
Women with  
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F ratio p value 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
UR Muscle Strength 
ER (kg) 
FE Normalized 
ER Normalized 
IR  Normalized 
 
5.1 (1.7) 
.10 (.02) 
.06 (.02) 
.08 (.03) 
 
6.2 (1.6) 
.14 (.05) 
.09 (.03) 
.12 (.04) 
 
6.7 (1.4) 
.14 (.04) 
.10 (.02) 
.12 (.03) 
 
2, 29 
2, 29 
2, 29 
2, 29 
 
2.550 
3.776 
7.602 
4.745 
 
p = .097 
p = .036 
p = .002 
p = .017 
CP  Active ROM 
ER at 0° ABD 
ER at 90° ABD 
Pectoralis Minor Length 
Resting# 
Resting* 
Elongated# 
Elongated* 
Elongated-Resting# 
Elongated-Resting* 
 
59.4 (13.8) 
73.8 (13.6) 
 
96.5 (11.1) 
73.6 (10.2) 
107.4 (12.6) 
82.0 (12.0) 
10.9 (4.6) 
8.4 (3.7) 
 
69.3 (11.8) 
87.9 (11.9) 
 
90.2 (7.2) 
63.5 (4.7) 
97.5 (8.2) 
68.6 (5.2) 
7.3 (2.5) 
5.1 (1.7) 
 
 
 
55.0 (13.7) 
80.7 (12.1) 
 
85.5 (11.4) 
61.3 (5.5) 
95.1 (12.1) 
68.2 (5.5) 
9.6 (2.3) 
6.9 (1.5) 
 
2, 29 
2, 29 
 
2, 29 
2, 29 
2, 29 
2, 29 
2, 29 
2, 29 
 
3.095 
3.607 
 
2.834 
7.777 
3.485 
9.003 
3.417 
6.426 
 
p = .062 
p = .041 
 
p = .076 
p = .002 
p = .045 
p = .001 
p = .048 
p = .018 
# - normalized by clavicle length; * - normalized by sternum length; FE – forward elevation; ER -  external rotation; IR – internal rotation; ABD – 
abduction; UR – upward rotation; CP – clavicular protraction 
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Table 5: Results of the discriminant analysis for angle-angle graphs for un-weighted reaching 
 
Task Rotation Clinical Variables in 
Discriminant Analysis 
Structure 
Matrix  
Correlations 
Wilks’ 
Lambda 
Canonical 
Correlation 
(Effect Size) 
p value Cross-
validation 
classification 
(% correctly 
grouped) 
 U
n-
w
ei
gh
te
d 
R
ea
ch
in
g UR ER muscle strength (N) 1.0 F1 = .640 F1 = .60 (.36) p = .002 43.3 
 
 
CP  
Resting PML (S) 
Elongated PML (S) 
Active ER at 0° ABD ROM 
Active ER at 90° ABD ROM 
F1 
.74 
.79 
-.08 
.40 
F2 
-.22 
-.06 
.66 
.45 
 
F1 = .323 
F2 = .659 
 
F1 = .71 (.50) 
F2 = .58 (.34) 
 
p = .000 
p = .014 
 
 
 
73.3 
PML- pectoralis minor length; F1- function 1 of discriminant analysis; F2- function 2 of discriminant analysis;  
ER -external rotation; ABD - abduction; ROM - range of motion; UR: upward rotation; CP: clavicular protraction 
(N): normalized by body weight; (S): normalized by sternum length 
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Table 6: Significant Results of ANOVAs for Relative Motion Graphs Analysis during Un-weighted Reaching 
 
Task Rotation Clinical Variable Women with 
Less Motion 
Mean (SD) 
Women with 
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F Ratio p value 
  
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
UR Active ROM 
ABD (°) 
Passive ROM 
ABD (°) 
ER at 0° ABD (°) 
ER at 90° ABD (°) 
Pectoralis Major Flexibility 
Length (°) 
Lymphedema 
      ILVD (%) 
 
151.8 (22.4) 
 
159.0 (22.4) 
66.4 (11.8) 
81.4 (12.0) 
 
234.4 (24.4) 
 
-1.3 (4.4) 
 
158.2 (21.3) 
 
166.7 (22.3) 
73.0 (9.5) 
86.6 (11.9) 
 
245.3 (22.6) 
 
3.5 (5.7) 
 
108.7 (31.0) 
 
114.3 (52.0) 
47.7 (21.0) 
54.4 (48.6) 
 
198.8 (75.1) 
 
1.8 (4.4) 
 
2, 29 
 
2, 28 
2, 29 
2, 29 
 
2, 29 
 
2, 29 
 
5.751 
 
4.759 
4.817 
3.936 
 
2.631 
 
3.007 
 
p = .098 
 
p = .017 
p = .016 
p = .032 
 
p = .090 
 
p = .066 
CE Active ROM 
FE (°) 
ABD (°) 
ER at 0° ABD (°) 
IR(vertebral level) 
Passive ROM 
ABD (°) 
ER at 0° ABD (°) 
ER at 90° ABD (°) 
IR (vertebral level) 
Muscle Strength 
ER (kg) 
Pectoralis Major Flexibility 
Length (°) 
 
139.9 (16.1) 
151.5 (22.6) 
68.4 (9.7) 
T9 (4) 
 
155.8 (28.0) 
69.0 (12.1) 
84.0 (10.8) 
T9 (4) 
 
6.5 (1.7) 
 
237.4 (26.2) 
 
145.5 (13.6) 
158.5 (22.1) 
61.9 (13.2) 
7.3 (1.1) 
 
170.6 (8.7) 
68.6 (11.3) 
83.9 (12.0) 
T7 (1) 
 
5.9 (1.0) 
 
242.0 (18.5) 
 
123.0 (17.4) 
109.3 (31.2) 
39.0 (13.2) 
L2 (5) 
 
115.7 (51.7) 
47.7 (21.0) 
49.7 (47.0) 
L2 (5) 
 
3.6 (1.3) 
 
190.7 (74.0) 
 
2, 28 
2, 28 
2, 28 
2, 28 
 
2, 27 
2, 28 
2, 28 
2, 28 
 
2, 28 
 
2, 28 
 
2.972 
5.709 
8.233 
4.546 
 
5.505 
3.409 
5.598 
4.159 
 
5.136 
 
3.689 
 
p = .069 
p = .009 
p = .002 
p = .020 
 
p = .010 
p = .048 
p = .010 
p = .027 
 
p = .013 
 
p = .039 
CP Muscle Strength 
IR (kg)  
Pain 
Penn Shoulder Subscale 
 
10.8 (2.2) 
 
28.3 (2.9) 
 
8.8 (1.9) 
 
27.9 (7.9) 
 
6.5 (2.6) 
 
23.0 (5.9) 
 
2, 27 
 
2, 27 
 
5.972 
 
2.603 
 
p = .008 
 
p = 0.94 
h - normalized by height; FE – forward elevation; ER -  external rotation; IR – internal rotation; ABD – abduction; UR – upward rotation;  
CE – clavicular elevation; CP – clavicular protraction; ILVD: interlimb volume difference  
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Table 7: Significant results of the Kruskal-Wallis tests for relative motion graphs for un-
weighted reaching (p < .10)* 
 
Rotation Resting Scapular Alignment Variable 
Upward Rotation Resting alignment final score 
Clavicular Elevation Clavicle was horizontal or slightly (10°) elevated 
*: There was no significant differences in resting scapular alignment variables between 
groups classified based on angle-angle graphs 
 
 
 
 
Table 8: Results of the discriminant analysis for relative motion graphs for un-weighted reaching 
 
Task Rotation Clinical Variables in 
Discriminant Analysis 
Structure 
Matrix  
Correlations 
Wilks’ 
Lambda 
Canonical 
Correlation 
(Effect size) 
p value Cross-validation 
classification 
(% correctly 
grouped) 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
UR*  
Active ABD ROM 
ILVD 
F1 
1.0 
-.33 
F2 
.17 
.96 
 
F1 = .562 
F2 = .814 
 
F1 = .56 (.31) 
F2 = .43 (.18) 
 
p = .005 
p = .022 
73.3 
 
 
 
CE*  
Passive ABD 
Active ER at 0° ABD ROM 
F1 
.60 
1.0 
F2 
.80 
-.08 
 
F1 = .458 
F2 = .757 
 
F1 = .63 (.40) 
F2 = .49 (.24) 
 
p = .001 
p = .009 
 
71.4 
 
 
CP IR muscle strength 1.0 F1 = .677 F1 = .57 (.32) p = .008 67.9 
 
* - indicates that resting scapular alignment variable not entered into analysis due to causing fewer than two nonsingular group covariance matrices;  
F1- function 1 of discriminant analysis; F2 - function 2 of discriminant analysis; IR - internal rotation; ER- external rotation; ABD - abduction;  
ROM - range of motion; UR: upward rotation; CE: clavicular elevation; CP: clavicular protraction 
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APPENDIX A: Reliability and Measurement Error for Clinical Measures 
 
 
 
Table:  Summary of literature investigating the reliability and measurement error associated with clinical shoulder measures 
 
Authors Subjects Clinical Measure ICC SEM MDC (90%) 
Mintken et 
al. 200938 
101 adults with shoulder pain who 
received physical therapy (mean age +/- 
SD of stable patients = 44.4 +/- 17.4 
years; mean age +/- SD of improved 
patients = 39.1 +/- 18.8 years) 
Numeric Pain 
Rating Scale 
Test-retest = .74 1.07 points 2.5 points 
Leggin et al. 
199642 
17 adults (7 men with mean age = 31 
+/- 5 years; 10 women with mean age 
30 +/- 6 years) with no known shoulder 
dysfunction 
Shoulder Strength Intra-rater 
IR=.94- .97 
ER=.89- .95 
Elev. =.84-.96 
 
Inter-rater 
IR=.90 
ER=.94 
Elevation=.79  
Not reported Not reported 
Leggin et al. 
200362 
40 adults (22 men with mean age = 42.4 
+/- 11.7 years; 18 women with mean 
age = 54.8 +/- 17.1 years) receiving 
post-operative or non-operative 
rehabilitation for a variety of shoulder 
conditions 
Shoulder Strength Interrater 
IR=.91 
ER=.89 
Elevation=.93 
IR=2.2kg 
ER=1.4kg 
Elevation=1.9kg 
IR=3.1kg 
ER=3.3kg 
Elevation=2.7kg 
 
 
Leggin et al. 
200362 
 
40 adults (22 men with mean age +/- SD 
= 42.4 +/- 11.7 years; 18 women with 
mean age +/- SD = 54.8 +/- 17.1 years) 
receiving post-operative or non-
operative rehabilitation for a variety of 
shoulder conditions 
Shoulder ROM Interrater 
FE=.89 
ER at 0°=.89 
ER at 90°=.88 
IR=.86 
FE=12.3° 
ER at 0°=10.3° 
ER at 90°=17.9° 
IR=2 levels 
FE=17.4° 
ER at 0°=14.6° 
ER at 90°=25.3° 
IR=3 levels 
 
 
ICC = intraclass correlation coefficient; SEM = standard error of measurement; MDC = minimal detectable change; ROM = range of motion; 
FE = forward elevation; ER = external rotation; IR = internal rotation; V = volume; h = height; C = circumference 
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Table (continued): Summary of literature investigating the reliability and measurement error associated with clinical shoulder measures  
 
Authors Subjects Clinical Measure ICC SEM MDC (90%) 
Harrington 
et al. 
201163 
Pilot data on breast cancer survivors 
(number of subjects was not reported) 
Shoulder AROM/PROM 
(supine flexion, ER at 0° 
abduction, ER at 90° 
abduction, IR at 90° 
abduction, prone 
extension 
Intrarater 
AROM = .84-1.0 
PROM = .97-1.0 
Not reported Not reported 
Ebaugh 
and 
Oravitz, 
200864 
8 healthy subjects (4 men; mean age = 
24.1 years) 
Pectoralis Minor Length 
(resting and elongated) 
 
Intra-rater = 
.98-.99 
 
Inter-rater =  
.86-.95 
Not reported Intra-rater 
.5 – .8 cm 
 
Inter-rater 
1.4 – 2.2 cm 
Sander et 
al. 200265 
 
50 women with primary or secondary 
lymphedema (mean age +/- SD = 56  +/- 
13.3 years) 
Limb volume 
V =  
Σ (hCi
2/4π) 
 
h = 3, 6, or 9cm 
Intra-rater = .99 
Inter-rater = .99    
h= 3cm: 120mL 
h= 6cm: 124 mL 
h= 9cm: 130mL 
Not reported 
Deltombe 
et al. 
200766 
30 women with unilateral breast cancer 
related lymphedema (mean age +/- SD 
= 63 +/- 9 years) 
Limb volume 
V =  
Σ (hCi
2/4π) 
 
h = 5cm 
Intra-rater = .99 
Inter-rater = .99    
Not reported Not reported 
Czerniec et 
al. 201067 
33 women with breast cancer related 
lymphedema (mean age +/- SD = 58.6 
+/-10 years); 
 
18 women without history of either 
lymphedema or breast cancer (mean age 
+/- SD = 52.2 +/-7 years) 
Limb volume 
V= 
Σ h (Ci
2+Ci2Ci-12 +Ci-12 ) 
/12π 
 
h = 10 cm 
 
Lymphedema 
group 
Inter-rater = .98 
 
Control group 
Inter-rater = .98 
 
93mL Not reported 
ICC = intraclass correlation coefficient; SEM = standard error of measurement; MDC = minimal detectable change; ROM = range of motion; 
FE = forward elevation; ER = external rotation; IR = internal rotation; V = volume; h = height; C = circumference 
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Table: Intraclass correlation coefficient (ICC(3, 2)), standard error of measurement (SEM) and minimal detectable change (MDC90%) values for pectoralis 
minor length and pectoralis major length calculated from 10 of the women with history of breast cancer treatment 
 
 ICC (95%CI) SEM MDC90% 
Resting PML normalized by clavicle length .98 (.99, 1.0) 1.4 3.2 
Resting PML normalized by sternum length .99 (.94, 1.0) .8 1.9 
Resting PML normalized by height .98 (.90, .99) .1 .3 
Elongated PML normalized by clavicle length .97 (.86, .99) 1.8 4.1 
Elongated PML normalized by sternum length .98 (.91, 1.0) 1.3 3.0 
Elongated PML normalized by height .95 (.79, .99) .2 .4 
Elongated – Resting PML normalized by clavicle length .82 (.27, .96) 1.2 2.7 
Elongated – Resting PML normalized by sternum length .80 (.20, .95) .9 2.2 
Elongated – Resting PML normalized by sternum length .79 (.16, .95) .1 .3 
Pectoralis Major Length (°) .99 (.99, 1.0) 4.8 11.1 
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Appendix B:  Coupling Angles and Minimal Detectable Change Calculations 
 
 
Coupling angles were derived from the following formula:  
Coupling angle = 𝑎𝑎 𝑡𝑡𝑎𝑎𝑡𝑡 [𝑌𝑌𝑌𝑌+1 − 𝑌𝑌𝑖𝑖
𝑋𝑋𝑖𝑖+1− 𝑋𝑋𝑖𝑖 ] 
, where Y and X are data points obtained from angle-angle graphs in which  motion of the 
distal segment is plotted on the x-axis and motion of the proximal segment is plotted on 
the y-axis.24 
 
Minimal detectable change values were calculated from the following formula:  
𝑀𝑀𝑀𝑀𝑀𝑀% = 𝑧𝑧 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠 ∗ 𝑆𝑆𝑆𝑆𝑀𝑀 ∗ √2 
, where the z score for 95% is 1.96.  SEM is standard error of measurement calculated 
from the following formula: 
𝑆𝑆𝑆𝑆𝑀𝑀 = 𝑆𝑆𝑀𝑀√1 − 𝐼𝐼𝑀𝑀𝑀𝑀 
, where SD is the standard deviation across subjects.  ICC is the intraclass correlation 
coefficient calculated from the following formula: 
ICC (2, 3) = 𝑀𝑀𝑀𝑀𝐵𝐵𝑆𝑆−𝑀𝑀𝑀𝑀𝐸𝐸
𝑀𝑀𝑀𝑀𝐵𝐵𝑆𝑆−
𝑘𝑘 (𝑀𝑀𝑆𝑆𝐵𝐵𝐵𝐵−𝑀𝑀𝑆𝑆𝐸𝐸)
𝑛𝑛
 
,where MSBS is the between-subjects mean square; MSE is the error mean square; MSBR 
is the between-raters mean square; k is number of raters; and n is number of subjects. 
ICC coefficients were calculated from a pilot study in our lab that investigated the 
between day reliability of our kinematic measurements. 
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Appendix C: Weighted Reaching Analysis 
 
 
 
Table: Significant results of ANOVAs for angle-angle graph analysis during weighted reaching 
 
Task Rotation Clinical Variables Women with  
Less Motion 
Mean (SD) 
Women with  
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F ratio p value 
W
ei
gh
te
d 
R
ea
ch
in
g 
IR Pectoralis Minor Length 
Resting# 
Elongated# 
Lymphedema 
     ILVD (%) 
 
99.9 (11.1) 
110.6 (12.5) 
 
-.7 (4.5) 
 
88.2 (8.4) 
97.3 (9.8) 
 
-.2 (4.3) 
 
91.8 (12.8) 
99.1 (15.2) 
 
5.6 (7.9) 
 
2, 28 
2, 28 
2, 28 
 
3.414 
3.323 
2.662 
 
p = .048 
p = .052 
p = .089 
UR Muscle Strength 
FE Normalized 
ER Normalized 
IR Normalized 
 
.10 (.02) 
.06 (.02) 
.08 (.03) 
 
.14 (.05) 
.09 (.03) 
.12 (.04) 
 
.14 (.04) 
.10(.02) 
.12 (.03) 
 
2, 28 
2, 28 
2, 28 
 
2.804 
6.627 
3.417 
 
p = .079 
p = .005 
p = .048 
AT Active ROM 
IR (vertebral level) 
Passive ROM 
IR (vertebral level) 
 
T6 (4) 
 
T6 (4) 
 
T9 (2) 
 
T9 (2) 
 
T10 (4) 
 
T10 (4) 
 
2, 28 
 
2, 28 
 
2.632 
 
2.625 
 
p = .091 
 
p = .092 
CP  Active ROM 
IR (vertebral level) 
Passive ROM 
IR (vertebral level) 
ER at 90° ABD (°) 
Pectoralis Minor Length 
Elongated-Resting# 
Elongated-Resting* 
 
T11 (3) 
 
T11 (3) 
65.9 (33.0) 
 
11.5 (5.6) 
8.8 (4.5) 
 
T7 (3) 
 
T7 (3) 
85.4 (11.6) 
 
8.0 (2.6) 
5.8 (2.0) 
 
T10 (4) 
 
T10 (4) 
82.8 (14.6) 
 
10.4 (3.4) 
7.6 (2.6) 
 
2, 28 
 
2, 28 
2, 28 
 
2, 28 
2, 28 
 
3.243 
 
3.148 
2.575 
 
2.545 
2.991 
 
p = .055 
 
p = .060 
p = .095 
 
p = .098 
p = .068 
# - normalized by clavicle length; * - normalized by sternum length; FE – forward elevation; ER -  external rotation; IR – internal rotation; ABD – abduction; 
ILVD – interlimb volume difference; UR – upward rotation; AT – anterior tilt; CP – clavicular protraction 
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Table: Significant results of the Kruskal-Wallis tests for angle-angle graphs for weighted reaching 
(p < .10)* 
 
Rotation Resting Scapular Alignment Variable 
Clavicular Protraction Scapular lies flat against thorax 
 
 
 
Table: Results of the discriminant analysis for angle-angle graphs for weighted reaching 
 
Task Rotation Clinical Variables in 
Discriminant Analysis 
Structure 
Matrix  
Correlations 
Wilks’ 
Lambda 
Canonical 
Correlation 
p value Cross-validation 
classification 
(% correctly grouped) 
W
ei
gh
te
d 
R
ea
ch
in
g 
IR  
Resting PML (C)  
ILVD 
F1 
.90 
-.35 
F2 
.44 
.94 
 
F1 = .655 
F2 = .837 
 
F1 = .47 
F2 = .40 
 
p = .029 
p = .033 
 
69.0 
UR ER muscle strength (N) 1.0 F1 = .662 F1 = .58 p = .005 51.7 
AT Active IR ROM 1.0 F1 = .832 F1 = .41 p = .091 63.3 
CP  
Active IR ROM 
RSA 
Resting-Elongated PML (S) 
 
F1 
.37 
.35 
.36 
F2 
-.86 
.67 
-.04 
 
F1 = .352 
F2 = .992 
 
 
F1 = .80 
F2 = .09 
 
 
p = .000 
p = .097 
 
 
 
55.2 
PML - pectoralis minor length; F1 - function 1 of discriminant analysis; F2 - function 2 of discriminant analysis; IR - internal rotation;  
ER -external rotation; ABD - abduction; ROM - range of motion; ILVD - inter-limb volume difference; UR - upward rotation; AT-  anterior tilt;  
CP - clavicular protraction 
(N) - normalized by body weight; (C) - normalized by clavicle length; (S) - normalized by sternum length; 
RSA - resting scapular alignment variable  “scapula lies flat against thorax” resting scapular alignment 
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Table: Significant results of ANOVAs for relative motion graphs analysis during weighted reaching 
 
Task Rotation Clinical Variable Women with 
Less Motion 
Mean (SD) 
Women with 
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F Ratio p value 
W
ei
gh
te
d 
R
ea
ch
in
g 
IR Active ROM 
FE 
ABD 
Passive ROM 
ABD 
Muscle Strength 
FE_Normalized 
 
144.0 (15.5) 
159.0 (23.7) 
 
158.3 (28.8) 
 
.14 (.04) 
 
144 (12.0) 
155.1 (15.8) 
 
171.6 (6.8) 
 
.13 (.03) 
 
131.4 (14.3) 
129.6 (32.9) 
 
135.3 (38.2) 
 
.10 (.03) 
 
2, 26 
2, 26 
 
2, 25 
 
2, 26 
 
2.651 
3.720 
 
4.319 
 
2.951 
 
p = .091 
p = .039 
 
p = .026 
 
p = .071 
UR Active ROM 
ABD 
ER at 0° ABD 
IR (vertebral level) 
Passive ROM 
ABD 
ER at 0° ABD 
ER at 90° ABD 
IR (vertebral level 
Muscle Strength 
FE_Normalized 
Lymphedema  
      ILVD (%) 
 
154.0 (20.4) 
64.8 (13.1) 
T8 (3) 
 
162.0 (18.8) 
69.1 (11.5) 
84.0 (12.5) 
T8 (3) 
 
.13 (.04) 
 
-1.7 
 
168.5 (11.8) 
68.0 (15.0) 
T7 (1) 
 
177.0 (4.8) 
72.8 (12.0) 
85.9 (7.6) 
T7 (1) 
 
.14 (.01) 
 
6.2 (3.4) 
 
129.3 (35.0) 
50.2 (14.9) 
T11 (5) 
 
132.2 (44.1) 
53.2 (14.7) 
65.1 (34.7) 
T11 (4) 
 
.10 (.02) 
 
1.7 (6.4) 
 
2, 25 
2, 25 
2, 25 
 
2, 24 
2, 25 
 
2, 25 
 
2, 25 
 
2, 25 
 
3.924 
2.702 
2.783 
 
4.241 
3.765 
 
2.646 
 
2.813 
 
4.456 
 
p = .034 
p = .088 
p = .083 
 
p = .028 
p = .038 
 
p = .092 
 
p = .081 
 
p = .023 
CP Muscle Strength 
ER_Normalized 
IR_Normalized 
 
.06 (.02) 
.09 (.02) 
 
 
.09 (.01) 
.11 (.04) 
 
.09 (.02) 
.11 (.04) 
 
2, 26 
2, 26 
 
6.239 
3.097 
 
p = .007 
p = .064 
FE – forward elevation; ER - external rotation; IR – internal rotation; ABD – abduction; UR – upward rotation; CP – clavicular protraction; ILVD: interlimb 
volume difference  
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Table: Significant results of the Kruskal-Wallis tests for relative motion graphs for weighted 
reaching (p < .10)* 
 
Rotation Resting Scapular Alignment Variable 
Upward Rotation Clavicle was horizontal or slightly (10°) elevated 
Anterior Tilt Clavicle was horizontal or slightly (10°) elevated 
Clavicular Protraction Clavicle was horizontal or slightly (10°) elevated 
 
 
 
Table: Results of the discriminant analysis for relative motion graphs for weighted reaching 
 
Task Rotation Clinical Variables in Discriminant 
Analysis 
Structure 
Matrix  
Correlations 
Wilks’ Lambda Canonical 
Correlation 
p value Cross-validation 
classification 
(% correctly grouped) 
W
ei
gh
te
d 
R
ea
ch
in
g 
IR Active ABD ROM# 1.0 F1 = .763 F1 = .49 p = .039 44.4 
 
UR  
Passive ABD ROM 
ILVD 
RSA  
F1 
-.48 
.15 
.53 
F2 
.35 
.92 
-.11 
 
F1 = .285 
F2 = .695 
 
F1 = .77 
F2 = .55 
 
p = .000 
p = .022 
 
 
76.0 
 
 
 
CP ER muscle strength (N) 1.0 F1 = .658 F1 = .59 p = .007 66.7 
 
F1- function 1 of discriminant analysis; F2 - function 2 of discriminant analysis; IR - internal rotation; ABD - abduction; ROM - range of motion;  
ILVD - inter-limb volume difference; (N) - normalized by body weight (kg);  
# - only clinical variable entered due fewer than two nonsingular group covariance matrices when other variables entered into discriminant analysis;  
RSA-  resting scapular alignment variable “the clavicle was either horizontal or elevated by 6°-10° at the acromial end” 
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Appendix D: Internal Rotation and Anterior Tilt Analysis for Un-weighted Reaching 
 
 
 
Table: Significant results of ANOVAs for angle-angle graph analysis during un-weighted reaching 
 
Task Rotation Clinical Variables Women with  
Less Motion 
Mean (SD) 
Women with  
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F ratio p value 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
IR Pectoralis Minor Length 
Resting# 
 
100.3 (8.6) 
 
88.9 (9.5) 
 
94.9 (13.4) 
 
2, 29 
 
2.984 
 
p = .067 
AT Active ROM 
ABD 
ER at 0° ABD 
IR(vertebral level) 
Passive ROM 
ABD 
ER at 0° ABD 
ER at 90° ABD 
IR (vertebral level) 
 
165.8 (19.8) 
70.6 (8.4) 
T7 (4) 
 
174.6 (7.8) 
76.2 (8.2) 
91.2 (4.4) 
T7 (4) 
 
150.9 (21.0) 
64.7 (12.0) 
T9 (3) 
 
159.5 (21.9) 
67.6 (11.3) 
82.6 (11.6) 
T9 (3) 
 
130.8 (36.9) 
50.3 (16.8) 
T12 (4) 
 
133.7 (36.9) 
55.2 (17.7) 
64.0 (34.3) 
T12 (4) 
 
2, 29 
2, 29 
2, 29 
 
2, 29 
2, 29 
2, 29 
2, 29 
 
2.943 
3.873 
2.695 
 
3.399 
3.867 
3.766 
2.547 
 
p = .070 
p = .033 
p = .086 
 
p = .049 
p = .033 
p = .036 
p = .097 
# - normalized by clavicle length; ER -  external rotation; IR – internal rotation; ABD – abduction; AT – anterior tilt 
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Table: Results of the discriminant analysis for angle-angle graphs for un-weighted reaching 
 
Task Rotation Clinical Variables in 
Discriminant Analysis 
Structure 
Matrix  
Correlations 
Wilks’ 
Lambda 
Canonical 
Correlation 
p value Cross-validation 
classification 
(% correctly grouped) 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
IR Resting PML (C) 1.0 F1 = .819 F1 = .43 p = .067 73.3 
 
 
 
 
AT Passive ER at 0° ABD ROM 1.0 F1 = .761 F1 = .49 p = .029 63.3 
 
 
 
 
PML - pectoralis minor length; F1 - function 1 of discriminant analysis; ER - external rotation; ABD - abduction; ROM - range of motion; AT - anterior tilt; (C) - 
normalized by clavicle length  
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Table: Significant results of ANOVAs for relative motion graphs analysis during un-weighted reaching 
 
Task Rotation Clinical Variable Women with 
Less Motion 
Mean (SD) 
Women with 
Normal Motion 
Mean (SD) 
Women with 
More Motion 
Mean (SD) 
df F Ratio p value 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
IR Active ROM 
FE (°) 
ABD (°) 
ER at 0° ABD (°) 
ER at 90° ABD (°) 
IR (vertebral level) 
Passive ROM 
FE (°) 
ABD (°) 
ER at 0° ABD (°) 
ER at 90° ABD (°) 
IR (vertebral level) 
Muscle Strength 
FE (Normalized) 
IR (Normalized) 
Pectoralis Minor Length 
Restingh 
Elongatedh 
Pectoralis Major Flexibility 
Length (°) 
Pain 
Penn Shoulder Subscale 
      Pain with motion 
 
152.3 (4.0) 
170.9 (4.3) 
72.1 (7.9) 
92.7 (8.8) 
T7 (3) 
 
166.3 (6.1) 
174.4 (5.2) 
73.0 (7.0) 
90.5 (2.9) 
T7 (3) 
 
.15 (.03) 
.14 (.03) 
 
9.1 (1) 
10.1 (1.1) 
 
256.8 (8.5) 
 
29.4 (1.1) 
0.0 
 
142.4 (14.6) 
155.5 (18.2) 
62.4 (14.9) 
80.5 (12.0) 
T8 (3) 
 
154.8 (11.0) 
166.0 (19.6) 
69.3 (13.4) 
81.6 (14.4) 
T8 (3) 
 
.13 (.03) 
.11 (.03) 
 
8.4 (.9) 
9.3 (.9) 
 
236.5 (23.1) 
 
27.8 (4.8) 
.8 (1.9) 
 
123.3 (13.3) 
117.4 (25.4) 
55.1 (13.5) 
70.3 (14.3) 
L1 (4) 
 
137.0 (15.9) 
118.7 (28.7) 
54.7 (14.5) 
65.3 (29.7) 
T12 (4) 
 
.08 (.01) 
.08 (.03) 
 
9.7 (1.1) 
10.7 (1.6) 
 
202.3 (42.2) 
 
19.0 (5.5) 
3.4 (2.4) 
 
2, 28 
2, 28 
2, 28 
2, 28 
2, 28 
 
2, 28 
2, 27 
2, 28 
2, 28 
2, 28 
 
2, 28 
2, 28 
 
2, 28 
2, 28 
 
2, 28 
 
2, 28 
2, 28 
 
9.946 
17.155 
3.007 
6.449 
5.685 
 
12.016 
16.751 
3.975 
3.787 
5.481 
 
9.031 
5.597 
 
4.050 
3.628 
 
7.759 
 
12.461 
7.408 
 
p = .001 
p = .000 
p = .067 
p = .005 
p = . 009 
 
p = .000 
p = .000 
p = .031 
p = .036 
p = .01 
 
p = .001 
p = .010 
 
p = .029 
p = .041 
 
p = .002 
 
p = .000 
p = .003 
AT Muscle Strength 
ER (Normalized) 
 
.07 (0.03) 
 
.08 (.02) 
 
.10 (.03) 
 
2, 27 
 
3.029 
 
p = .066 
h - normalized by height; FE – forward elevation; ER -  external rotation; IR – internal rotation; ABD – abduction; AT – anterior tilt  
 
 
147 
  
 
 
 
  
Table: Significant results of the Kruskal-Wallis tests for relative motion graphs for un-weighted 
reaching (p < .10)* 
 
Rotation Resting Scapular Alignment Variable 
Anterior Tilt Scapula lies flat against the thorax 
*: There was no significant differences in resting scapular alignment variables between groups 
classified based on angle-angle graphs 
 
 
Table: Results of the discriminant analysis for relative motion graphs for un-weighted reaching 
 
Task Rotation Clinical Variables in Discriminant 
Analysis 
Structure 
Matrix  
Correlations 
Wilks’ Lambda Canonical 
Correlation 
p value Cross-validation 
classification 
(% correctly grouped) 
U
n-
w
ei
gh
te
d 
R
ea
ch
in
g 
IR  
Passive ABD ROM 
Penn Shoulder Score Pain Subscale 
Pectoralis Major Length 
Resting PML (H) 
IR muscle strength (N) 
F1 
.64 
.54 
.39 
-.29 
.34 
F2 
.24 
.21 
.35 
.25 
.40 
 
F1 = .332 
F2 = .805 
 
F1 = .87 
F2 = .73 
 
p = .000 
p = .002 
 
 
75.0 
 
 
 
 
AT* ER muscle strength (N) 1.0 F1 = .805 F1 = .44 p = .066 46.4 
 
 
* - indicates that resting scapular alignment variable not entered into analysis due to causing fewer than two nonsingular group covariance matrices;  
F1 - function 1 of discriminant analysis; F2 - function 2 of discriminant analysis; IR - internal rotation; ER - external rotation; ABD - abduction;  
ROM-  range of motion; (N): normalized by body weight (kg); AT: anterior tilt
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CHAPTER 4: SUMMARY CHAPTER 
 
 Breast cancer is the most common type of cancer that affects women.1  Due to 
advancements in breast cancer treatment survival rates have improved.1  However, many 
women experience shoulder and arm problems after treatment that negatively impacts 
health related quality of life (HRQoL).2,3  Impaired shoulder motion is a well-
documented problem that some women continue to experience years after treatment.4  
The rationale for impaired shoulder motion amongst breast cancer survivors is 
that these women frequently experience impairments such as soft tissue pain4,5, decreased 
shoulder girdle muscle strength4,5, decreased tissue flexibility6, altered resting scapular 
alignment7,8, and lymphedema4,9.  However, the association between these impairments 
and impaired motion and coordination of the shoulder complex has yet to be supported.  
Furthermore, the current understanding of impaired shoulder motion is limited to 
traditional measures of shoulder motion such as the amount of humeral motion with 
respect to the trunk with little regard to the complex interaction between glenohumeral 
(GH) and scapulothoracic (ST) motion (scapulohumeral coordination). 
 The objective of this dissertation was to determine the effect that breast cancer 
treatment (lumpectomy/radiation and mastectomy/reconstruction) has on shoulder girdle 
motion, shoulder girdle coordination, and select musculoskeletal structures of the 
shoulder.  The rationale for this research is that a better understanding of motion and 
coordination impairments, and the clinical factors associated with these problems may 
lead to improved evidence based examination, intervention, and prevention procedures.  
This in turn may lead to a reduction in the prevalence of shoulder pain and dysfunction, 
which could then lead to improved HRQoL amongst breast cancer survivors.   
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The following two specific aims were addressed in this dissertation: 1) determine 
the effect that breast cancer treatments (lumpectomy and radiation, and mastectomy with 
breast reconstruction) have on motion and coordination of the shoulder complex; 2) 
identify clinical factors associated with impaired coordination of the shoulder complex in 
women with a history of breast cancer treatment.  Chapter 2 (Specific Aim 1) focused on 
determining whether women with history of breast cancer demonstrated group 
differences in shoulder girdle motion (glenohumeral and scapulothoracic) compared to 
women without a history of breast cancer during functional reaching tasks.  Chapter 3 
(Specific Aim 2) focused on identifying the proportion of women with a history of breast 
cancer who demonstrated impaired shoulder girdle coordination.  In order to accomplish 
this, a statistical approach that is novel to the shoulder complex was employed.  The 
statistical approach involved deriving continuous motion angle-angle and relative motion 
graphs with prediction bands.  Additionally, a discriminant analysis procedure was used 
to identify clinical factors that were able to classify women with history of breast cancer 
as having impaired shoulder girdle coordination.  
 
CONCLUSIONS 
The results of the Specific Aim 1 study, reported in Chapter 2, failed to support 
our hypothesis that: 1) women with a history of breast cancer will demonstrate 
impairments in GH and ST motion during functional reaching tasks compared to women 
without a history of breast cancer treatment, 2) women with a history of lumpectomy and 
radiation will demonstrate greater impairments in motion during functional reaching tasks 
when compared to women treated with mastectomy and reconstruction, and 3) women 
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with a history of mastectomy and reconstruction will demonstrate impairments in motion 
during functional reaching tasks compared to women without a history of breast cancer 
treatment.  
 Women with a history of breast cancer had an average (SD) of 141.1° (16.1°) of 
active forward elevation range of motion (ROM), 150.0° (26.1°) of active abduction 
(ABD) ROM, and 81.2° (13.9°) of active external rotation (ER) at 90° ABD ROM.  
Although the amount of forward elevation, ABD, and ER were significantly different 
than women without history of breast cancer [women without history of breast cancer had 
an average (SD) of 148.9° (7.7°) of forward elevation, 164.6° (9.5°) of ABD, and 96.6° 
(10.5°) of ER at 90° ABD], the minimum amount of forward elevation ROM amongst 
women with history of breast cancer was 115°, which is significantly greater than the 85° 
of humerothoracic elevation at which we derived our ST and GH ROM data.  
 The average maximum humerothoracic elevation that women without a history of 
breast cancer achieved during overhead reaching in our study was 117.0° (range 99.8° to 
135.2°).  Women with a history of breast cancer across breast treatments achieved similar 
amounts of humerothoracic elevation (an average of 119.6° of humerothoracic elevation 
and range of 91.7° to 140.0°). The average maximum humerothoracic elevation that was 
achieved during hair combing in women without and with a history of breast cancer was 
113.2° (range 89.7° to 141.8°) and 115.0° (range 89.6° to 133.6°), respectively. This is 
consistent with Rundquist et al 200910, who reported women achieved an average of 119° 
during hair combing.  
 Both groups of women (with and without a history of breast cancer) demonstrated 
similar patterns of ST and GH motion.  Across subjects, the scapula generally upwardly 
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rotated and posteriorly tilted during overhead reaching and hair combing, while the 
clavicle elevated and retracted.  Minimal amounts of ST internal/external rotation 
occurred during all three functional tasks.  The predominant ST and GH motions that 
occurred during all functional tasks were ST upward rotation and GH elevation, 
respectively.  Across all three tasks, women on average demonstrated 17.4° to 19.2° of 
ST upward rotation and 57.0° to 60.0° of GH elevation.   
 Failure to find group differences in motion may be because of the fact that women 
in our study demonstrated relatively low levels of shoulder pain and disability. Only 
46.7% of women with history of breast cancer reported experiencing shoulder pain with 
the average pain ± SD level on the Penn Shoulder Score-Pain Subscale being 26.1 ± 5.8, 
where 30 indicates no pain.  The average Penn Shoulder Score-Function Subscale score 
for women with a history of breast cancer was 51.2 ± 11.7 while women without a history 
of breast cancer average ± SD score was 57.5 ± 4.4, where 60 indicates no functional 
deficits related to the upper extremity.  Review of the Penn Shoulder Score responses 
revealed that items which were similar to the tasks women performed in our study were 
performed “without difficulty” for the majority of our subjects with a history of breast 
cancer. Only 6 out of 30 women with a history of breast cancer reported at least “some 
difficulty” related to combing hair (item 5). Seven out of 30 women with history of breast 
cancer reported at least “some difficulty” with reaching a shelf above head (item 14), and 
8 out of 30 reported at least “some difficulty” with placing a soup can (1-2 lb.) on a shelf 
overhead (item 15). All of the women with a history of breast that reported at least “some 
difficulty” were treated with lumpectomy and radiation, and not a single woman treated 
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with mastectomy and reconstruction reported difficulty with combing hair, reaching a 
shelf, or placing a soup can overhead.   
Of interest is the finding that a significant correlation existed between women 
with a history of breast cancer’s Penn Shoulder Score-Pain Subscale scores and 
glenohumeral external rotation during un-weighted reaching (r = .57, p < .05) and weight 
reaching (r = .48, p < .05), scapulothoracic upward rotation ROM during un-weighted 
reaching (r = .36, p < .05), and clavicular retraction ROM during hair combing (r = .37, p 
< .05).  Penn Shoulder Score-Function Subscale scores were significantly correlated with 
glenohumeral external rotation ROM during un-weighted (r = .57, p < .05) and weighted 
reaching (r = .53, p < .05). For all subjects (women with and without a history of breast 
cancer), there was a significant correlation between Penn Shoulder Score-Pain Subscale 
scores and scapulothoracic upward rotation ROM during un-weighted reaching (r = .31, p 
= .02), hair combing (r = .30 p = .02), and clavicular retraction ROM during hair combing 
(r = .29, p = .02).  Penn Shoulder Score-Function Subscale scores were significantly 
correlated with glenohumeral external rotation during un-weighted (r = .30, p = .02) and 
weighted reaching (r = .28, p = .03). This suggests that findings from the Penn Shoulder 
Score may be useful for helping clinicians determine which shoulder complex motions 
should be a focus of their examination. The relationship between shoulder pain and 
disability as measured by a functional outcome score and motion of the shoulder complex 
in women with a history of breast cancer warrants further investigation.   
 Relatively low shoulder pain and disability scores were reported by women in our 
study. This may be due to the fact that 73.3% reported being educated on a home exercise 
program, which women reported being approximately 65.9% adherent to, and 56.7% 
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reported attending physical therapy for an average of 7.5 visits. Home exercise program 
education and performance may also have contributed to the lack of motion differences 
between these groups. This point needs to be systematically examined in prospective 
studies. 
 Although we did not find group differences between women with and without a 
history of breast cancer in the amount of ST and GH motion across functional tasks, 
findings from the study conducted in Chapter 3 indicate that the majority women with a 
history of breast cancer demonstrate impaired scapulohumeral coordination.  In Chapter 3 
we used a statistical approach and continuous kinematic data to derive angle-angle and 
relative motion graphs along with predication bands.  Individually comparing the 
movement patterns of a woman with a history of breast cancer to a population of women 
without a history of breast cancer allowed for the identification of the proportion of 
women with impaired scapulohumeral coordination during overhead reaching tasks.  
Analysis of angle-angle and relative motion graphs revealed that over 93% of women 
with history of breast cancer demonstrated impaired scapulohumeral coordination during 
un-weighted and weighted reaching.   
 Although differences in the absolute position of the scapula (angle-angle graphs) 
and relative motion of the scapula or clavicle compared to motion of the humerus 
(relative motion graphs) were found between women with and without a history of breast 
cancer, which scapular or clavicular rotation was impaired [i.e. clavicular protraction 
(CP), scapular upward rotation (UR), etc.) and the impairment direction  (i.e. more or less 
motion) varied between subjects.  This is not surprising because women with a history of 
breast cancer may or may not experience a different number of impairments (soft tissue 
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pain4,5, decreased shoulder girdle muscle strength4,5, decreased tissue flexibility6, altered 
resting scapular alignment7,8, and lymphedema4,9) that can influence scapulohumeral 
coordination.11  However, a number of clinical variables were associated with normal, 
more, or less relative scapular and clavicular motion. ABD ROM was the only clinical 
variable, across multiple scapular and clavicular rotations, that was able to classify 
women with a history of breast cancer into normal, more, or less relative motion during 
un-weighted reaching.  Our findings revealed that women with less ABD demonstrated 
more relative scapulothoracic UR and CE during un-weighted reaching.  Women with 
more relative CE had an average (SD) of 115.7° (51.7°) of passive ABD, while women 
with normal relative CE had an average of 170.6° (8.7°) and women with less relative CE 
had an average of 155.8° (28.0°) of passive ABD.  Women with more relative upward 
rotation had an average (SD) of 108.7° (31.0°) of active ABD, while women with normal 
and less relative UR had an average (SD) of 158.2° (21.3°) and 151.8° (22.4°), 
respectively.  
 The clinical variables that were associated with impaired scapulohumeral 
coordination were dependent on whether the absolute position of the scapula or relative 
motion of the scapula was impaired.  For example, shoulder ER ROM and pectoralis 
minor length were associated with an impairment in the anterior/posterior absolute 
position of the scapula (clavicular protraction) on the thorax during overhead reaching. 
However, isometric shoulder force production (IR during un-weighted reaching) was 
associated with impaired relative motion of the scapula (clavicular protraction) compared 
to the humerus during overhead reaching.  Finally, clinical factors associated with 
impaired scapulohumeral coordination were dependent on which scapular or clavicular 
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rotation was impaired.   For example during un-weighted reaching, impaired relative UR 
was associated with active shoulder ABD ROM and % inter-limb volume difference 
while as previously mentioned impaired relative CP was associated with measures of 
muscle strength.  
   
SUMMARY OF MODIFICATIONS 
Recruitment Strategy and Eligibility Criteria Modifications 
 The initial plan was to recruit 75 women (25 women treated with lumpectomy and 
radiation, 25 women treated with mastectomy and reconstruction, and 25 women without 
history of breast) to participate in the study.  Despite concerted efforts, subject 
recruitment was difficult even though a number of recruitment strategy modifications 
were made.  Funding was obtained from the American Physical Therapy Association 
Oncology Section and University of Pennsylvania Transdisciplinary Research on 
Energetics and Cancer (TREC) Center to compensate subjects for time and travel, and 
support subject recruitment.  Funding was initially used to support the Recruitment 
Outcome Assessment Resource (ROAR) within the Hospital of the University of 
Pennsylvania Health System (UPHS). ROAR assisted with recruitment by reviewing 
medical records, sending letters to potentially eligible women, and contacting women via 
telephone.  Over an 8-month period only 2 subjects were enrolled at which time their 
services were discontinued.  Funds were then used to support research staff within UPHS 
to assist with recruitment.  The research assistant was responsible for reviewing physician 
schedules and medical records to identify potentially eligible women, and to approach 
women in the clinic to determine whether they would be interested in participating in the 
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study.  Over a 7-month period an additional 20 subjects were enrolled. At this time all 
remaining recruitment funds had been utilized.  Throughout this 15 month recruitment 
period other strategies included recruitment from; 1) local oncologists’ offices, 2) local 
physical therapy clinics, 3) personal contact and 4) advertising sources such as Craig’s 
List and the Metro. These efforts led to the enrollment of 8 additional women with 
history of breast cancer.  In total, we enrolled 30 women with history of breast cancer (10 
mastectomy/reconstruction and 20 lumpectomy/radiation) in a 25-month time period.  In 
order to have equal numbers of women with and without breast cancer, we increased the 
number of women without breast cancer to 30.  We also modified our eligibility criteria 
for women with a history of breast cancer.  The initial plan was to recruit women 30-70 
years of age who were 1 to 3 years post-surgery.  The age range was modified to 30 – 75 
years and time since surgery was modified to 1 to 5 years. 
 A total of 134 women with a history of breast cancer were assessed for eligibility 
for this dissertation.  A total of 39 women did not meet the inclusion/exclusion criteria, 
and 65 women declined to participate.   Reasons for women not wishing to participate 
included already being enrolled in a number of research studies, too many medical 
appointments, and the distance from their home to our research lab.  A number of women 
commented they would have been interested in participating if testing could have been 
completed at the same location and time of their medical appointment.  This was not 
possible because the equipment used in this dissertation to measure shoulder complex 
motion and coordination was not portable.  
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Subjects Modification 
 A total of 60 women participated in the study (10 mastectomy and reconstruction, 
20 lumpectomy and radiation, and 30 without history of breast cancer).  As previously 
stated, the initial plan was to enroll 25 women treated with lumpectomy and 25 women 
treated with mastectomy and reconstruction.  Our inability to enroll the 50 women with 
history of breast cancer caused us to modify the statistical analysis in Chapter 2.  Because 
an equal number of women with and without a history of breast cancer participated in the 
study, statistical analyses were performed to determine whether differences in ST and GH 
motion existed between women with and without a history of breast cancer during 
overhead reaching and combing hair tasks.  In order to determine the effect that different 
breast cancer treatments (lumpectomy and radiation, and mastectomy with breast 
reconstruction) have on ST and GH motion (Aim 1a and 1b), we chose to perform the 
statistical analyses using data from an equal number (10 per group) of women treated 
with mastectomy/reconstruction, lumpectomy/radiation, and women without a history of 
breast cancer within the same age range (30-50 years or 50+ years) and BMI (normal, 
overweight, obese) category.  Reducing our sample size resulted in low statistical power 
(power < .49 for two group comparison and power < .39 for three group comparison).  
However, we found small group differences in ST and GH motion between groups.  The 
largest group mean difference for ST and GH motion was 3.8° of ST posterior tilt and 
8.2° of GH adduction, respectively.  Even if we were able to recruit enough subjects to 
achieve power of .80, these differences have questionable meaningfulness because they 
fail to exceed minimal detectable change 95% (MDC95%) values established in our lab on 
a separate group of 19 healthy subjects [13 females; 24.5 ± 3.9 years].  The MDC95% 
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values for ST posterior and GH adduction from a separate study were as high as 4.4° and 
8.6°, respectively.  
 
Modification to Definition of Impaired Shoulder Motion and Coordination 
 In order to classify women with breast cancer as has having impaired 
scapulohumeral coordination, our initial plan was to divide the angle-angle and relative 
motion graphs into 4 phases of movement: 0%-24%, 25%-50%, 51%-75%, and 76%-
100%.  Women were to be considered to have impaired scapulohumeral coordination if a 
single rotation’s movement patterns fell outside the MDCB95% for at least 2 of the 4 
entire phases, or at least 2 rotations fell outside the MDCB95% for at least 1 entire phase.  
However, it became apparent that if this definition was used, a woman could have been 
classified as having normal motion even if one of her rotation patterns fell outside the 
MDCB95% from 5% -24%, 25%-50%, and 51%-70% of the movement.  With this 
scenario, a woman would have been classified has having normal coordination since her 
movement pattern would have only fell outside of the MDCB95% for only 1 entire phase 
(25-50%).   Therefore, due to the novelty of using MDCBs to classify movement 
patterns, we decided to use a more liberal approach to our classification system.  We 
considered a woman with history of breast cancer as having impaired scapulohumeral 
coordination if her curve fell outside the MDCB95% for greater than 10% of the 
movement during the raising or lowering phases of arm movement.  This decision was 
based on the fact that the prediction bands used to classify a movement pattern were 
based on the 95% confidence interval associated with minimal detectable change values.  
Using this approach allowed us to state, with 95% confidence that a true difference 
  
 
167 
existed between movement patterns of a woman with a history of breast cancer and 
women without a history of breast cancer at the particular data point(s) where the women 
with breast cancer’s curve fell outside of the prediction band.  The rationale for selecting 
10 data points outside of the prediction band as the cut point for classifying a movement 
pattern as being impaired was our intent to reduce the risk of type I error.  
 Our initial plan was to simply classify women as having normal or impaired 
scapulohumeral coordination.  Once again it became apparent that more than one type of 
impaired scapulohumeral coordination pattern could occur.   It was noted that some 
motion curves from women with a history of breast cancer fell above the upper boundary 
of the prediction band while others fell below the lower boundary of the prediction band.  
This information was felt to be of value for investigating the association between clinical 
factors and impaired scapulohumeral coordination so we decided to classify women as 
having normal (curve fell within MDCB95%), more (curve fell outside the upper limit of 
the MDCB95%), or less  (curve fell outside the lower limit of the MDCB95%) motion. 
 
 Statistical Analysis Modification 
  The initial plan was to use binary logistic regression to identify clinical factors 
associated with impaired scapulohumeral coordination. However, with the change in the 
approach to classify women into three groups, (normal, more, or less motion) a binary 
logistic regression was no longer appropriate.   Therefore, a discriminant analysis was 
used to determine relationships between clinical factors and whether women with history 
of breast cancer demonstrated normal, more, or less motion.  Discriminant analysis is 
similar to logistic regression in that discriminant analysis can be used to assess the 
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relationship between multiple independent variables and a categorical variable.  While 
the dependent variable with binary logistic regression can only have two levels, the 
dependent variable in discriminant analysis can have multiple levels.  
 
LIMITATIONS AND FUTURE STUDIES 
 An electromagnetic device (LibertyTM, Polhemus, Colchester, Vermont) was used 
to collect continuous kinematic data of the scapula and humerus.  This approach required 
sensors to be secured to the subjects skin. Surface sensors have been shown to be 
accurate for measuring GH and ST motion.12,13  However, measurement error may occur 
secondary to skin motion artifact and/or difficulty palpating bony landmarks, which is an 
important step in the digitization process.  A larger amount of measurement error has 
been found in individuals with a body mass index greater than 25.12  It should be noted 
that 60% of the women with a history of breast cancer had a BMI in excess of 25.  
 The functional tasks that women were asked to perform were overhead reaching, 
weighted (0.9 kg) overhead reaching, and hair combing.  These tasks place fairly low 
demands on the shoulder complex since they are not performed at end ranges of motion 
and do not require significant force to complete.  Additionally, only 5 repetitions of each 
task were performed.  The effect that higher demanding tasks and/or a greater number of 
repetitions might have on scapulothoracic and glenohumeral motion is worthy of further 
investigation.  
 In order to determine the effect that breast cancer treatments (lumpectomy and 
radiation, and mastectomy with breast reconstruction) have on shoulder complex motion 
and coordination the kinematic data from the affected sides of women with history of 
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breast cancer (n = 30) were compared to age and BMI matched women without a history 
of breast cancer (n = 30).  Age and BMI may be confounding factors when investigating 
differences in shoulder complex motion and coordination due to their association with 
shoulder complex kinematic variables.   In this dissertation, there were significant 
correlations between age and resting position of the humerus, and between BMI and 
resting position of the humerus and scapula (Table 1).  There were also significant 
correlations between BMI and ST and GH motion at the maximum humeral elevation 
angle that women achieved during the un-weighted reaching task (Table 1). The 
maximum humeral elevation angles that women achieved during un-weighted reaching 
were inversely associated with age supporting the notion that range of motion declines as 
women age (Table 1). It should also be noted that there was a significant correlation 
between age and BMI (r = .31), indicating that being older was associated with a higher 
BMI.   
Although women in this dissertation were matched by age and BMI, assessing the 
differences in kinematic data between the affected and unaffected sides of women with a 
history of breast cancer and left and right sides of women without a history of breast 
cancer would be important to clearly show changes in motion and coordination of the 
shoulder complex after treatment for breast cancer.  Comparing these differences between 
sides would be less affected by age or soft tissue artifact, since these factors would affect 
both sides in a similar way.14 However, it should be noted that comparing unilateral 
shoulder complex motion between groups of subjects is common amongst shoulder 
research studies.14-18  
In Chapter 2, we performed statistical analyses using data from an equal number 
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of women within each group (10 per group) because of the unequal number of women 
treated with mastectomy/reconstruction (n = 10), lumpectomy/radiation (n = 20), and 
women without a history of breast cancer (n = 30). Subjects in the lumpectomy/ radiation 
and control group were selected to ensure that comparison was made within the same age 
range (30-50 years or 50+ years) and BMI category (normal, overweight, obese).  
Although the effect of hand dominance on scapular kinematics is contradictory19-23, it 
should be noted that we attempted to match women treated with lumpectomy/radiation 
and women treated with mastectomy/reconstruction by whether the affected side was the 
dominant or non-dominant side.  Of the 10 women, 6 were matched by whether the 
affected side was the dominant or non-dominant side. 
 A potential limitation of this study was the method by which prediction bands 
were calculated.  Prediction bands used in this dissertation were based on minimal 
detectable change 95% (MDCB95%). MDCB95% may underestimate the variability in 
normal movement thereby reducing the “coverage probability” of the band, which may 
have led to women with history of breast cancer being falsely classified has having 
impaired coordination.24 Other methods such as ±1 standard deviations, ±1.7 standard 
deviations, and Bootstrap have been used to capture movement variability.24, 25 
 Another limitation of this study was that not all clinical factors that may influence 
scapulohumeral coordination were assessed.  For example, we did not measure serratus 
anterior or trapezius muscle strength.  These muscles have been shown to play an 
important role in the production and control of scapular upward rotation.26 Other muscle 
performance measures such as endurance or electromyography activity were not included 
in this dissertation as well.  Future studies should consider scapulothoracic muscle 
  
 
171 
strength measures along with other measures of shoulder muscle performance.  
 Finally, the measure of pectoralis major flexibility used in this dissertation was 
based on a computer simulation model and the validity of the measure has yet to be 
supported.27  Women with history of breast cancer may experience decreased pectoralis 
major flexibility due to pectoralis muscle trauma that may occur from surgery.   A 
window may be made in the pectoralis muscle and underlying rib to access circulation 
during a free flap breast reconstruction procedure, or the pectoralis major may be used to 
create a submuscular pouch during a breast implant reconstruction procedure.27  Impaired 
pectoralis major flexibility may be due to women limiting arm motion secondary to pain 
or fear of complications and resultant protective posturing.28 Additionally, radiation 
therapy has been shown to alter collagen synthesis29-31, and cause soft tissue fibrosis 
affecting the flexibility of tissues within the radiation field contributing to impaired 
motion.31-33 A valid and reliable clinical measure of pectoralis major flexibility would be 
a valuable assessment tool for the breast cancer population. 
 
IMPLICATIONS FOR REHABILITATION 
 Rehabilitation professionals routinely include assessment of shoulder ABD ROM 
as part of their clinical examination.   Findings from these studies show that less ABD 
ROM is associated with more relative CE and UR during overhead reaching.  This 
suggests that women who demonstrate less shoulder ABD ROM use compensatory 
shoulder girdle movement strategies during overhead reaching.  Increasing the amount of 
CE and UR may increase the overall amount of arm elevation in order to position the 
hand in space to perform functional activities. Another relevant finding is that clinical 
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measures of pectoralis minor length were associated with impaired CP during overhead 
reaching.  This highlights the importance of including measures of flexibility when 
evaluating women with a history of breast cancer.  Understanding that measures of 
shoulder ROM and flexibility are associated with specific patterns of impaired 
scapulohumeral coordination will allow clinicians to design interventions aimed at 
restoring normal scapulohumeral coordination. It is our hope that this will, in turn, help to 
maximize functional abilities and reduce the risk of shoulder pain and dysfunction in 
women with a history of breast cancer.   
 
SUMMARY 
 Previous studies have shown that women with history of breast cancer 
demonstrate impaired scapulothoracic motion post-operatively.14-18  However, significant 
differences in scapulothoracic motion between women with and without a history of 
breast cancer during a series of functional tasks were not found in this dissertation. 
Results of this dissertation did show that the majority of women with a history of breast 
cancer demonstrate impaired scapulohumeral coordination with respect to the absolute 
position of the scapula and relative motion of the scapula with respect to the humerus. 
However, which scapular or clavicular rotation was impaired (i.e. CP, scapular UR, etc) 
and direction of impairment (i.e. more or less motion) varied between subjects.  This is 
not surprising since women with a history of breast cancer may or may not experience a 
different number of impairments (soft tissue pain4,5, decreased shoulder girdle muscle 
strength4,5, decreased tissue flexibility6, altered resting scapular alignment7,8, and 
lymphedema4,9) that can influence scapulohumeral coordination.11 The impairments or 
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clinical factors that were associated with impaired scapulohumeral coordination were 
dependent on whether the absolute position of the scapula or relative motion of the 
scapula was impaired along with which scapular or clavicular rotation was impaired.  The 
results of this dissertation highlight impairments to be screened for and addressed by 
rehabilitation professionals in order to restore typical shoulder complex coordination.  
Both are important steps towards reducing the risk for developing musculoskeletal 
shoulder pathologies, reducing disability, and maximizing HRQoL.  
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Table 1: Pearson correlation coefficients for the relationship between age and body mass index and humeral 
and scapular kinematic variables. 
 
 
 
Kinematic 
Rotation 
Resting 
Position 
Maximum Angle 
during 
Un-weighted 
Reaching 
Range of Motion 
during Un-weighted 
Reaching# 
Age BMI Age BMI Age BMI 
HT Ele .38** .69** -.27* -.21 -.41** -.55** 
 
 
ST 
IR .15 .20 .25 .29* .24 .25 
UR -.15 -.27* -.03 -.00 .10 .25 
PT .35** .46** .25 .27* -.02 -.11 
CE .13 .25 .14 .12 .03 -.13 
CR -.02 .10 -.16 -.33* -.13 -.38** 
 
GH 
Ele .17 .44** -.32* -.36** -.42** -.62** 
Add .29* .37** .37** .57** .21 .39** 
IR -.27* -.52** 0.16 0.11 .37** .57** 
ST: scapulothoracic; GH: glenohumeral; IR: internal rotation; ER: external rotation; UR: upward rotation; 
PT: posterior tilt; CE: clavicular elevation; CR: clavicular retraction; Elv: elevation; Add: adduction; LR:  
lumpectomy/radiation; MR: mastectomy/reconstruction 
 
# - maximum – resting; * - significant at .05; ** - significant at .01 
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